[
    {
        "Mutation ID":"MUT0001",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q65.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6256C>C",
        "Protein Change":"p.Arg424Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003879%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92088640",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0002",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q33.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1873G>G",
        "Protein Change":"p.Gly201Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00606%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58351806",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0003",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q50.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.963G>G",
        "Protein Change":"p.Gln143Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007303%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41730106",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0004",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q93.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4004C>C",
        "Protein Change":"p.Leu261Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00457%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14990870",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0005",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q38.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2365T>A",
        "Protein Change":"p.Gln136Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003388%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59786424",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0006",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q13.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2439G>A",
        "Protein Change":"p.Arg409Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006154%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74374893",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0007",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q96.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4563T>G",
        "Protein Change":"p.Arg370Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002169%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91786536",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0008",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q52.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5192C>T",
        "Protein Change":"p.Ser224Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00345%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82531897",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0009",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q87.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2701T>G",
        "Protein Change":"p.Arg417Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000172%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12874316",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0010",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q83.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4528T>A",
        "Protein Change":"p.Ser388Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009263%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11524659",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0011",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q25.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4817G>G",
        "Protein Change":"p.Gly492Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007776%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82694118",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0012",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q83.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.901G>A",
        "Protein Change":"p.Gln434Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006107%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78121735",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0013",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q30.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5083T>C",
        "Protein Change":"p.Ser493Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007392%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92945052",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0014",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q65.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4085C>A",
        "Protein Change":"p.Pro199Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004221%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67986836",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0015",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q17.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7141C>G",
        "Protein Change":"p.Gln292Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003794%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28283412",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0016",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q8.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.163T>A",
        "Protein Change":"p.Gln312Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004268%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57220088",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0017",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q96.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8332G>A",
        "Protein Change":"p.Gly74Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007236%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39013756",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0018",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q80.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6669A>T",
        "Protein Change":"p.Gln245Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009023%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74120652",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0019",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q80.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8442T>A",
        "Protein Change":"p.Gln181Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00323%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80018555",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0020",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q45.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9612A>G",
        "Protein Change":"p.Ser147Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001113%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39372677",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0021",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q40.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2294A>A",
        "Protein Change":"p.Ser292Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002905%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51843632",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0022",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q90.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3555T>T",
        "Protein Change":"p.Pro111Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006789%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69775763",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0023",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q1.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.910C>A",
        "Protein Change":"p.Gly195Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00565%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66385785",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0024",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q52.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1955G>T",
        "Protein Change":"p.Pro241Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006476%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35097726",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0025",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q68.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5261C>G",
        "Protein Change":"p.Arg211Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006766%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23815862",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0026",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q11.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5505C>A",
        "Protein Change":"p.Arg146Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001899%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27534093",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0027",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q15.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8029C>A",
        "Protein Change":"p.Leu226Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004057%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64076230",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0028",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q94.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3632C>C",
        "Protein Change":"p.Gly344Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008912%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33964009",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0029",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q29.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.720A>T",
        "Protein Change":"p.Pro18Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004233%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32225289",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0030",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q93.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2598A>A",
        "Protein Change":"p.Leu250Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000821%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92270617",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0031",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q29.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4570G>C",
        "Protein Change":"p.Gly323Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004283%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91251089",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0032",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q44.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5798A>C",
        "Protein Change":"p.Pro68Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00381%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17856022",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0033",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q12.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4986G>T",
        "Protein Change":"p.Arg216Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002404%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35667766",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0034",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q43.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7739T>T",
        "Protein Change":"p.Gln69Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004306%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31945358",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0035",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q25.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3181A>C",
        "Protein Change":"p.Gly20Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001446%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89998876",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0036",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q68.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8727C>G",
        "Protein Change":"p.Leu230Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004145%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:27710901",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0037",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q79.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6502G>T",
        "Protein Change":"p.Leu170Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002528%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49048593",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0038",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q99.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1908A>C",
        "Protein Change":"p.Arg246Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002066%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36572179",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0039",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q5.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5597G>T",
        "Protein Change":"p.Ser303Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001092%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99339765",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0040",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q90.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7151C>T",
        "Protein Change":"p.Pro373Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009357%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71767349",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0041",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q29.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4270T>G",
        "Protein Change":"p.Leu239Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003231%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22140560",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0042",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q61.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7646A>G",
        "Protein Change":"p.Leu193Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005742%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29880281",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0043",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q45.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.662C>C",
        "Protein Change":"p.Leu1Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007547%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90631027",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0044",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q57.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4812T>G",
        "Protein Change":"p.Ser436Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008443%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28618758",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0045",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q30.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2589A>A",
        "Protein Change":"p.Gln150Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004297%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66918396",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0046",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q44.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7584G>G",
        "Protein Change":"p.Pro75Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000475%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86831563",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0047",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q10.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8404G>G",
        "Protein Change":"p.Ser36Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002046%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60790468",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0048",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q65.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7395G>T",
        "Protein Change":"p.Pro52Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004891%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56382097",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0049",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q47.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7487A>C",
        "Protein Change":"p.Arg155Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006927%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27671365",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0050",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q52.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1016G>G",
        "Protein Change":"p.Arg298Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00103%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78786701",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0051",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q93.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5446G>C",
        "Protein Change":"p.Leu170Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00079%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25468369",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0052",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q48.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5409C>T",
        "Protein Change":"p.Pro438Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008091%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18007375",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0053",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q69.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1177A>T",
        "Protein Change":"p.Gly10Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00245%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70974305",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0054",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q78.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8694T>G",
        "Protein Change":"p.Leu93Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008918%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70382777",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0055",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q2.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9059T>T",
        "Protein Change":"p.Gln67Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009038%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20309029",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0056",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q22.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9075G>T",
        "Protein Change":"p.Gln379Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008274%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54593210",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0057",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q95.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3870A>T",
        "Protein Change":"p.Gln488Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00909%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31392415",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0058",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q67.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8651T>T",
        "Protein Change":"p.Gly282Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004481%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89807596",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0059",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q7.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7180C>G",
        "Protein Change":"p.Gly115Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001665%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32103556",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0060",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q89.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3939C>G",
        "Protein Change":"p.Leu166Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003982%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43546615",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0061",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q10.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3549G>C",
        "Protein Change":"p.Arg294Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006129%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70775166",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0062",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q38.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9099T>G",
        "Protein Change":"p.Arg60Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32629934",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0063",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q67.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2730T>A",
        "Protein Change":"p.Ser417Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006627%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94552541",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0064",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q40.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3849A>T",
        "Protein Change":"p.Arg229Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005072%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36497982",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0065",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q56.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4170A>G",
        "Protein Change":"p.Arg39Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001382%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14755142",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0066",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q83.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6803T>C",
        "Protein Change":"p.Ser397Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007312%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92332157",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0067",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q63.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7348G>T",
        "Protein Change":"p.Gln89Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009112%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15847213",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0068",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q8.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7333C>C",
        "Protein Change":"p.Pro185Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00552%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36178735",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0069",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q40.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5429A>T",
        "Protein Change":"p.Gln358Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008622%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54750347",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0070",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q82.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7020A>A",
        "Protein Change":"p.Arg165Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004262%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29051092",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0071",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q8.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4518G>T",
        "Protein Change":"p.Ser198Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00773%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86654622",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0072",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q73.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5847G>A",
        "Protein Change":"p.Gly379Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000865%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62110495",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0073",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q93.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7835C>G",
        "Protein Change":"p.Gln198Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00024%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71684560",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0074",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q99.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.508G>G",
        "Protein Change":"p.Pro31Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008686%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48137784",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0075",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q69.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1684A>C",
        "Protein Change":"p.Arg261Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004837%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68464013",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0076",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q87.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5025C>T",
        "Protein Change":"p.Arg198Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007487%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60893019",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0077",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q42.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9856A>T",
        "Protein Change":"p.Gly141Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007776%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63722281",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0078",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q69.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7861G>T",
        "Protein Change":"p.Leu163Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001561%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65274230",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0079",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q51.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6528A>C",
        "Protein Change":"p.Gly151Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004887%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98728826",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0080",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q72.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3345T>G",
        "Protein Change":"p.Leu351Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008524%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31052024",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0081",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q24.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7703A>A",
        "Protein Change":"p.Ser157Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000629%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87277093",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0082",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q28.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5983G>T",
        "Protein Change":"p.Gly171Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002913%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:57785946",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0083",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q20.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6015A>T",
        "Protein Change":"p.Pro217Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006877%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45326722",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0084",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q37.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2962C>G",
        "Protein Change":"p.Arg223Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004842%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88558291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0085",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q40.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8365C>A",
        "Protein Change":"p.Gly62Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003588%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79901751",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0086",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q45.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.638T>C",
        "Protein Change":"p.Arg251Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004468%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80791386",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0087",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q77.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5507T>A",
        "Protein Change":"p.Arg142Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003572%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39000151",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0088",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q63.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2261T>G",
        "Protein Change":"p.Arg88Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007053%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52742667",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0089",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q88.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6432T>T",
        "Protein Change":"p.Pro47Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004061%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20908094",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0090",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q30.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7444A>C",
        "Protein Change":"p.Arg56Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006583%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81550827",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0091",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q39.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6456C>G",
        "Protein Change":"p.Gly397Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001099%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62902340",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0092",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q1.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8407A>T",
        "Protein Change":"p.Arg377Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004786%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98080583",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0093",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q16.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8011A>T",
        "Protein Change":"p.Arg480Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002161%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75915335",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0094",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q74.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.255C>C",
        "Protein Change":"p.Pro398Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005754%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98781776",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0095",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q41.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4661T>G",
        "Protein Change":"p.Gly37Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005476%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98367271",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0096",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q49.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9982G>C",
        "Protein Change":"p.Ser119Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00828%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94981611",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0097",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q59.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4604T>C",
        "Protein Change":"p.Leu70Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000935%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78018662",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0098",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q62.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8232C>A",
        "Protein Change":"p.Leu12Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002363%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71086907",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0099",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q43.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4243A>G",
        "Protein Change":"p.Leu424Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001411%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95935069",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0100",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q36.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6672G>T",
        "Protein Change":"p.Gln315Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003697%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95552313",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0101",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q23.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2877A>A",
        "Protein Change":"p.Pro80Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000434%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34625955",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0102",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q91.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8020G>T",
        "Protein Change":"p.Gly87Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000847%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80189888",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0103",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q62.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5006C>T",
        "Protein Change":"p.Leu72Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004473%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90901793",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0104",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q44.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9661C>G",
        "Protein Change":"p.Arg1Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009998%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53132755",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0105",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q45.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6685C>A",
        "Protein Change":"p.Leu130Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00723%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16112532",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0106",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q52.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5104A>A",
        "Protein Change":"p.Gly121Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002091%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73027119",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0107",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q82.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4643A>T",
        "Protein Change":"p.Leu11Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000136%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70998660",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0108",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q84.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8483G>C",
        "Protein Change":"p.Ser483Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004354%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64394133",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0109",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q22.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1396T>A",
        "Protein Change":"p.Arg147Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008981%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52394113",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0110",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q64.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3533G>C",
        "Protein Change":"p.Leu120Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008748%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80619772",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0111",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q9.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2179G>C",
        "Protein Change":"p.Gln207Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007354%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15520123",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0112",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q5.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8217T>T",
        "Protein Change":"p.Leu397Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006731%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66119521",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0113",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q59.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4342G>G",
        "Protein Change":"p.Leu329Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00322%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22189866",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0114",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q54.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.845C>G",
        "Protein Change":"p.Gln402Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00615%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28776377",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0115",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q18.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4015G>T",
        "Protein Change":"p.Ser14Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004783%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62104768",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0116",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q35.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1716G>G",
        "Protein Change":"p.Gly28Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004979%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72996712",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0117",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q17.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1642G>T",
        "Protein Change":"p.Ser450Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005243%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43781143",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0118",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q27.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8502G>A",
        "Protein Change":"p.Gln422Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006415%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17641684",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0119",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q19.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3566T>A",
        "Protein Change":"p.Gln451Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008657%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72345373",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0120",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q5.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3374G>T",
        "Protein Change":"p.Gly48Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009939%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42911329",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0121",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q33.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6214G>C",
        "Protein Change":"p.Ser310Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000344%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16975905",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0122",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q43.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2780T>C",
        "Protein Change":"p.Gln26Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008544%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84022001",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0123",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q50.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6563T>C",
        "Protein Change":"p.Gln455Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000423%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38345160",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0124",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q40.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4933G>A",
        "Protein Change":"p.Ser360Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008559%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21358540",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0125",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q46.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8663T>G",
        "Protein Change":"p.Gln28Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003657%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79540732",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0126",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q27.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8843A>G",
        "Protein Change":"p.Pro418Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00274%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33337193",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0127",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q81.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2468C>T",
        "Protein Change":"p.Arg484Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005502%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74432495",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0128",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q68.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1145T>C",
        "Protein Change":"p.Arg125Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006162%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53992093",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0129",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q3.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6216T>C",
        "Protein Change":"p.Gly462Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000166%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23990357",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0130",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q20.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4166G>C",
        "Protein Change":"p.Gly500Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007576%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29330693",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0131",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q91.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8694G>T",
        "Protein Change":"p.Pro147Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001574%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82073229",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0132",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q71.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.930G>G",
        "Protein Change":"p.Arg107Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007798%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82714371",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0133",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q27.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9305G>T",
        "Protein Change":"p.Ser458Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009715%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79342097",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0134",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q86.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1057A>C",
        "Protein Change":"p.Gln192Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00047%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44311903",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0135",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q9.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4269G>A",
        "Protein Change":"p.Ser476Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000867%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87663997",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0136",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q20.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7154G>A",
        "Protein Change":"p.Leu53Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004039%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28442401",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0137",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q33.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5475G>A",
        "Protein Change":"p.Gly71Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009983%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94336371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0138",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q5.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1263A>T",
        "Protein Change":"p.Pro435Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00465%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57376362",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0139",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q63.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.960G>A",
        "Protein Change":"p.Arg491Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007692%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77473060",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0140",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q85.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8597A>C",
        "Protein Change":"p.Leu289Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005787%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96272825",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0141",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q43.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.391C>T",
        "Protein Change":"p.Gln497Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000198%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47725004",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0142",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q63.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1174T>A",
        "Protein Change":"p.Gln142Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000621%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32956106",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0143",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q22.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3259A>C",
        "Protein Change":"p.Ser99Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005532%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76294183",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0144",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q91.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6954A>A",
        "Protein Change":"p.Pro477Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003728%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11408240",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0145",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q96.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8178G>T",
        "Protein Change":"p.Ser371Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005567%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53449163",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0146",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q19.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4345C>T",
        "Protein Change":"p.Gln186Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006034%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65548038",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0147",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q18.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.609A>C",
        "Protein Change":"p.Leu86Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004685%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16126009",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0148",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q95.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3480T>T",
        "Protein Change":"p.Gln72Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005219%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38941776",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0149",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q96.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7307T>C",
        "Protein Change":"p.Arg249Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0095%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14729513",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0150",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q50.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3548G>T",
        "Protein Change":"p.Gln75Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004879%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56476458",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0151",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q74.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6359C>C",
        "Protein Change":"p.Leu206Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001342%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89715293",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0152",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q52.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6347A>T",
        "Protein Change":"p.Leu121Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001715%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86834527",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0153",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q44.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4813G>C",
        "Protein Change":"p.Gln245Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007268%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69278976",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0154",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q61.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5980C>T",
        "Protein Change":"p.Pro263Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0041%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71374046",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0155",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q72.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7350A>C",
        "Protein Change":"p.Pro401Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005211%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93026945",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0156",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q55.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1181A>G",
        "Protein Change":"p.Pro76Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000979%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14799437",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0157",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q42.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8435G>A",
        "Protein Change":"p.Gly60Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009155%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21074984",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0158",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q32.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4475C>C",
        "Protein Change":"p.Leu233Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002778%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47689142",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0159",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q25.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5549C>C",
        "Protein Change":"p.Arg113Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006238%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29901559",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0160",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q62.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8810G>G",
        "Protein Change":"p.Pro408Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005912%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90390685",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0161",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q87.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3766T>T",
        "Protein Change":"p.Arg60Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003975%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59468092",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0162",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q5.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7855C>C",
        "Protein Change":"p.Gln147Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005203%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78627610",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0163",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q6.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1141G>T",
        "Protein Change":"p.Pro234Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005639%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36777774",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0164",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q44.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1299G>C",
        "Protein Change":"p.Gly66Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002941%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79939679",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0165",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q35.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5118G>T",
        "Protein Change":"p.Pro403Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0067%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96273695",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0166",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q45.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.583T>A",
        "Protein Change":"p.Leu157Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001368%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56041295",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0167",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q80.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9270T>T",
        "Protein Change":"p.Ser436Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005146%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23754844",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0168",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q61.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4446C>G",
        "Protein Change":"p.Gly267Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000728%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55093445",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0169",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q36.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9480T>C",
        "Protein Change":"p.Leu224Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009995%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90815940",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0170",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q9.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2976C>A",
        "Protein Change":"p.Ser124Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005393%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32048942",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0171",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q89.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2257G>T",
        "Protein Change":"p.Pro399Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005749%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32190098",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0172",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q37.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2017A>C",
        "Protein Change":"p.Leu304Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004301%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83400084",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0173",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q41.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8851T>A",
        "Protein Change":"p.Leu152Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002948%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22305775",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0174",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q29.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7522C>A",
        "Protein Change":"p.Gln484Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007086%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52354620",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0175",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q97.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4509G>A",
        "Protein Change":"p.Pro1Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006715%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10026127",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0176",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q3.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1778A>G",
        "Protein Change":"p.Gly462Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005507%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16863273",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0177",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q43.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6634A>C",
        "Protein Change":"p.Gln449Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003062%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78382145",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0178",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q70.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8327C>T",
        "Protein Change":"p.Pro44Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007982%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32168010",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0179",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q29.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.515T>T",
        "Protein Change":"p.Gly67Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003345%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81562113",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0180",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q29.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3118A>G",
        "Protein Change":"p.Pro335Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003577%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91614138",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0181",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q68.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8379G>G",
        "Protein Change":"p.Gln20Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009259%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30205257",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0182",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q21.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4301A>A",
        "Protein Change":"p.Leu213Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001281%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37600592",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0183",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q28.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1166G>T",
        "Protein Change":"p.Gln444Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001181%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71793541",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0184",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q98.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9298T>G",
        "Protein Change":"p.Ser330Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005433%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26252727",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0185",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q8.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9007G>A",
        "Protein Change":"p.Gln50Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002309%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76030045",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0186",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q54.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4985A>A",
        "Protein Change":"p.Arg417Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002509%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72567944",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0187",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q16.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3303T>T",
        "Protein Change":"p.Ser69Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007645%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32387839",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0188",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q91.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1279A>A",
        "Protein Change":"p.Gln18Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007747%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87934861",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0189",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q49.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5898T>A",
        "Protein Change":"p.Pro62Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00775%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20646410",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0190",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q97.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8879T>G",
        "Protein Change":"p.Gln120Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007628%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55991427",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0191",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q53.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3260G>G",
        "Protein Change":"p.Leu89Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006013%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20098065",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0192",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q66.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.410C>G",
        "Protein Change":"p.Gly206Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009895%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20603738",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0193",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q77.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1597A>C",
        "Protein Change":"p.Gln465Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008014%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34850134",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0194",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q38.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8817C>G",
        "Protein Change":"p.Gln264Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003987%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77780007",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0195",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q71.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1478A>T",
        "Protein Change":"p.Gln80Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005824%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69201961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0196",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q60.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9339A>C",
        "Protein Change":"p.Ser451Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008393%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41864040",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0197",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q18.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7742A>T",
        "Protein Change":"p.Leu291Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007331%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48652772",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0198",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q85.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6720T>T",
        "Protein Change":"p.Pro467Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003489%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88363534",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0199",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q63.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9497G>T",
        "Protein Change":"p.Gly477Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001101%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49552647",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0200",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q20.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2937C>G",
        "Protein Change":"p.Pro320Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001678%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22136546",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0201",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q30.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.599C>C",
        "Protein Change":"p.Ser267Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005093%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44880199",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0202",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q9.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3032G>C",
        "Protein Change":"p.Arg387Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003008%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23715148",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0203",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q35.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2419T>A",
        "Protein Change":"p.Arg16Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000631%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26975794",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0204",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q91.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4195G>G",
        "Protein Change":"p.Gly82Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008599%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99609500",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0205",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q25.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4288C>C",
        "Protein Change":"p.Arg106Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003232%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51410372",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0206",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q46.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6591C>A",
        "Protein Change":"p.Gln302Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006721%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85643567",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0207",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q50.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5605C>A",
        "Protein Change":"p.Arg154Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008074%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46638502",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0208",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q67.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8871A>G",
        "Protein Change":"p.Pro222Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001143%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69129933",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0209",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q52.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.296T>G",
        "Protein Change":"p.Ser494Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009317%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22449423",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0210",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q40.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1839A>C",
        "Protein Change":"p.Leu34Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003938%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67556132",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0211",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q57.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1735G>T",
        "Protein Change":"p.Gly437Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002423%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25465312",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0212",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q30.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4964C>G",
        "Protein Change":"p.Gln432Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008154%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10110579",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0213",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q91.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6657C>G",
        "Protein Change":"p.Leu26Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002226%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50081023",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0214",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q15.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2468C>G",
        "Protein Change":"p.Gln310Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004054%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49349086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0215",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q64.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.204T>C",
        "Protein Change":"p.Ser252Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003377%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64128830",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0216",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q11.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4067C>T",
        "Protein Change":"p.Gln470Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007251%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83770258",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0217",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q34.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4293A>G",
        "Protein Change":"p.Gly254Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00238%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71627205",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0218",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q26.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5866G>A",
        "Protein Change":"p.Gln187Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000797%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12025787",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0219",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q26.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9576A>A",
        "Protein Change":"p.Leu180Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004758%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35774894",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0220",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q56.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7163A>A",
        "Protein Change":"p.Ser288Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00099%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91603751",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0221",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q38.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7600A>C",
        "Protein Change":"p.Arg327Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003375%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64509352",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0222",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q85.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3432A>C",
        "Protein Change":"p.Leu496Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008792%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62726439",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0223",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q44.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2645C>T",
        "Protein Change":"p.Pro160Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009175%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79726547",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0224",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q42.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4359C>T",
        "Protein Change":"p.Gln89Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005291%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51707245",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0225",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q45.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2239A>A",
        "Protein Change":"p.Gly293Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007557%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59555576",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0226",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q94.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6825T>C",
        "Protein Change":"p.Gly330Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002396%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40407575",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0227",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q86.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7630A>T",
        "Protein Change":"p.Ser294Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001907%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62744070",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0228",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q87.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.692G>A",
        "Protein Change":"p.Arg212Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008706%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96701347",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0229",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q60.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5261A>G",
        "Protein Change":"p.Leu189Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000983%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62275352",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0230",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q92.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8325C>A",
        "Protein Change":"p.Ser190Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008574%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79821990",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0231",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q7.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9789C>A",
        "Protein Change":"p.Leu286Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005814%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75789322",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0232",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q71.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9784C>C",
        "Protein Change":"p.Arg311Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004861%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:90754629",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0233",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q13.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6707G>T",
        "Protein Change":"p.Pro102Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00108%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64238308",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0234",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q46.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.359C>A",
        "Protein Change":"p.Gly269Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008304%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27378287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0235",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q89.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2213A>G",
        "Protein Change":"p.Pro190Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004708%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11476923",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0236",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q80.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3595C>G",
        "Protein Change":"p.Gln18Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002036%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69163249",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0237",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q14.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1404C>T",
        "Protein Change":"p.Pro379Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003603%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71571965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0238",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q64.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2840T>A",
        "Protein Change":"p.Pro441Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00074%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83323122",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0239",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q18.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5989G>A",
        "Protein Change":"p.Gly322Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009008%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46335895",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0240",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q11.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.433C>A",
        "Protein Change":"p.Ser391Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0098%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71571771",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0241",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q97.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7561T>G",
        "Protein Change":"p.Arg451Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001793%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35008043",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0242",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q56.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8595A>A",
        "Protein Change":"p.Arg82Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004083%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49528128",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0243",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q80.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9531G>G",
        "Protein Change":"p.Leu400Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007114%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54877575",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0244",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q12.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4944A>C",
        "Protein Change":"p.Leu209Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006456%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64343457",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0245",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q83.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.426A>A",
        "Protein Change":"p.Arg421Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003991%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11048883",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0246",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q21.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7191A>T",
        "Protein Change":"p.Ser219Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007814%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85143575",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0247",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q71.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6785A>G",
        "Protein Change":"p.Gly197Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0051%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27777642",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0248",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q46.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8707G>C",
        "Protein Change":"p.Ser178Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003434%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42802468",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0249",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q47.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.404A>T",
        "Protein Change":"p.Arg30Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007374%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60445129",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0250",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q17.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1891A>C",
        "Protein Change":"p.Leu208Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003673%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33452868",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0251",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q1.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8474T>C",
        "Protein Change":"p.Arg41Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004394%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75845686",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0252",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q85.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2314A>A",
        "Protein Change":"p.Ser109Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009865%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70373695",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0253",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q59.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1583C>C",
        "Protein Change":"p.Gln181Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003553%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28819931",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0254",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q49.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8203T>A",
        "Protein Change":"p.Gln372Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004575%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36304072",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0255",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q53.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5615T>A",
        "Protein Change":"p.Gln242Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009885%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76892747",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0256",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q56.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4281A>A",
        "Protein Change":"p.Gly250Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008429%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72992922",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0257",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q3.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4202T>C",
        "Protein Change":"p.Pro439Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005329%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71257084",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0258",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q91.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.633C>T",
        "Protein Change":"p.Gly463Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008065%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71486092",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0259",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q33.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2413C>T",
        "Protein Change":"p.Arg254Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003078%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76193010",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0260",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q1.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5012G>A",
        "Protein Change":"p.Arg337Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000223%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96478440",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0261",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q67.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1633T>A",
        "Protein Change":"p.Pro263Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003917%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26444182",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0262",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q42.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9714T>A",
        "Protein Change":"p.Leu350Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002521%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90007228",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0263",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q16.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9722C>A",
        "Protein Change":"p.Leu22Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00886%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11592652",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0264",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q83.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3604A>C",
        "Protein Change":"p.Gly179Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000502%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31365831",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0265",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q34.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9419C>C",
        "Protein Change":"p.Leu370Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003629%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33770514",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0266",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q33.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7366T>G",
        "Protein Change":"p.Leu415Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005205%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38828589",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0267",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q94.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5655C>T",
        "Protein Change":"p.Pro165Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008673%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42210230",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0268",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q9.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3649G>G",
        "Protein Change":"p.Gly315Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004692%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42948080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0269",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q68.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.119C>G",
        "Protein Change":"p.Gln452Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004506%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16923324",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0270",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q10.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1037T>T",
        "Protein Change":"p.Arg412Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001293%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77715569",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0271",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q38.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2682A>G",
        "Protein Change":"p.Pro421Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002849%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56609469",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0272",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q72.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2765G>G",
        "Protein Change":"p.Gln94Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005618%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29895149",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0273",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q62.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9195T>G",
        "Protein Change":"p.Arg178Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007829%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80552993",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0274",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q34.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4092T>T",
        "Protein Change":"p.Leu138Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004822%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61904221",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0275",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q85.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6413G>T",
        "Protein Change":"p.Gly119Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0093%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63224067",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0276",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q42.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9336T>C",
        "Protein Change":"p.Gln359Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002698%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66360275",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0277",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q98.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5410A>G",
        "Protein Change":"p.Gly357Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000134%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32838161",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0278",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q80.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7998T>T",
        "Protein Change":"p.Gln422Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000818%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56341941",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0279",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q71.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2863A>A",
        "Protein Change":"p.Pro2Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00366%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74217964",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0280",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q55.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6394A>G",
        "Protein Change":"p.Ser168Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003113%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34702940",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0281",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q35.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3780C>A",
        "Protein Change":"p.Leu412Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000377%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61015268",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0282",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q16.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7093G>T",
        "Protein Change":"p.Leu422Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005747%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15220213",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0283",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q28.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8352T>A",
        "Protein Change":"p.Ser21Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005509%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26494570",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0284",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q81.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2332C>A",
        "Protein Change":"p.Gln406Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005053%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71191820",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0285",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q21.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6373C>A",
        "Protein Change":"p.Gly343Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006945%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24333283",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0286",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q84.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8701G>T",
        "Protein Change":"p.Pro426Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000718%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85823291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0287",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q59.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2583T>C",
        "Protein Change":"p.Leu296Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003016%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26462091",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0288",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q59.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6187G>C",
        "Protein Change":"p.Leu126Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006712%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57156424",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0289",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q33.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8360C>T",
        "Protein Change":"p.Arg250Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008434%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79472861",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0290",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q16.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4972C>A",
        "Protein Change":"p.Ser444Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00819%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97235125",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0291",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q73.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2715T>T",
        "Protein Change":"p.Arg123Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009053%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97783393",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0292",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q85.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3951G>G",
        "Protein Change":"p.Ser196Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008409%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68197704",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0293",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q93.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3056A>C",
        "Protein Change":"p.Leu2Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003476%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:57033789",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0294",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q64.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6334C>A",
        "Protein Change":"p.Leu258Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005768%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79051550",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0295",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q40.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7253T>T",
        "Protein Change":"p.Gly125Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007847%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14886812",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0296",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q24.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1045C>T",
        "Protein Change":"p.Leu470Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00796%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34498847",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0297",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q49.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2297T>A",
        "Protein Change":"p.Gln353Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007025%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22125799",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0298",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q27.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7234A>C",
        "Protein Change":"p.Gly366Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001723%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10125399",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0299",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q33.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3855A>A",
        "Protein Change":"p.Ser382Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008644%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79156249",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0300",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q84.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.127A>G",
        "Protein Change":"p.Gln443Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005588%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92691125",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0301",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q7.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2520G>C",
        "Protein Change":"p.Gly453Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005981%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58847909",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0302",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q75.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2951G>C",
        "Protein Change":"p.Leu141Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001123%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24648156",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0303",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q32.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3343T>A",
        "Protein Change":"p.Gln419Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002133%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17340324",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0304",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q65.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2585C>C",
        "Protein Change":"p.Ser343Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00925%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50819960",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0305",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q99.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1955T>T",
        "Protein Change":"p.Arg347Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000913%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24789665",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0306",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q81.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4573A>C",
        "Protein Change":"p.Arg18Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008191%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67718966",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0307",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q59.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2928T>G",
        "Protein Change":"p.Pro362Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008866%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94303914",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0308",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q90.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5274C>G",
        "Protein Change":"p.Pro205Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00186%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83459730",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0309",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q4.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5783G>C",
        "Protein Change":"p.Gly161Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004092%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44436378",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0310",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q36.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8854T>G",
        "Protein Change":"p.Ser482Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007965%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31158696",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0311",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q12.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9615A>A",
        "Protein Change":"p.Gly110Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000281%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67430160",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0312",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q3.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4998G>A",
        "Protein Change":"p.Gly314Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008052%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12795150",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0313",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q57.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5137G>C",
        "Protein Change":"p.Leu170Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00394%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94908961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0314",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q2.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9389G>A",
        "Protein Change":"p.Arg308Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005477%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41817190",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0315",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q17.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8014C>A",
        "Protein Change":"p.Gly420Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007617%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17870919",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0316",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q61.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1152G>G",
        "Protein Change":"p.Gln296Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003628%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91022811",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0317",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q47.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5255T>A",
        "Protein Change":"p.Gln367Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001646%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87525533",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0318",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q97.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3926C>G",
        "Protein Change":"p.Ser295Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004849%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62442970",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0319",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q59.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8711G>G",
        "Protein Change":"p.Gly184Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00586%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31427477",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0320",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q95.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5061C>C",
        "Protein Change":"p.Gly375Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004488%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16714184",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0321",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q74.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4451T>G",
        "Protein Change":"p.Gln18Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007026%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59472664",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0322",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q30.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9058G>C",
        "Protein Change":"p.Leu417Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006531%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87240446",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0323",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q40.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7518G>A",
        "Protein Change":"p.Ser222Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000709%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19168249",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0324",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q38.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7546T>G",
        "Protein Change":"p.Arg495Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005184%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53134837",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0325",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q30.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4920A>A",
        "Protein Change":"p.Pro123Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008777%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22751894",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0326",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q95.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6606G>G",
        "Protein Change":"p.Ser281Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001413%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75238004",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0327",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q85.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8822C>C",
        "Protein Change":"p.Arg379Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00835%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84093451",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0328",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q1.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7042T>A",
        "Protein Change":"p.Gly66Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004437%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32372730",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0329",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q9.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9730A>G",
        "Protein Change":"p.Ser403Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00925%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20533643",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0330",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q40.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4008A>T",
        "Protein Change":"p.Ser225Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008473%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55787170",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0331",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q87.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5312T>T",
        "Protein Change":"p.Leu250Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001801%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66446109",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0332",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q40.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4788C>T",
        "Protein Change":"p.Gly17Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001893%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36430948",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0333",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q11.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2345A>T",
        "Protein Change":"p.Gly63Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00836%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32604087",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0334",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q18.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7466C>C",
        "Protein Change":"p.Leu466Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006498%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50903172",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0335",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q11.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.700C>C",
        "Protein Change":"p.Arg303Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005403%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52482011",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0336",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q33.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7040T>A",
        "Protein Change":"p.Ser25Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005274%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11656350",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0337",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q53.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6417G>G",
        "Protein Change":"p.Pro463Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009139%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66979819",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0338",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q28.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9097G>A",
        "Protein Change":"p.Leu56Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000478%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16019763",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0339",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q63.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9243C>T",
        "Protein Change":"p.Gln115Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004775%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37337773",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0340",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q97.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1192A>G",
        "Protein Change":"p.Ser457Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009244%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24812549",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0341",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q23.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5901T>G",
        "Protein Change":"p.Pro121Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00566%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21711671",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0342",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q53.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4122G>T",
        "Protein Change":"p.Pro1Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001813%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67082147",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0343",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q47.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.669G>C",
        "Protein Change":"p.Gln132Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004084%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58650003",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0344",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q45.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2995C>G",
        "Protein Change":"p.Pro275Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003076%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44699256",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0345",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q25.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9914G>C",
        "Protein Change":"p.Pro483Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00627%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21795784",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0346",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q63.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8545A>C",
        "Protein Change":"p.Gln336Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009506%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47331329",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0347",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q98.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9749T>A",
        "Protein Change":"p.Ser92Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003175%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35793812",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0348",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q17.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2873T>T",
        "Protein Change":"p.Arg286Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002962%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14942317",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0349",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q19.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7736T>C",
        "Protein Change":"p.Leu350Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005988%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40383773",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0350",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q42.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.293C>T",
        "Protein Change":"p.Ser493Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005632%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:43343838",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0351",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q55.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7190T>G",
        "Protein Change":"p.Pro452Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006757%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45609973",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0352",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q60.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3851T>G",
        "Protein Change":"p.Leu302Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001442%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87333136",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0353",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q21.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9372A>G",
        "Protein Change":"p.Pro260Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004903%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81901324",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0354",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q71.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7686T>C",
        "Protein Change":"p.Leu54Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00676%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83504302",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0355",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q88.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9788T>T",
        "Protein Change":"p.Arg84Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00965%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32980744",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0356",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q9.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6504G>G",
        "Protein Change":"p.Gly182Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004881%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32629862",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0357",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q61.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9883T>A",
        "Protein Change":"p.Pro132Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007447%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95660285",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0358",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q18.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2839A>A",
        "Protein Change":"p.Ser360Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009432%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31296779",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0359",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q8.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8672G>T",
        "Protein Change":"p.Pro60Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003407%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30536425",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0360",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q96.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1055A>A",
        "Protein Change":"p.Leu65Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004058%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43101740",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0361",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q55.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9744C>T",
        "Protein Change":"p.Ser121Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007527%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12531050",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0362",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q91.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4608T>C",
        "Protein Change":"p.Ser190Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006273%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72953163",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0363",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q96.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2860A>T",
        "Protein Change":"p.Ser182Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003401%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:93458430",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0364",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q43.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9655T>A",
        "Protein Change":"p.Gln11Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00865%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16401736",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0365",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q30.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4868C>A",
        "Protein Change":"p.Pro101Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009586%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45922688",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0366",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q82.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3395T>C",
        "Protein Change":"p.Gly190Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006594%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72544053",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0367",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q4.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7163T>A",
        "Protein Change":"p.Gly277Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00576%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16831985",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0368",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q9.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5845G>G",
        "Protein Change":"p.Arg389Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003785%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71424176",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0369",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q59.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4007G>A",
        "Protein Change":"p.Ser89Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008223%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75392811",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0370",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q27.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7197C>T",
        "Protein Change":"p.Gln134Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009758%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26100176",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0371",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q78.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6869A>T",
        "Protein Change":"p.Pro322Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002818%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98308889",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0372",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q77.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7441T>G",
        "Protein Change":"p.Leu474Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001128%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39476207",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0373",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q38.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4134G>C",
        "Protein Change":"p.Gly416Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007196%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10776565",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0374",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q30.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4380G>A",
        "Protein Change":"p.Gln171Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005789%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78444682",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0375",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q5.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.664A>T",
        "Protein Change":"p.Leu63Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006557%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52972823",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0376",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q49.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9978C>G",
        "Protein Change":"p.Gly422Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007601%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43532782",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0377",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q10.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6736T>T",
        "Protein Change":"p.Pro450Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000163%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35078312",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0378",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q78.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6896A>G",
        "Protein Change":"p.Pro47Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005791%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48636739",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0379",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q84.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5060A>T",
        "Protein Change":"p.Gln296Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001657%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61134279",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0380",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q24.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8531A>C",
        "Protein Change":"p.Arg151Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003768%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78082314",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0381",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q54.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2555G>A",
        "Protein Change":"p.Pro307Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003671%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42021965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0382",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q11.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6743C>A",
        "Protein Change":"p.Pro374Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006442%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12630374",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0383",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q72.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3923T>T",
        "Protein Change":"p.Arg133Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00902%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62258512",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0384",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q25.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7008C>G",
        "Protein Change":"p.Gly346Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002136%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33457290",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0385",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q84.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6156G>G",
        "Protein Change":"p.Pro340Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006523%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66630658",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0386",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q45.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9136G>G",
        "Protein Change":"p.Gly97Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001106%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79704409",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0387",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q86.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3326G>C",
        "Protein Change":"p.Arg427Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00398%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64047293",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0388",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q99.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2191C>G",
        "Protein Change":"p.Leu427Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009228%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25868511",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0389",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q83.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4370A>C",
        "Protein Change":"p.Pro452Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008287%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71855035",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0390",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q51.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9459T>T",
        "Protein Change":"p.Leu192Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000628%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81209187",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0391",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q47.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1547C>C",
        "Protein Change":"p.Ser309Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009447%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47867279",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0392",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q78.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.305T>A",
        "Protein Change":"p.Pro90Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002205%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99122614",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0393",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q48.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7515A>T",
        "Protein Change":"p.Gly173Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001197%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52801002",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0394",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q17.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7711G>T",
        "Protein Change":"p.Leu351Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005023%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94329529",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0395",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q34.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7061G>C",
        "Protein Change":"p.Pro371Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006873%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55798671",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0396",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q5.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9056C>C",
        "Protein Change":"p.Arg201Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006311%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62492080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0397",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q2.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3833C>A",
        "Protein Change":"p.Arg367Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005424%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39710855",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0398",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q1.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9532T>C",
        "Protein Change":"p.Arg414Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001579%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54972341",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0399",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q13.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2785A>G",
        "Protein Change":"p.Leu396Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003918%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10846569",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0400",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q54.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.548T>C",
        "Protein Change":"p.Ser44Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007932%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38778784",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0401",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q14.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5984G>G",
        "Protein Change":"p.Gly327Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006219%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41282383",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0402",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q52.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2210C>A",
        "Protein Change":"p.Gln349Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00673%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33223840",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0403",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q70.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9201G>A",
        "Protein Change":"p.Gln163Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006963%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75285328",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0404",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q89.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8513A>C",
        "Protein Change":"p.Ser254Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002509%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58645204",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0405",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q92.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2489A>A",
        "Protein Change":"p.Gly9Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008219%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98936645",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0406",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q85.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9953C>C",
        "Protein Change":"p.Gln497Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009859%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85965181",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0407",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q57.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6274G>C",
        "Protein Change":"p.Gly240Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00533%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19490900",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0408",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q68.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4627T>C",
        "Protein Change":"p.Pro200Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003025%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82127202",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0409",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q64.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8971G>C",
        "Protein Change":"p.Ser138Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00209%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24688501",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0410",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q86.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1102G>C",
        "Protein Change":"p.Ser343Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005643%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77944484",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0411",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q62.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9837G>C",
        "Protein Change":"p.Ser441Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004358%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27476866",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0412",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q77.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2720C>T",
        "Protein Change":"p.Arg122Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004032%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67009678",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0413",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q66.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8573G>G",
        "Protein Change":"p.Gly181Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002567%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34233910",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0414",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q1.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9447A>T",
        "Protein Change":"p.Ser312Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009187%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20267576",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0415",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q11.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1052C>T",
        "Protein Change":"p.Arg356Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004239%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:57696488",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0416",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q92.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8070T>A",
        "Protein Change":"p.Pro1Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002211%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41627577",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0417",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q98.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2451A>G",
        "Protein Change":"p.Leu333Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002052%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25031944",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0418",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q67.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7907G>A",
        "Protein Change":"p.Ser289Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003765%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59412487",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0419",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q10.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9317G>T",
        "Protein Change":"p.Gly178Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004156%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15990734",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0420",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q77.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2169G>C",
        "Protein Change":"p.Gly410Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005374%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99111633",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0421",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q47.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6616A>C",
        "Protein Change":"p.Ser95Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004234%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41085177",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0422",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q30.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.553A>T",
        "Protein Change":"p.Gly96Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001661%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90666290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0423",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q81.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2875G>A",
        "Protein Change":"p.Arg274Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001074%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27171396",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0424",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q59.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6015G>G",
        "Protein Change":"p.Gln220Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004821%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61036344",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0425",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q48.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5336T>A",
        "Protein Change":"p.Gln248Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007769%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46501938",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0426",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q54.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2327C>A",
        "Protein Change":"p.Arg448Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001139%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53820148",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0427",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q48.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1293A>A",
        "Protein Change":"p.Gly194Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008516%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81461690",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0428",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q64.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6698A>T",
        "Protein Change":"p.Pro387Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000257%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29534407",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0429",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q12.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1131G>T",
        "Protein Change":"p.Ser41Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005942%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49270846",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0430",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q73.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5806G>T",
        "Protein Change":"p.Gln17Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009686%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54910560",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0431",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q56.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.548T>A",
        "Protein Change":"p.Ser216Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006038%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88519841",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0432",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q81.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7397G>T",
        "Protein Change":"p.Pro381Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008729%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89858007",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0433",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q48.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7216C>C",
        "Protein Change":"p.Pro215Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006208%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54202526",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0434",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q2.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5005T>C",
        "Protein Change":"p.Ser147Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000133%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42894534",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0435",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q18.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5254A>T",
        "Protein Change":"p.Gly271Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003278%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67670433",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0436",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q66.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2049A>C",
        "Protein Change":"p.Ser340Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009447%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35676615",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0437",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q66.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3233A>G",
        "Protein Change":"p.Ser65Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002765%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89505289",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0438",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q12.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2942A>C",
        "Protein Change":"p.Pro255Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001054%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81848282",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0439",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q37.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2379T>G",
        "Protein Change":"p.Arg45Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63594967",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0440",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q72.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9201C>A",
        "Protein Change":"p.Gly485Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000161%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55849851",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0441",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q25.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3838T>A",
        "Protein Change":"p.Gly325Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002339%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72870727",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0442",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q7.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4910C>T",
        "Protein Change":"p.Gly476Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009807%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20865207",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0443",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q71.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8253G>A",
        "Protein Change":"p.Ser207Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007385%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48748759",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0444",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q86.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4532C>G",
        "Protein Change":"p.Gly20Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00086%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56369377",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0445",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q50.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2950C>A",
        "Protein Change":"p.Leu365Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002917%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52711054",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0446",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q74.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2067C>C",
        "Protein Change":"p.Pro91Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003351%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91113478",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0447",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q66.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3397T>C",
        "Protein Change":"p.Ser187Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001292%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30809903",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0448",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q93.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2721C>C",
        "Protein Change":"p.Arg163Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00129%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24641766",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0449",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q40.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4307A>C",
        "Protein Change":"p.Pro370Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000934%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65799510",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0450",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q36.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8182A>G",
        "Protein Change":"p.Arg397Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003452%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58437418",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0451",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q8.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6134T>A",
        "Protein Change":"p.Arg372Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000462%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65928056",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0452",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q39.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6356A>A",
        "Protein Change":"p.Leu402Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007275%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61835516",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0453",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q71.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.492T>T",
        "Protein Change":"p.Gln427Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006532%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27666561",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0454",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q74.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9184C>C",
        "Protein Change":"p.Pro438Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001626%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:90818748",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0455",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q51.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9641G>T",
        "Protein Change":"p.Pro396Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009982%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95450054",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0456",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q65.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5491C>C",
        "Protein Change":"p.Pro130Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007385%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46874267",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0457",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q28.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.314T>C",
        "Protein Change":"p.Ser100Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005048%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77411594",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0458",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q42.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8803T>C",
        "Protein Change":"p.Gln84Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007612%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44464005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0459",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q86.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5508A>T",
        "Protein Change":"p.Pro135Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001003%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61302097",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0460",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q42.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4959A>T",
        "Protein Change":"p.Leu66Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65351139",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0461",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q82.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5564A>T",
        "Protein Change":"p.Gly468Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004501%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34229446",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0462",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q50.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5460G>T",
        "Protein Change":"p.Arg334Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000307%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66669529",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0463",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q16.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6480G>G",
        "Protein Change":"p.Pro465Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009793%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65334598",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0464",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q68.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9185A>T",
        "Protein Change":"p.Gln189Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001464%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92997363",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0465",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q51.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4773T>T",
        "Protein Change":"p.Leu214Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003276%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:97620186",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0466",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q77.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.120G>A",
        "Protein Change":"p.Gly441Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00294%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85634212",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0467",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q63.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.123G>A",
        "Protein Change":"p.Leu299Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004073%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73382444",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0468",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q38.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6026C>C",
        "Protein Change":"p.Arg213Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000303%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39665848",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0469",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q79.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5787T>C",
        "Protein Change":"p.Gly67Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000294%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51592778",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0470",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q11.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.130C>C",
        "Protein Change":"p.Ser221Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008606%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84752414",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0471",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q9.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8115A>C",
        "Protein Change":"p.Arg11Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003136%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47401495",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0472",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q73.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5606G>A",
        "Protein Change":"p.Pro150Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004844%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27069583",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0473",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q86.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7347A>T",
        "Protein Change":"p.Pro369Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002411%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14816907",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0474",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q12.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9416T>G",
        "Protein Change":"p.Leu240Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007155%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65842291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0475",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q7.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9409T>G",
        "Protein Change":"p.Gln487Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003955%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29356645",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0476",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q7.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8368G>C",
        "Protein Change":"p.Arg246Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007676%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56773377",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0477",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q47.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6645T>C",
        "Protein Change":"p.Gly304Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006987%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16249223",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0478",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q36.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5050G>C",
        "Protein Change":"p.Ser86Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004363%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22842192",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0479",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q14.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6474T>G",
        "Protein Change":"p.Ser86Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007189%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80136025",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0480",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q31.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6042A>A",
        "Protein Change":"p.Gly396Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00454%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84835900",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0481",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q49.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3241G>A",
        "Protein Change":"p.Leu44Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001582%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40439785",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0482",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q94.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9244G>A",
        "Protein Change":"p.Leu400Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003189%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26246965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0483",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q19.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6323A>A",
        "Protein Change":"p.Pro86Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005568%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36219385",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0484",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q13.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2755C>G",
        "Protein Change":"p.Gly53Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007253%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67492316",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0485",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q23.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8818G>T",
        "Protein Change":"p.Leu116Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009509%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38043640",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0486",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q97.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1716C>A",
        "Protein Change":"p.Pro447Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005873%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78213847",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0487",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q9.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8626G>G",
        "Protein Change":"p.Leu309Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00419%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90095188",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0488",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q43.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7081C>C",
        "Protein Change":"p.Leu12Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003177%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91604818",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0489",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q33.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3503A>G",
        "Protein Change":"p.Gly112Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003142%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58593300",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0490",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q85.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6345A>G",
        "Protein Change":"p.Gln344Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00597%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23986016",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0491",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q18.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3792A>A",
        "Protein Change":"p.Arg418Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002673%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66236358",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0492",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q9.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3459G>T",
        "Protein Change":"p.Gly79Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90418482",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0493",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q23.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1229G>A",
        "Protein Change":"p.Gly498Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006635%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64900111",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0494",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q31.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9002A>C",
        "Protein Change":"p.Gly45Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002988%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44996641",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0495",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q99.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5974A>T",
        "Protein Change":"p.Gln73Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005471%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97479085",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0496",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q59.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4814A>C",
        "Protein Change":"p.Leu225Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004503%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16872374",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0497",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q43.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.846C>C",
        "Protein Change":"p.Ser371Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002311%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73956947",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0498",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q76.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4533T>G",
        "Protein Change":"p.Arg301Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005909%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23457575",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0499",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q86.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5267T>C",
        "Protein Change":"p.Pro201Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002507%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60307036",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0500",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q70.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5540A>T",
        "Protein Change":"p.Gly7Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001166%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80107176",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0501",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q92.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4864A>G",
        "Protein Change":"p.Pro322Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005586%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49786631",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0502",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q93.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7434C>A",
        "Protein Change":"p.Ser373Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007679%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58701994",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0503",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q15.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7008A>G",
        "Protein Change":"p.Ser163Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002308%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83685710",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0504",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q80.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6102A>C",
        "Protein Change":"p.Ser455Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000518%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70996732",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0505",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q18.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8241C>A",
        "Protein Change":"p.Arg372Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000463%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39906326",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0506",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q14.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9258C>A",
        "Protein Change":"p.Gln390Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002467%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79608780",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0507",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q96.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1506A>G",
        "Protein Change":"p.Pro176Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000558%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56085080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0508",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q7.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9307T>A",
        "Protein Change":"p.Pro440Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003544%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92455969",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0509",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q41.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6849C>G",
        "Protein Change":"p.Pro314Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001036%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70323023",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0510",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q71.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8561A>G",
        "Protein Change":"p.Arg435Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006111%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67348776",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0511",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q70.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5376T>T",
        "Protein Change":"p.Pro50Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007262%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24830570",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0512",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q98.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4437G>A",
        "Protein Change":"p.Arg135Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003016%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17371902",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0513",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q49.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6208G>G",
        "Protein Change":"p.Ser306Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002393%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92660014",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0514",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q30.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4409A>T",
        "Protein Change":"p.Gly68Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006635%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72347311",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0515",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q56.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4206C>C",
        "Protein Change":"p.Ser234Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001856%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58739048",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0516",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q48.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5871A>T",
        "Protein Change":"p.Leu41Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005717%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70150636",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0517",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q19.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8172C>A",
        "Protein Change":"p.Gly153Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000509%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20143629",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0518",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q10.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8547C>G",
        "Protein Change":"p.Pro360Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005688%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19301956",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0519",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q53.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8807C>C",
        "Protein Change":"p.Arg176Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001217%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86809359",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0520",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q66.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1638C>A",
        "Protein Change":"p.Leu492Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009715%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23266773",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0521",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q85.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.916T>T",
        "Protein Change":"p.Ser10Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009377%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42140660",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0522",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q47.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6600A>C",
        "Protein Change":"p.Arg176Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007525%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55640187",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0523",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q8.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9334T>C",
        "Protein Change":"p.Leu339Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007356%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38373895",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0524",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q14.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1998T>G",
        "Protein Change":"p.Gly293Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009272%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14937250",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0525",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q21.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8623T>G",
        "Protein Change":"p.Pro248Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000298%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67250141",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0526",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q3.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9996T>A",
        "Protein Change":"p.Ser301Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005225%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97407093",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0527",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q52.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7126G>A",
        "Protein Change":"p.Gln149Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007937%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89431205",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0528",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q26.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5301G>C",
        "Protein Change":"p.Leu377Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003239%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74909245",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0529",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q64.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8396G>G",
        "Protein Change":"p.Ser437Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009825%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80397454",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0530",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q8.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.373G>C",
        "Protein Change":"p.Leu27Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008725%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39851276",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0531",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q86.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9261C>T",
        "Protein Change":"p.Ser40Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005244%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18784831",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0532",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q66.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4573A>C",
        "Protein Change":"p.Ser368Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002606%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89237898",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0533",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q6.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5541G>G",
        "Protein Change":"p.Gln98Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003391%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57311817",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0534",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q71.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6308T>T",
        "Protein Change":"p.Gln423Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008068%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14038377",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0535",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q72.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4310C>C",
        "Protein Change":"p.Gln195Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003836%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61727648",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0536",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q6.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2655T>A",
        "Protein Change":"p.Gly211Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004781%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72382635",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0537",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q78.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6022A>A",
        "Protein Change":"p.Ser451Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009281%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44968631",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0538",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q12.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1396A>G",
        "Protein Change":"p.Arg195Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004765%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33566524",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0539",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q88.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2778C>G",
        "Protein Change":"p.Pro34Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003497%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49224768",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0540",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q52.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4686A>C",
        "Protein Change":"p.Arg405Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009848%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48086927",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0541",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q30.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6909T>A",
        "Protein Change":"p.Ser40Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004685%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69010450",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0542",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q96.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5879A>C",
        "Protein Change":"p.Pro84Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001546%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81814340",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0543",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q14.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1852G>A",
        "Protein Change":"p.Gln227Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001861%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60384417",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0544",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q66.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7712T>A",
        "Protein Change":"p.Arg38Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005866%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95776153",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0545",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q2.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2050A>C",
        "Protein Change":"p.Gln204Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00982%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20891366",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0546",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q28.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1916T>C",
        "Protein Change":"p.Gln99Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002622%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49052925",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0547",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q69.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.501C>A",
        "Protein Change":"p.Arg378Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008453%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84360041",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0548",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q21.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5366T>A",
        "Protein Change":"p.Arg382Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00579%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89514044",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0549",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q65.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4048A>C",
        "Protein Change":"p.Gly472Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007491%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16448156",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0550",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q79.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9469C>C",
        "Protein Change":"p.Ser484Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004475%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66295604",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0551",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q31.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2739A>G",
        "Protein Change":"p.Gly315Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004602%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:57147911",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0552",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q46.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7795T>C",
        "Protein Change":"p.Ser344Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003855%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88895566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0553",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q49.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1919G>A",
        "Protein Change":"p.Gln389Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000311%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97886540",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0554",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q68.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.108G>G",
        "Protein Change":"p.Ser211Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005065%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15261488",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0555",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q1.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1800C>A",
        "Protein Change":"p.Arg173Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008721%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43165910",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0556",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q2.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8743G>G",
        "Protein Change":"p.Ser397Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000282%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89636428",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0557",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q38.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.113G>A",
        "Protein Change":"p.Gly385Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009395%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42203689",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0558",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q99.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3073G>G",
        "Protein Change":"p.Arg263Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001206%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32638163",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0559",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q37.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2619T>C",
        "Protein Change":"p.Arg145Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007624%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12497249",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0560",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q71.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5628T>T",
        "Protein Change":"p.Leu337Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009809%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35446170",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0561",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q83.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2069G>C",
        "Protein Change":"p.Arg384Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00071%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33082064",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0562",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q3.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3314T>G",
        "Protein Change":"p.Pro474Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00158%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69049981",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0563",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q98.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2885T>G",
        "Protein Change":"p.Ser304Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000645%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36741382",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0564",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q72.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2029A>T",
        "Protein Change":"p.Ser253Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00392%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75244655",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0565",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q40.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5419A>C",
        "Protein Change":"p.Pro474Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003328%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23391742",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0566",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q76.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6502A>T",
        "Protein Change":"p.Gly218Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000747%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31139745",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0567",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q96.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9579A>G",
        "Protein Change":"p.Arg105Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002439%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56493070",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0568",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q17.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2738G>C",
        "Protein Change":"p.Pro331Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001059%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57813330",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0569",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q67.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3814G>A",
        "Protein Change":"p.Gln345Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009992%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28908309",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0570",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q91.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.700C>G",
        "Protein Change":"p.Arg19Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002119%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82984578",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0571",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q6.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3402G>G",
        "Protein Change":"p.Ser254Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006754%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47888346",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0572",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q49.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4291C>G",
        "Protein Change":"p.Arg278Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008625%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78161230",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0573",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q99.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9919C>A",
        "Protein Change":"p.Ser88Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003169%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33054476",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0574",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q10.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.623A>T",
        "Protein Change":"p.Gln294Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003299%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32759649",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0575",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q83.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5925C>T",
        "Protein Change":"p.Ser311Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006877%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20201972",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0576",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q8.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4556T>C",
        "Protein Change":"p.Ser228Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009396%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:43581416",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0577",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q16.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5352T>T",
        "Protein Change":"p.Gln193Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005439%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77210135",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0578",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q22.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7739T>T",
        "Protein Change":"p.Pro246Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002352%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41462936",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0579",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q97.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4078A>A",
        "Protein Change":"p.Pro310Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007072%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42581796",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0580",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q21.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5622G>T",
        "Protein Change":"p.Pro427Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000148%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17947499",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0581",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q3.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5801C>G",
        "Protein Change":"p.Arg400Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006321%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42686115",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0582",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q40.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.172A>T",
        "Protein Change":"p.Pro256Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00945%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14054511",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0583",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q71.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8791T>A",
        "Protein Change":"p.Leu201Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008182%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85128350",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0584",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q32.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6594C>A",
        "Protein Change":"p.Gln188Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00792%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39800143",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0585",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q52.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2433G>A",
        "Protein Change":"p.Ser320Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006969%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84116634",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0586",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q72.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9797C>G",
        "Protein Change":"p.Leu341Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003795%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25782381",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0587",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q33.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7606G>T",
        "Protein Change":"p.Arg111Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008212%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21859604",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0588",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q73.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6757T>A",
        "Protein Change":"p.Gly496Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00035%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67304823",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0589",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q62.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3130C>G",
        "Protein Change":"p.Gln235Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000799%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99099836",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0590",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q46.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.538G>G",
        "Protein Change":"p.Gly385Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004621%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36482332",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0591",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q76.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2467T>G",
        "Protein Change":"p.Pro426Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005926%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78779737",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0592",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q1.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7029A>C",
        "Protein Change":"p.Gln77Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009939%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41860943",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0593",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q8.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8686A>G",
        "Protein Change":"p.Gln123Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001276%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94439391",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0594",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q74.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5111T>G",
        "Protein Change":"p.Leu473Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000664%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13769102",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0595",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q46.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6248C>T",
        "Protein Change":"p.Ser178Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004929%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72061716",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0596",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q36.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3330C>A",
        "Protein Change":"p.Arg334Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006053%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28679179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0597",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q69.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8590A>G",
        "Protein Change":"p.Arg15Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008816%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90682004",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0598",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q40.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8879T>A",
        "Protein Change":"p.Pro62Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001754%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24751532",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0599",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q81.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9137T>G",
        "Protein Change":"p.Arg177Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009252%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73648906",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0600",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q82.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.969T>T",
        "Protein Change":"p.Pro185Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001942%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37869085",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0601",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q28.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8737A>G",
        "Protein Change":"p.Arg477Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002556%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86535440",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0602",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q50.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5699C>G",
        "Protein Change":"p.Pro208Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005752%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77553931",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0603",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q75.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4383A>A",
        "Protein Change":"p.Leu206Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008449%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51742982",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0604",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q41.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8360T>A",
        "Protein Change":"p.Arg283Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006678%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99770396",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0605",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q90.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4269T>T",
        "Protein Change":"p.Ser129Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00323%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11511885",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0606",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q36.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5777G>T",
        "Protein Change":"p.Ser211Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001785%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40657887",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0607",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q39.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1767T>G",
        "Protein Change":"p.Gly34Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000134%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57500552",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0608",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q15.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8270T>C",
        "Protein Change":"p.Arg460Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006974%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72935495",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0609",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q57.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7429G>C",
        "Protein Change":"p.Arg116Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008789%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34634803",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0610",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q28.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2931G>A",
        "Protein Change":"p.Gln23Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000442%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76327843",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0611",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q91.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1890G>C",
        "Protein Change":"p.Pro191Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007488%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26935037",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0612",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q18.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2889A>T",
        "Protein Change":"p.Arg21Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007462%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81649638",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0613",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q84.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6365G>A",
        "Protein Change":"p.Leu231Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006318%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28254035",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0614",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q46.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6420T>G",
        "Protein Change":"p.Gly227Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008139%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41804004",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0615",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q19.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.901C>C",
        "Protein Change":"p.Leu163Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005796%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12672359",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0616",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q14.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5777G>T",
        "Protein Change":"p.Arg417Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007927%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79790971",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0617",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q31.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1393C>G",
        "Protein Change":"p.Ser87Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007065%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48980076",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0618",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q6.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7490T>A",
        "Protein Change":"p.Ser72Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008416%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99477496",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0619",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q64.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3223A>T",
        "Protein Change":"p.Gln151Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004977%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97727676",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0620",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q98.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1669T>T",
        "Protein Change":"p.Gln163Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005559%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12622200",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0621",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q20.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8866T>A",
        "Protein Change":"p.Pro417Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009682%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86193716",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0622",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q52.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9413G>C",
        "Protein Change":"p.Arg133Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008537%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22086521",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0623",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q68.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6672G>A",
        "Protein Change":"p.Gln195Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005613%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29601666",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0624",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q49.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6909T>G",
        "Protein Change":"p.Gln251Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003417%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71839911",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0625",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q82.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2049G>T",
        "Protein Change":"p.Arg275Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004279%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61771008",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0626",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q3.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9214C>A",
        "Protein Change":"p.Leu335Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009479%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43497612",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0627",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q7.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6726G>C",
        "Protein Change":"p.Ser434Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002802%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74592668",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0628",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q88.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9177T>A",
        "Protein Change":"p.Leu364Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003754%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80672929",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0629",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q76.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4335G>C",
        "Protein Change":"p.Ser126Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00354%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10015353",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0630",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q73.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.803A>A",
        "Protein Change":"p.Pro467Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007211%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99733049",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0631",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q97.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1880G>T",
        "Protein Change":"p.Gly84Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004127%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82721042",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0632",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q40.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7007C>C",
        "Protein Change":"p.Pro85Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004146%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30361591",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0633",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q98.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1906A>A",
        "Protein Change":"p.Pro91Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006498%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41617349",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0634",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q37.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8893A>A",
        "Protein Change":"p.Arg7Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005942%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26024617",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0635",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q95.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2837A>C",
        "Protein Change":"p.Gly271Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007176%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80298460",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0636",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q96.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5957C>A",
        "Protein Change":"p.Pro300Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004986%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16164853",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0637",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q60.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6451G>T",
        "Protein Change":"p.Pro228Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006268%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44715171",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0638",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q43.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8797A>G",
        "Protein Change":"p.Gln50Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008651%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60504867",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0639",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q66.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2076T>G",
        "Protein Change":"p.Pro147Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004089%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64286569",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0640",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q6.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2737T>G",
        "Protein Change":"p.Arg287Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008804%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43182008",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0641",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q25.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8404T>C",
        "Protein Change":"p.Pro93Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003748%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28533017",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0642",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q94.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2204C>T",
        "Protein Change":"p.Gly363Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008212%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98699750",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0643",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q65.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4974A>T",
        "Protein Change":"p.Leu244Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003802%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49837750",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0644",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q83.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7572C>T",
        "Protein Change":"p.Pro24Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004326%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22634200",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0645",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q45.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7920C>T",
        "Protein Change":"p.Leu231Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002208%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70761193",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0646",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q13.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2258T>A",
        "Protein Change":"p.Gln414Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003093%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49039310",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0647",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q99.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3646T>A",
        "Protein Change":"p.Gly325Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007096%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49023517",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0648",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q31.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7321C>A",
        "Protein Change":"p.Ser227Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00129%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38427196",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0649",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q65.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1732A>C",
        "Protein Change":"p.Ser66Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009261%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86938798",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0650",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q93.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3722G>G",
        "Protein Change":"p.Gly141Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003233%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77401275",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0651",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q31.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9001C>A",
        "Protein Change":"p.Gln145Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002379%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60962200",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0652",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q50.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.507C>A",
        "Protein Change":"p.Ser476Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004857%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86722491",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0653",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q28.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2687C>A",
        "Protein Change":"p.Ser198Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008894%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98015304",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0654",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q4.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6979T>T",
        "Protein Change":"p.Arg151Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008471%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33793371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0655",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q13.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3193G>T",
        "Protein Change":"p.Leu163Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005349%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76109442",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0656",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q38.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2663A>A",
        "Protein Change":"p.Ser285Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005176%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96828547",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0657",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q18.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7916T>A",
        "Protein Change":"p.Ser131Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008799%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57607156",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0658",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q50.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4667C>C",
        "Protein Change":"p.Ser136Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001792%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36048135",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0659",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q77.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3724G>G",
        "Protein Change":"p.Arg179Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008979%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81679892",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0660",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q99.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8467T>C",
        "Protein Change":"p.Gly462Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001665%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52938464",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0661",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q99.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5341G>A",
        "Protein Change":"p.Gln294Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002675%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24513500",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0662",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q12.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1998G>T",
        "Protein Change":"p.Leu379Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009494%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90295282",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0663",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q46.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2294T>C",
        "Protein Change":"p.Pro43Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008927%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80781313",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0664",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q92.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2285C>C",
        "Protein Change":"p.Pro391Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002581%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11172528",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0665",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q28.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7416T>T",
        "Protein Change":"p.Leu488Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008752%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70648263",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0666",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q90.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9260A>A",
        "Protein Change":"p.Gln277Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001488%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64261526",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0667",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q25.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7140T>C",
        "Protein Change":"p.Arg105Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005075%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30723924",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0668",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q57.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7928C>T",
        "Protein Change":"p.Pro149Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002851%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43916207",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0669",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q54.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8666A>G",
        "Protein Change":"p.Gly347Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009379%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93426877",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0670",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q18.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3165T>C",
        "Protein Change":"p.Pro323Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002287%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10341575",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0671",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q29.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7276G>G",
        "Protein Change":"p.Gly272Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000628%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19549891",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0672",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q90.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7462G>T",
        "Protein Change":"p.Ser72Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009639%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56958858",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0673",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q72.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8567T>C",
        "Protein Change":"p.Arg17Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00281%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50487488",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0674",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q12.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4546T>C",
        "Protein Change":"p.Gly339Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005416%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12020540",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0675",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q16.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4503G>A",
        "Protein Change":"p.Leu300Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006311%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87443614",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0676",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q65.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.724A>T",
        "Protein Change":"p.Leu485Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00954%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10069870",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0677",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q62.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6530A>G",
        "Protein Change":"p.Ser138Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001696%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15032014",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0678",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q57.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3146C>T",
        "Protein Change":"p.Leu374Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000791%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27109190",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0679",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q47.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2255T>G",
        "Protein Change":"p.Leu289Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006599%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14422168",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0680",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q93.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5157C>C",
        "Protein Change":"p.Ser29Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009685%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90280995",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0681",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q96.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1392C>C",
        "Protein Change":"p.Arg471Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002832%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33573053",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0682",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q16.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9915C>A",
        "Protein Change":"p.Gln475Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001847%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13303574",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0683",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q34.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4363T>C",
        "Protein Change":"p.Leu162Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00413%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10960706",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0684",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q98.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.846G>T",
        "Protein Change":"p.Ser423Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002117%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77216004",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0685",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q82.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7052G>T",
        "Protein Change":"p.Gln312Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000452%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16870911",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0686",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q38.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2085C>G",
        "Protein Change":"p.Gln471Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007742%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12645670",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0687",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q19.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.600A>G",
        "Protein Change":"p.Ser428Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009893%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38891620",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0688",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q99.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5731A>T",
        "Protein Change":"p.Ser472Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000361%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35327389",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0689",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q17.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8314T>T",
        "Protein Change":"p.Gly460Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005032%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15398483",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0690",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q38.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7690T>A",
        "Protein Change":"p.Arg36Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00548%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64244053",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0691",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q51.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6440A>T",
        "Protein Change":"p.Leu446Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008047%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49390436",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0692",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q11.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6090G>C",
        "Protein Change":"p.Arg76Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009836%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99990841",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0693",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q31.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3771C>C",
        "Protein Change":"p.Leu400Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005175%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62669733",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0694",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q17.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6885G>G",
        "Protein Change":"p.Pro34Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001913%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17960099",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0695",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q66.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3574C>G",
        "Protein Change":"p.Arg140Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00243%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22171760",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0696",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q61.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4408C>G",
        "Protein Change":"p.Arg208Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007813%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14593648",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0697",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q51.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1154C>A",
        "Protein Change":"p.Leu376Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006983%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68489025",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0698",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q69.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8322G>G",
        "Protein Change":"p.Leu249Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006136%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58204539",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0699",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q34.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.285C>T",
        "Protein Change":"p.Gly433Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009745%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76515018",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0700",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q58.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4012T>C",
        "Protein Change":"p.Gln176Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00302%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33890287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0701",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q76.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2998T>C",
        "Protein Change":"p.Pro360Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008098%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93754080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0702",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q20.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6325T>A",
        "Protein Change":"p.Gln492Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006651%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94313079",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0703",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q66.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1701A>A",
        "Protein Change":"p.Pro359Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006509%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11129142",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0704",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q13.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5848C>T",
        "Protein Change":"p.Ser384Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006363%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71860092",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0705",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q44.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9728T>C",
        "Protein Change":"p.Arg350Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003612%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44100086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0706",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q11.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5533G>C",
        "Protein Change":"p.Pro424Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006473%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41244247",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0707",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q40.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7008A>C",
        "Protein Change":"p.Gln353Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008813%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44945837",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0708",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q32.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3424G>T",
        "Protein Change":"p.Pro357Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000307%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44051567",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0709",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q93.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3216T>T",
        "Protein Change":"p.Leu402Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007489%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15148718",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0710",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q91.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2824T>T",
        "Protein Change":"p.Arg483Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002002%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30467380",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0711",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q26.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1173G>A",
        "Protein Change":"p.Leu495Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00111%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13922228",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0712",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q82.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1331T>A",
        "Protein Change":"p.Gly131Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002344%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28008902",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0713",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q23.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7277A>A",
        "Protein Change":"p.Gln472Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000183%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77422234",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0714",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q9.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2604C>T",
        "Protein Change":"p.Leu468Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007208%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25459440",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0715",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q88.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4723G>G",
        "Protein Change":"p.Arg240Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005216%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59874660",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0716",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q75.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5779T>A",
        "Protein Change":"p.Arg54Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005821%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19519230",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0717",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q34.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5678A>A",
        "Protein Change":"p.Pro29Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000818%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66146107",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0718",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q9.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5705A>T",
        "Protein Change":"p.Leu13Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003294%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16017274",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0719",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q81.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5247G>G",
        "Protein Change":"p.Leu104Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007822%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75886411",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0720",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q91.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3990A>C",
        "Protein Change":"p.Gly397Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002228%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53071539",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0721",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q34.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8396T>T",
        "Protein Change":"p.Gly179Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009516%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38404413",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0722",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q4.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8883C>C",
        "Protein Change":"p.Gln365Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004914%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48755577",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0723",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q15.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1442T>C",
        "Protein Change":"p.Ser190Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007716%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88070531",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0724",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q57.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3192T>T",
        "Protein Change":"p.Gln7Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003942%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50795985",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0725",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q92.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6997G>A",
        "Protein Change":"p.Gly212Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005104%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67019701",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0726",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q89.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4201A>G",
        "Protein Change":"p.Gln498Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006146%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21752968",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0727",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q93.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3722G>G",
        "Protein Change":"p.Gly483Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007189%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73805761",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0728",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q36.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2495G>T",
        "Protein Change":"p.Gln475Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009187%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99908332",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0729",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q82.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3468G>G",
        "Protein Change":"p.Gln106Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006179%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39137032",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0730",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q64.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.428T>T",
        "Protein Change":"p.Leu188Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009408%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48219041",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0731",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q52.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2391G>G",
        "Protein Change":"p.Ser240Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009476%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92507216",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0732",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q46.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1590G>C",
        "Protein Change":"p.Gly438Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00502%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47420797",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0733",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q42.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8402A>G",
        "Protein Change":"p.Arg362Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008974%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41799389",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0734",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q87.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2557C>A",
        "Protein Change":"p.Leu445Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009607%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60270086",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0735",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q2.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7315T>T",
        "Protein Change":"p.Pro75Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00216%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17136298",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0736",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q14.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.137T>C",
        "Protein Change":"p.Arg247Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002419%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82211849",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0737",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q37.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2594T>G",
        "Protein Change":"p.Gly472Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004726%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64117637",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0738",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q13.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7227G>G",
        "Protein Change":"p.Gly220Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004399%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43578234",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0739",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q3.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4219C>C",
        "Protein Change":"p.Gln155Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009365%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23628880",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0740",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q27.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.663A>T",
        "Protein Change":"p.Gly88Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008855%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53810997",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0741",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q40.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.869T>G",
        "Protein Change":"p.Arg125Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006014%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63955614",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0742",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q46.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9681T>G",
        "Protein Change":"p.Gln494Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007355%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71080153",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0743",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q56.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7191C>T",
        "Protein Change":"p.Leu251Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000314%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12283179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0744",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q4.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5888C>C",
        "Protein Change":"p.Pro186Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003451%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28424322",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0745",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q3.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6386G>A",
        "Protein Change":"p.Arg63Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005101%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51032126",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0746",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q16.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.534A>A",
        "Protein Change":"p.Gln194Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004127%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18269488",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0747",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q40.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7497T>T",
        "Protein Change":"p.Ser485Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009358%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60368889",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0748",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q57.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9913T>C",
        "Protein Change":"p.Arg480Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009824%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50774183",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0749",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q33.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6038T>A",
        "Protein Change":"p.Pro189Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001834%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72447077",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0750",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q6.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5469T>T",
        "Protein Change":"p.Arg417Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007756%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22307207",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0751",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q63.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1185G>C",
        "Protein Change":"p.Gly303Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005136%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53437823",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0752",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q58.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9076T>G",
        "Protein Change":"p.Pro81Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00928%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23094785",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0753",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q97.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7714A>G",
        "Protein Change":"p.Arg307Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009647%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54947653",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0754",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q49.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8144T>G",
        "Protein Change":"p.Arg460Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003456%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51520761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0755",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q7.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8302T>A",
        "Protein Change":"p.Ser331Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009137%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35966424",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0756",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q88.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5030T>T",
        "Protein Change":"p.Leu216Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005695%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10953360",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0757",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q38.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1958G>G",
        "Protein Change":"p.Arg1Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001686%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60990830",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0758",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q70.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.896C>G",
        "Protein Change":"p.Pro171Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001739%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15300477",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0759",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q10.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2066G>C",
        "Protein Change":"p.Ser484Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008959%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86442188",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0760",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q97.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1425C>A",
        "Protein Change":"p.Arg143Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007873%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10431069",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0761",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q48.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1991A>G",
        "Protein Change":"p.Gln27Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001154%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35674859",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0762",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q47.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9977A>C",
        "Protein Change":"p.Pro413Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00284%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29242611",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0763",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q71.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1147A>T",
        "Protein Change":"p.Gly466Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003178%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93868974",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0764",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q98.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1841C>A",
        "Protein Change":"p.Ser338Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003446%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39956744",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0765",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q88.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2651A>A",
        "Protein Change":"p.Arg232Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009907%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82775796",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0766",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q59.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8017T>T",
        "Protein Change":"p.Arg146Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000453%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69336411",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0767",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q29.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1819T>T",
        "Protein Change":"p.Arg406Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005301%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62115363",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0768",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q70.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9512A>A",
        "Protein Change":"p.Ser360Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008424%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77339715",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0769",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q66.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8246G>A",
        "Protein Change":"p.Ser499Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00572%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31404631",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0770",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q79.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.100C>C",
        "Protein Change":"p.Gly398Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00067%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58910144",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0771",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q50.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4739T>G",
        "Protein Change":"p.Leu242Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001959%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21247468",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0772",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q12.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.532C>C",
        "Protein Change":"p.Ser48Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003023%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:90723691",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0773",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q35.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2010T>T",
        "Protein Change":"p.Pro432Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008245%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82997718",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0774",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q56.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.553G>G",
        "Protein Change":"p.Ser139Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002385%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43337645",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0775",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q41.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3670G>A",
        "Protein Change":"p.Arg452Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00222%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67298472",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0776",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q15.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4070A>T",
        "Protein Change":"p.Pro445Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003832%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77122792",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0777",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q82.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5086A>A",
        "Protein Change":"p.Gly337Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005118%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70076350",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0778",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q72.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7208G>G",
        "Protein Change":"p.Ser344Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009129%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64452046",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0779",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q84.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3724C>A",
        "Protein Change":"p.Leu243Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009107%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35341023",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0780",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q21.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2537T>G",
        "Protein Change":"p.Gly397Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001013%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72758841",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0781",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q56.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3195A>C",
        "Protein Change":"p.Arg82Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001759%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62788780",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0782",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q69.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6207C>A",
        "Protein Change":"p.Leu232Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000283%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58106566",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0783",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q7.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8534C>G",
        "Protein Change":"p.Arg35Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009671%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58052254",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0784",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q72.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4038T>A",
        "Protein Change":"p.Arg4Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00039%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48155418",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0785",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q85.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2561A>G",
        "Protein Change":"p.Arg355Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001477%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20419952",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0786",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q55.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4675T>C",
        "Protein Change":"p.Pro252Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000703%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54882032",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0787",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q86.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2990C>A",
        "Protein Change":"p.Arg428Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007279%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24622944",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0788",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q47.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6819G>A",
        "Protein Change":"p.Gln190Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005674%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33452909",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0789",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q85.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9051C>G",
        "Protein Change":"p.Gln377Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004071%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20511423",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0790",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q66.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9093A>T",
        "Protein Change":"p.Leu404Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000647%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71420850",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0791",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q99.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.974C>C",
        "Protein Change":"p.Ser423Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007574%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96937068",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0792",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q26.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3726T>G",
        "Protein Change":"p.Leu187Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007871%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32855181",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0793",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q16.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5674A>T",
        "Protein Change":"p.Pro395Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005249%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82193586",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0794",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q18.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3815T>T",
        "Protein Change":"p.Gly280Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000894%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83716562",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0795",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q9.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7221C>A",
        "Protein Change":"p.Arg493Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001016%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56332755",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0796",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q13.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2343T>T",
        "Protein Change":"p.Pro361Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003262%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74045116",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0797",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q55.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7943C>A",
        "Protein Change":"p.Gln86Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007154%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84983926",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0798",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q92.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1910T>T",
        "Protein Change":"p.Leu184Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006567%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26200112",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0799",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q43.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4224G>C",
        "Protein Change":"p.Ser286Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006965%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38543849",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0800",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q92.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4967A>A",
        "Protein Change":"p.Ser346Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000943%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47312007",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0801",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q76.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1395G>T",
        "Protein Change":"p.Arg487Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00795%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59571426",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0802",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q54.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.302G>G",
        "Protein Change":"p.Arg49Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009372%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52263354",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0803",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q32.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2662G>A",
        "Protein Change":"p.Leu158Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009946%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42605914",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0804",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q98.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9350A>A",
        "Protein Change":"p.Pro91Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000344%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90308779",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0805",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q48.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6330G>A",
        "Protein Change":"p.Ser450Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003338%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30093063",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0806",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q30.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4528G>C",
        "Protein Change":"p.Arg457Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003135%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78851405",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0807",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q65.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8580T>G",
        "Protein Change":"p.Pro386Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000324%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17241172",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0808",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q28.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8502T>C",
        "Protein Change":"p.Arg95Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003426%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88995898",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0809",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q75.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6861A>T",
        "Protein Change":"p.Gly342Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007168%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59461646",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0810",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q44.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2566C>T",
        "Protein Change":"p.Arg474Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005997%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52340988",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0811",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q70.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5903T>A",
        "Protein Change":"p.Ser437Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008519%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48425155",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0812",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q48.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2659A>A",
        "Protein Change":"p.Leu395Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00283%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38243573",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0813",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q64.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4634T>C",
        "Protein Change":"p.Gln48Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007601%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65786161",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0814",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q33.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7193C>G",
        "Protein Change":"p.Gln446Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008608%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71918316",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0815",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q91.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.450T>C",
        "Protein Change":"p.Ser418Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009262%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24157060",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0816",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q83.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9046C>T",
        "Protein Change":"p.Pro102Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008581%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38888005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0817",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q80.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1245G>T",
        "Protein Change":"p.Gly179Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009635%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12172224",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0818",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q68.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3853C>C",
        "Protein Change":"p.Arg203Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002956%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46977098",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0819",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q80.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1961C>T",
        "Protein Change":"p.Leu453Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002858%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74951239",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0820",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q64.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1719A>A",
        "Protein Change":"p.Gly242Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002647%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82472900",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0821",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q18.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3128T>A",
        "Protein Change":"p.Gly494Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009233%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65424107",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0822",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q59.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.422G>T",
        "Protein Change":"p.Gly202Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006201%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83851232",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0823",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q78.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.902A>T",
        "Protein Change":"p.Pro440Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005168%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24455012",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0824",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q29.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3706T>G",
        "Protein Change":"p.Ser47Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006082%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69376232",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0825",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q79.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7727G>T",
        "Protein Change":"p.Gln113Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009428%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63451392",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0826",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q38.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8583C>T",
        "Protein Change":"p.Arg308Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006544%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82221771",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0827",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q73.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5254T>G",
        "Protein Change":"p.Arg132Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003916%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96676170",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0828",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q23.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1558A>G",
        "Protein Change":"p.Gly140Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004436%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31705513",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0829",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q7.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2664C>A",
        "Protein Change":"p.Pro238Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008797%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39332649",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0830",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q55.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1287C>A",
        "Protein Change":"p.Gly474Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008338%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22300803",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0831",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q26.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6537A>T",
        "Protein Change":"p.Ser125Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00407%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22330845",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0832",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q21.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9730T>C",
        "Protein Change":"p.Gln287Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009365%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38690031",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0833",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q2.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6466C>T",
        "Protein Change":"p.Gln41Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001705%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34624560",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0834",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q85.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2730G>A",
        "Protein Change":"p.Leu318Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009833%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46982387",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0835",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q6.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4294T>A",
        "Protein Change":"p.Gly459Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000493%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29035924",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0836",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q62.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7529C>G",
        "Protein Change":"p.Pro464Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009219%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79724394",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0837",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q88.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1457A>A",
        "Protein Change":"p.Ser149Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009354%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30678941",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0838",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q72.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.283G>C",
        "Protein Change":"p.Gln494Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006114%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97920315",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0839",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q70.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6559A>A",
        "Protein Change":"p.Leu250Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005504%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40826336",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0840",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q76.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4759C>T",
        "Protein Change":"p.Pro152Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006357%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65670796",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0841",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q77.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.422G>T",
        "Protein Change":"p.Pro248Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006618%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81190152",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0842",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q1.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1021T>C",
        "Protein Change":"p.Leu391Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004975%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59039155",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0843",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q61.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.765A>A",
        "Protein Change":"p.Gln494Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006493%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47656919",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0844",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q90.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6125G>T",
        "Protein Change":"p.Gln60Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001481%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57058446",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0845",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q9.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9737A>A",
        "Protein Change":"p.Arg187Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004309%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41168055",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0846",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q77.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9902G>T",
        "Protein Change":"p.Ser53Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001075%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15045333",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0847",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q17.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.519A>A",
        "Protein Change":"p.Pro309Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009825%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77803719",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0848",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q33.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8000G>C",
        "Protein Change":"p.Ser276Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003962%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69313913",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0849",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q96.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5802G>A",
        "Protein Change":"p.Gly234Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003902%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94215087",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0850",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q94.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3762C>A",
        "Protein Change":"p.Ser332Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003228%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91937998",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0851",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q41.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2634G>C",
        "Protein Change":"p.Gln493Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001115%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58186638",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0852",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q41.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2263G>G",
        "Protein Change":"p.Arg17Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00305%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71254766",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0853",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q81.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9934A>T",
        "Protein Change":"p.Arg159Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000991%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56858847",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0854",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q22.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2679T>G",
        "Protein Change":"p.Gly4Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00659%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78534600",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0855",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q70.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4051T>T",
        "Protein Change":"p.Pro474Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005186%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81320251",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0856",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q89.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2494A>C",
        "Protein Change":"p.Gly135Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000295%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38355225",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0857",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q92.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4323A>T",
        "Protein Change":"p.Gly52Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008937%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21871873",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0858",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q69.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6013A>T",
        "Protein Change":"p.Arg236Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002617%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83848363",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0859",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q73.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8882A>C",
        "Protein Change":"p.Leu192Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00963%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82810164",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0860",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q60.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2548G>G",
        "Protein Change":"p.Gly271Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002855%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26438287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0861",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q89.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6844G>A",
        "Protein Change":"p.Ser282Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005955%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90206108",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0862",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q80.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4698C>C",
        "Protein Change":"p.Gly30Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004862%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91725930",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0863",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q81.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6617C>G",
        "Protein Change":"p.Leu370Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003912%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14625393",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0864",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q52.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9318T>T",
        "Protein Change":"p.Gly9Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00042%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85205100",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0865",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q46.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1572T>G",
        "Protein Change":"p.Gln119Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000641%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91488290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0866",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q31.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.665C>T",
        "Protein Change":"p.Gly306Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005208%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20500561",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0867",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q20.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2277G>C",
        "Protein Change":"p.Gly323Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006733%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21253207",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0868",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q28.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2423C>T",
        "Protein Change":"p.Arg307Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004085%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37963838",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0869",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q1.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3155G>C",
        "Protein Change":"p.Ser349Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005523%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26362521",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0870",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q64.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1912T>A",
        "Protein Change":"p.Pro373Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003766%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86475486",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0871",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q82.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9059G>A",
        "Protein Change":"p.Arg216Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002524%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:27950275",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0872",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q83.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3997C>T",
        "Protein Change":"p.Leu499Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006431%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34257374",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0873",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q67.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4365A>C",
        "Protein Change":"p.Pro77Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005784%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58208574",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0874",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q62.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5191C>C",
        "Protein Change":"p.Gly163Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004224%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82294375",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0875",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q51.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3728C>A",
        "Protein Change":"p.Ser203Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001106%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61233700",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0876",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q25.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8722A>A",
        "Protein Change":"p.Gly431Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005282%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22523343",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0877",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q6.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8086C>C",
        "Protein Change":"p.Ser350Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007994%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60945613",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0878",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q82.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6849T>T",
        "Protein Change":"p.Ser408Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009812%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63561014",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0879",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q38.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9060G>A",
        "Protein Change":"p.Pro457Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001745%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93453411",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0880",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q94.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3009G>T",
        "Protein Change":"p.Ser419Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004041%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59465387",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0881",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q68.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7727A>T",
        "Protein Change":"p.Leu23Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002506%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15109038",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0882",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q34.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4505A>G",
        "Protein Change":"p.Gln397Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006545%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44611147",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0883",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q87.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3810A>C",
        "Protein Change":"p.Leu498Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001528%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:50506751",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0884",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q23.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8434T>G",
        "Protein Change":"p.Pro468Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001755%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49537355",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0885",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q75.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7060T>C",
        "Protein Change":"p.Ser350Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004579%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11477203",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0886",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q90.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6613C>C",
        "Protein Change":"p.Leu464Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006527%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61205804",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0887",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q98.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4175C>G",
        "Protein Change":"p.Gly187Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007633%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46435047",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0888",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q27.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9241G>G",
        "Protein Change":"p.Gln68Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006417%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39097914",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0889",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q50.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5342C>C",
        "Protein Change":"p.Gly410Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005033%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92072205",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0890",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q69.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2561A>A",
        "Protein Change":"p.Pro161Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009842%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41645816",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0891",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q54.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3123A>C",
        "Protein Change":"p.Arg423Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007688%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20854945",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0892",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q72.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.633C>T",
        "Protein Change":"p.Pro358Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008849%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97517706",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0893",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q62.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8668G>G",
        "Protein Change":"p.Ser89Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009976%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92592952",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0894",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q37.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8127G>C",
        "Protein Change":"p.Leu192Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004219%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32294461",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0895",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q84.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8031G>T",
        "Protein Change":"p.Pro324Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00558%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41325133",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0896",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q18.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.857T>C",
        "Protein Change":"p.Arg231Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003555%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88654959",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0897",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q42.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7497C>G",
        "Protein Change":"p.Arg158Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001891%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28094934",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0898",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q78.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4452G>G",
        "Protein Change":"p.Gly138Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000251%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21304195",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0899",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q67.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3160C>A",
        "Protein Change":"p.Arg496Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006884%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52002010",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0900",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q69.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9431T>G",
        "Protein Change":"p.Gln282Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009242%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17309513",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0901",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q45.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8705A>C",
        "Protein Change":"p.Pro327Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00496%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79122007",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0902",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q42.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9917A>G",
        "Protein Change":"p.Leu475Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007006%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94383586",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0903",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q88.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.736C>A",
        "Protein Change":"p.Leu447Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00387%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37279625",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0904",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q81.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5937C>C",
        "Protein Change":"p.Gly96Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003123%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22396931",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0905",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q19.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8320T>A",
        "Protein Change":"p.Gln219Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00297%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32761750",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0906",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q29.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2258G>C",
        "Protein Change":"p.Ser155Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005721%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77172032",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0907",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q39.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2092C>G",
        "Protein Change":"p.Pro143Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00712%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31307741",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0908",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q98.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.110T>T",
        "Protein Change":"p.Arg480Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00147%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64411310",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0909",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q45.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8140C>C",
        "Protein Change":"p.Gly119Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003315%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71100146",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0910",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q98.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6107T>T",
        "Protein Change":"p.Arg248Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00362%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23627005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0911",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q92.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2987A>G",
        "Protein Change":"p.Ser110Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00517%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29605787",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0912",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q53.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4075C>A",
        "Protein Change":"p.Pro34Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005438%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55390616",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0913",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q96.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1902A>T",
        "Protein Change":"p.Ser451Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003611%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25110671",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0914",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q12.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8155T>T",
        "Protein Change":"p.Leu332Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008859%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30400598",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0915",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q48.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7209G>T",
        "Protein Change":"p.Gln440Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002329%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25977388",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0916",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q1.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4721G>C",
        "Protein Change":"p.Pro289Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004618%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19889164",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0917",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q1.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5857T>G",
        "Protein Change":"p.Ser269Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006158%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54832791",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0918",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q38.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3557A>C",
        "Protein Change":"p.Arg408Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003324%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46583825",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0919",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q99.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1007C>C",
        "Protein Change":"p.Ser107Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002319%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66105996",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0920",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q71.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3938A>T",
        "Protein Change":"p.Gln72Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003041%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25024235",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0921",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q91.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1361T>A",
        "Protein Change":"p.Arg151Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003291%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26991466",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0922",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q27.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8287T>G",
        "Protein Change":"p.Ser271Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004237%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81711044",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0923",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q8.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1355C>T",
        "Protein Change":"p.Ser432Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00591%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42565664",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0924",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q99.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.150A>A",
        "Protein Change":"p.Pro181Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007114%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45302818",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0925",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q33.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5520G>C",
        "Protein Change":"p.Ser170Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00551%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77549143",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0926",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q10.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.717T>A",
        "Protein Change":"p.Gln212Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007992%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95839520",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0927",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q2.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8355A>C",
        "Protein Change":"p.Pro8Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005226%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50004092",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0928",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q85.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8537G>A",
        "Protein Change":"p.Pro126Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009367%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58398781",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0929",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q36.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3558C>C",
        "Protein Change":"p.Gln47Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005842%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70387669",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0930",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q73.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3907C>G",
        "Protein Change":"p.Gly311Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006782%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37845706",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0931",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q41.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7864T>A",
        "Protein Change":"p.Gly166Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007802%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62190901",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0932",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q83.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7206A>C",
        "Protein Change":"p.Gln251Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004056%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14342787",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0933",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q14.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6840C>A",
        "Protein Change":"p.Pro375Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009618%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30649907",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0934",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q24.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.142A>A",
        "Protein Change":"p.Ser84Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007134%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82959444",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0935",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q20.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.487C>C",
        "Protein Change":"p.Gly339Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006123%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20036704",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0936",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q81.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6928A>T",
        "Protein Change":"p.Arg83Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007355%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26938186",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0937",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q51.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.634A>T",
        "Protein Change":"p.Gly164Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004605%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76477486",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0938",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q99.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1651C>C",
        "Protein Change":"p.Gln486Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006277%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15962359",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0939",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q50.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4055T>T",
        "Protein Change":"p.Pro122Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00478%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39654749",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0940",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q7.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4448T>A",
        "Protein Change":"p.Arg101Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009801%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26669123",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0941",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q31.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3220A>C",
        "Protein Change":"p.Leu306Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005269%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53142118",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0942",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q56.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7138G>C",
        "Protein Change":"p.Gly338Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009621%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13752929",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0943",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q34.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9643G>T",
        "Protein Change":"p.Ser276Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001709%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30786148",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0944",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q58.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8255T>T",
        "Protein Change":"p.Ser101Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001571%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68956565",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0945",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q74.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.142T>C",
        "Protein Change":"p.Gln389Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009193%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31533183",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0946",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q59.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2933C>T",
        "Protein Change":"p.Arg359Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003071%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81061110",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0947",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q49.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7924T>T",
        "Protein Change":"p.Gln454Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009345%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90657942",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0948",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q3.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6020T>C",
        "Protein Change":"p.Leu109Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009204%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91417266",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0949",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q78.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7554T>C",
        "Protein Change":"p.Gln69Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005094%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27215696",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0950",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q94.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7023T>G",
        "Protein Change":"p.Arg281Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009763%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25988291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0951",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q76.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5828T>T",
        "Protein Change":"p.Arg167Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005931%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51886108",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0952",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q75.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8736A>A",
        "Protein Change":"p.Gln442Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000691%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62779938",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0953",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q98.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3581A>C",
        "Protein Change":"p.Leu40Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003081%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96277221",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0954",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q11.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4294G>T",
        "Protein Change":"p.Leu367Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004929%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55041666",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0955",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q78.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1522T>G",
        "Protein Change":"p.Arg192Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009379%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53915895",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0956",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q51.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6321C>C",
        "Protein Change":"p.Ser467Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008316%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72148217",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0957",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q81.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1197G>A",
        "Protein Change":"p.Leu254Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009091%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43001984",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0958",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q30.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3603A>T",
        "Protein Change":"p.Leu60Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003151%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90987493",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0959",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q16.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6725T>T",
        "Protein Change":"p.Pro373Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005253%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91487593",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0960",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q57.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.807A>C",
        "Protein Change":"p.Arg376Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009251%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33370311",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0961",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q81.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7186G>T",
        "Protein Change":"p.Ser265Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008782%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76289053",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0962",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q36.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5377T>A",
        "Protein Change":"p.Gly242Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004837%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46820127",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0963",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q10.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.731A>G",
        "Protein Change":"p.Ser87Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002622%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79214663",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0964",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q41.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.925C>G",
        "Protein Change":"p.Ser400Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008551%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15259292",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0965",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q90.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2875A>A",
        "Protein Change":"p.Arg283Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001607%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92252002",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0966",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q28.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6719G>T",
        "Protein Change":"p.Ser179Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008324%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87190583",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0967",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q7.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3158T>G",
        "Protein Change":"p.Ser40Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008018%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82752522",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0968",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q22.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7258C>G",
        "Protein Change":"p.Leu476Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005721%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51203403",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0969",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q78.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3987C>T",
        "Protein Change":"p.Arg226Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004257%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36167654",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0970",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q39.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7803G>G",
        "Protein Change":"p.Pro126Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009844%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24062858",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0971",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q50.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1370A>A",
        "Protein Change":"p.Gln11Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005428%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97269961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0972",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q84.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2910T>A",
        "Protein Change":"p.Gln401Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000464%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23287550",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0973",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q24.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5183C>T",
        "Protein Change":"p.Pro205Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005778%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48138788",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0974",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q47.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2113A>G",
        "Protein Change":"p.Gln451Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004811%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88720335",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0975",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q61.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.221C>A",
        "Protein Change":"p.Gly382Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008122%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28640290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0976",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q61.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.508C>G",
        "Protein Change":"p.Arg384Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004002%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81317178",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0977",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q83.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6340A>T",
        "Protein Change":"p.Ser64Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008347%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60478179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0978",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q37.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2569G>T",
        "Protein Change":"p.Gln395Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007966%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75819179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0979",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q31.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6030C>G",
        "Protein Change":"p.Gln479Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008439%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56112471",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0980",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q94.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8773C>C",
        "Protein Change":"p.Gln22Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005829%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64103420",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0981",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q10.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7809A>C",
        "Protein Change":"p.Gly51Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006872%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81146236",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0982",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q92.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.523A>T",
        "Protein Change":"p.Pro383Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005203%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51439010",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0983",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q12.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1824T>G",
        "Protein Change":"p.Arg458Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009534%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76553359",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0984",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q57.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9284T>G",
        "Protein Change":"p.Arg64Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002421%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47403296",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0985",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q65.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8645C>A",
        "Protein Change":"p.Gln425Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006514%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50414865",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0986",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q39.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.378A>A",
        "Protein Change":"p.Ser118Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00163%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89475985",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0987",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q55.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9749T>A",
        "Protein Change":"p.Pro328Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009107%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78855290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0988",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q99.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1415A>A",
        "Protein Change":"p.Gly478Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003726%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48664945",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0989",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q6.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2443T>T",
        "Protein Change":"p.Gln210Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009312%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67087213",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0990",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q13.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2419G>G",
        "Protein Change":"p.Gly339Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002996%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26405002",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0991",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q50.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6803A>T",
        "Protein Change":"p.Gly36Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009446%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28290088",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0992",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q9.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1495G>A",
        "Protein Change":"p.Gln79Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002807%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16893416",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0993",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q82.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2190A>C",
        "Protein Change":"p.Ser408Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006701%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17797154",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0994",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q21.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4795C>T",
        "Protein Change":"p.Leu433Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004247%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27972220",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT0995",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q7.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7813T>T",
        "Protein Change":"p.Gln117Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008246%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93473537",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0996",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q62.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3088G>G",
        "Protein Change":"p.Arg201Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001392%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74709404",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0997",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q22.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6210C>C",
        "Protein Change":"p.Arg320Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002941%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20552318",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT0998",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q21.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9240G>T",
        "Protein Change":"p.Arg102Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007895%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36022635",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT0999",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q25.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1078A>G",
        "Protein Change":"p.Pro198Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91920143",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1000",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q36.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2702C>T",
        "Protein Change":"p.Arg389Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007134%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74324373",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1001",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q46.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2078T>T",
        "Protein Change":"p.Leu165Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008819%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83047196",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1002",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q5.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3826G>A",
        "Protein Change":"p.Ser400Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001831%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40407675",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1003",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q1.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6148C>T",
        "Protein Change":"p.Gly207Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003118%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54281940",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1004",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q67.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8608C>T",
        "Protein Change":"p.Gln326Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000197%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36352086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1005",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q25.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.968G>G",
        "Protein Change":"p.Gly257Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005389%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55922767",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1006",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q6.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6985T>A",
        "Protein Change":"p.Arg63Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003212%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78410771",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1007",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q46.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4636T>G",
        "Protein Change":"p.Gly436Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000703%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70596792",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1008",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q62.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1008C>A",
        "Protein Change":"p.Ser318Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002828%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32774829",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1009",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q27.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3680A>C",
        "Protein Change":"p.Ser430Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006076%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10951410",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1010",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q72.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.320G>T",
        "Protein Change":"p.Arg402Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008905%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38923714",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1011",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q68.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9790C>T",
        "Protein Change":"p.Gln70Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003957%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28748142",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1012",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q1.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3178C>G",
        "Protein Change":"p.Gln113Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00952%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31368768",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1013",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q64.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3892T>G",
        "Protein Change":"p.Leu62Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004788%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95894243",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1014",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q49.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8860G>G",
        "Protein Change":"p.Gly242Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001942%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:40747546",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1015",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q39.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2597G>A",
        "Protein Change":"p.Gln317Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00295%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87468930",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1016",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q43.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6947C>T",
        "Protein Change":"p.Arg406Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000964%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35286598",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1017",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q81.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8640C>C",
        "Protein Change":"p.Arg272Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00199%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28544001",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1018",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q15.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5445G>G",
        "Protein Change":"p.Gln373Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005394%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23218311",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1019",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q85.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8502T>G",
        "Protein Change":"p.Leu355Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000472%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11050859",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1020",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q81.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5519T>T",
        "Protein Change":"p.Ser325Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00295%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94604037",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1021",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q5.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5220G>A",
        "Protein Change":"p.Pro39Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005942%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81177002",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1022",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q19.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5021G>G",
        "Protein Change":"p.Arg204Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005384%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76716636",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1023",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q10.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5209A>T",
        "Protein Change":"p.Arg121Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009442%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27693061",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1024",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q71.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7391G>A",
        "Protein Change":"p.Gly355Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006595%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71909398",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1025",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q45.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4644G>C",
        "Protein Change":"p.Gly296Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002299%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13160360",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1026",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q77.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2310G>A",
        "Protein Change":"p.Arg224Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007201%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84017177",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1027",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q22.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9335C>C",
        "Protein Change":"p.Pro312Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001205%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46083068",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1028",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q77.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2702C>T",
        "Protein Change":"p.Pro226Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005985%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71473080",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1029",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q13.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3546G>C",
        "Protein Change":"p.Leu192Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009735%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52879833",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1030",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q28.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4362T>G",
        "Protein Change":"p.Leu354Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002733%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11765748",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1031",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q82.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8059C>A",
        "Protein Change":"p.Arg67Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008443%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48408217",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1032",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q84.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.558C>T",
        "Protein Change":"p.Arg139Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004648%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67504000",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1033",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q22.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2997C>G",
        "Protein Change":"p.Gly47Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001189%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71753936",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1034",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q55.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2085T>C",
        "Protein Change":"p.Ser200Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008996%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64700255",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1035",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q57.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7293T>G",
        "Protein Change":"p.Ser387Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009437%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94005814",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1036",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q24.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6112T>T",
        "Protein Change":"p.Leu352Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006201%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56611526",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1037",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q76.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1542T>T",
        "Protein Change":"p.Gln25Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004669%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38276417",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1038",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q51.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1690G>A",
        "Protein Change":"p.Leu98Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000862%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67355041",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1039",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q75.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2707G>G",
        "Protein Change":"p.Gly241Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00747%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22847620",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1040",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q70.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.338A>C",
        "Protein Change":"p.Ser395Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002322%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53127530",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1041",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q70.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8944A>C",
        "Protein Change":"p.Pro156Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006523%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80796012",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1042",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q43.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8287G>G",
        "Protein Change":"p.Leu224Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004887%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75961662",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1043",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q86.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4029G>G",
        "Protein Change":"p.Arg372Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001762%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78612868",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1044",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q9.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.667T>C",
        "Protein Change":"p.Gln234Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009316%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97330566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1045",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q82.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7737T>T",
        "Protein Change":"p.Pro104Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002655%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21571882",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1046",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q91.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9691A>A",
        "Protein Change":"p.Gly193Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002511%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79122899",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1047",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q8.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9384G>G",
        "Protein Change":"p.Leu129Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003855%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13103260",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1048",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q37.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6872G>A",
        "Protein Change":"p.Ser485Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009763%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72393454",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1049",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q23.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2688A>T",
        "Protein Change":"p.Pro119Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000192%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76864926",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1050",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q87.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6349G>T",
        "Protein Change":"p.Ser167Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00011%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83505591",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1051",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q38.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1959A>G",
        "Protein Change":"p.Gly489Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008709%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43143538",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1052",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q7.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9908T>T",
        "Protein Change":"p.Pro212Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001751%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27694070",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1053",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q75.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6233A>A",
        "Protein Change":"p.Gly215Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007436%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10673660",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1054",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q52.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3571T>T",
        "Protein Change":"p.Arg55Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00975%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80959326",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1055",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q44.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2253G>C",
        "Protein Change":"p.Ser313Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004458%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82798234",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1056",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q78.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2379G>T",
        "Protein Change":"p.Gly256Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006817%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24841665",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1057",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q70.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4779A>T",
        "Protein Change":"p.Gly85Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009256%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54401292",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1058",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q83.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.797G>G",
        "Protein Change":"p.Arg404Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004651%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95954192",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1059",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q22.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6157T>T",
        "Protein Change":"p.Pro228Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007085%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88107230",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1060",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q62.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6920A>T",
        "Protein Change":"p.Gly421Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00303%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38883086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1061",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q82.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5610C>T",
        "Protein Change":"p.Arg7Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83980681",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1062",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q62.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.820C>A",
        "Protein Change":"p.Arg429Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007631%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75093951",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1063",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q98.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9231A>G",
        "Protein Change":"p.Leu399Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001763%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40447964",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1064",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q53.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3902G>C",
        "Protein Change":"p.Gly267Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006761%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68611291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1065",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q22.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2222T>A",
        "Protein Change":"p.Arg303Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007321%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55960509",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1066",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q35.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8206T>T",
        "Protein Change":"p.Leu189Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002034%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83851876",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1067",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q2.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.308C>T",
        "Protein Change":"p.Gln180Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008658%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68128129",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1068",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q72.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3548C>A",
        "Protein Change":"p.Arg372Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005243%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82127497",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1069",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q94.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1212T>A",
        "Protein Change":"p.Leu400Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007208%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14475664",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1070",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q85.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4966G>C",
        "Protein Change":"p.Gly460Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002345%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26685926",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1071",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q54.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2168G>C",
        "Protein Change":"p.Gln375Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00444%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60351591",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1072",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q21.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6118G>G",
        "Protein Change":"p.Pro323Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009117%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35852205",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1073",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q61.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4815C>G",
        "Protein Change":"p.Pro209Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009509%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93858983",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1074",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q70.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2386C>A",
        "Protein Change":"p.Ser327Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004281%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63365979",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1075",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q76.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3226T>T",
        "Protein Change":"p.Gln198Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008339%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71332744",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1076",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q47.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1758T>G",
        "Protein Change":"p.Arg261Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005733%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37510083",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1077",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q12.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4357T>T",
        "Protein Change":"p.Leu489Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005724%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15608540",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1078",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q15.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5542G>C",
        "Protein Change":"p.Gly270Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005213%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14392934",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1079",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q36.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2133A>G",
        "Protein Change":"p.Leu478Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000784%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22436234",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1080",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q44.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6449T>C",
        "Protein Change":"p.Arg116Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000271%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39535386",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1081",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q80.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7570T>G",
        "Protein Change":"p.Leu365Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002607%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98426000",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1082",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q60.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2073C>C",
        "Protein Change":"p.Gly213Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006405%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12084263",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1083",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q16.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3150C>T",
        "Protein Change":"p.Gln404Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006857%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53024883",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1084",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q80.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8607A>A",
        "Protein Change":"p.Arg367Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003569%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66381190",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1085",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q66.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5543T>G",
        "Protein Change":"p.Leu295Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006911%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93243220",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1086",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q12.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9864T>T",
        "Protein Change":"p.Pro469Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001619%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82557376",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1087",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q86.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9745G>A",
        "Protein Change":"p.Gln136Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00418%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41528798",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1088",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q48.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9184G>A",
        "Protein Change":"p.Gly247Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008866%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38947325",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1089",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q56.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6812C>C",
        "Protein Change":"p.Leu472Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006845%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33299186",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1090",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q38.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1432G>G",
        "Protein Change":"p.Gln219Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006153%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56318605",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1091",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q76.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5258T>C",
        "Protein Change":"p.Gly431Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004164%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74716856",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1092",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q99.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2490T>G",
        "Protein Change":"p.Gln423Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001513%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10617009",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1093",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q6.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2891A>A",
        "Protein Change":"p.Leu140Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00106%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56539557",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1094",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q85.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8398C>G",
        "Protein Change":"p.Arg372Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006893%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98333929",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1095",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q14.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8253C>T",
        "Protein Change":"p.Pro283Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00202%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19970908",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1096",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q63.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9018A>T",
        "Protein Change":"p.Leu232Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000814%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59267657",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1097",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q72.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4103A>T",
        "Protein Change":"p.Arg122Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009784%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79068979",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1098",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q22.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.602T>C",
        "Protein Change":"p.Ser96Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003208%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69587581",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1099",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q6.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2948C>G",
        "Protein Change":"p.Arg40Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009118%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83963029",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1100",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q52.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.857A>T",
        "Protein Change":"p.Pro411Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00804%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18029954",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1101",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q37.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.925C>G",
        "Protein Change":"p.Arg60Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002392%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33695553",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1102",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q57.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8619C>A",
        "Protein Change":"p.Gln280Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000786%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12059385",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1103",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q93.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7725G>T",
        "Protein Change":"p.Gly436Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001602%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50537392",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1104",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q65.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4783C>T",
        "Protein Change":"p.Gly245Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002053%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31725157",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1105",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q57.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2091C>A",
        "Protein Change":"p.Gln269Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009684%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81327689",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1106",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q81.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9805G>T",
        "Protein Change":"p.Arg211Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004512%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73589171",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1107",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q83.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.100T>T",
        "Protein Change":"p.Arg166Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0032%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41601050",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1108",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q44.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7208G>T",
        "Protein Change":"p.Pro308Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008082%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51254724",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1109",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q79.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4421A>A",
        "Protein Change":"p.Gln171Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000543%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79871532",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1110",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q69.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8893C>T",
        "Protein Change":"p.Gly424Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001065%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19773871",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1111",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q34.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5569C>T",
        "Protein Change":"p.Gln413Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009198%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:43305075",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1112",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q59.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5045C>A",
        "Protein Change":"p.Pro289Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007137%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50052260",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1113",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q47.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9115G>C",
        "Protein Change":"p.Gly110Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007585%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52775201",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1114",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q8.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6764G>G",
        "Protein Change":"p.Gly313Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002228%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23616732",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1115",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q16.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2999A>C",
        "Protein Change":"p.Leu224Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000116%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88641419",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1116",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q27.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8514A>T",
        "Protein Change":"p.Gln424Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001717%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96135721",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1117",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q29.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4538A>A",
        "Protein Change":"p.Pro149Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003048%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28557592",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1118",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q91.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5251T>A",
        "Protein Change":"p.Pro391Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00276%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60094265",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1119",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q57.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9795T>A",
        "Protein Change":"p.Gly272Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001834%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:43345535",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1120",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q1.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4021G>C",
        "Protein Change":"p.Gln283Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003089%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77465410",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1121",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q60.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4792C>A",
        "Protein Change":"p.Pro265Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005385%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72860743",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1122",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q48.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.146G>T",
        "Protein Change":"p.Leu475Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002382%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96591963",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1123",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q63.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.202G>T",
        "Protein Change":"p.Gly158Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002244%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47198521",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1124",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q95.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2793T>T",
        "Protein Change":"p.Gln249Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009321%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61110197",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1125",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q7.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2752A>A",
        "Protein Change":"p.Pro386Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00592%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61554964",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1126",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q54.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9174G>A",
        "Protein Change":"p.Pro375Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000883%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55403970",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1127",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q14.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2583T>A",
        "Protein Change":"p.Pro77Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00733%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33261701",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1128",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q33.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6806T>A",
        "Protein Change":"p.Gly351Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002783%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62730124",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1129",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q86.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1323A>C",
        "Protein Change":"p.Pro442Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007933%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68440383",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1130",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q15.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8950T>C",
        "Protein Change":"p.Pro248Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001457%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35965315",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1131",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q3.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1969G>A",
        "Protein Change":"p.Arg183Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006543%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91481682",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1132",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q84.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9568T>A",
        "Protein Change":"p.Gln141Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006029%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30191570",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1133",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q73.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2391T>G",
        "Protein Change":"p.Gly364Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005072%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36270109",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1134",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q20.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7745G>G",
        "Protein Change":"p.Arg420Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000608%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20195612",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1135",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q16.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2331G>A",
        "Protein Change":"p.Ser9Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000433%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83292647",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1136",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q46.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8877C>G",
        "Protein Change":"p.Leu129Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005841%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16107943",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1137",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q93.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2078C>A",
        "Protein Change":"p.Pro413Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007712%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76073939",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1138",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q67.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.450A>T",
        "Protein Change":"p.Gly208Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002171%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99257689",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1139",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q18.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4248A>G",
        "Protein Change":"p.Gly479Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007697%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54430143",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1140",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q20.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5417A>T",
        "Protein Change":"p.Gln365Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006833%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53894211",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1141",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q35.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1947A>A",
        "Protein Change":"p.Arg400Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008947%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29247989",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1142",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q42.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4471A>A",
        "Protein Change":"p.Ser21Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006284%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96830220",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1143",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q7.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7138C>G",
        "Protein Change":"p.Pro65Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002834%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85079278",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1144",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q84.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6219C>G",
        "Protein Change":"p.Pro116Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003613%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27977415",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1145",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q25.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3889A>C",
        "Protein Change":"p.Gly68Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00217%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57083447",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1146",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q50.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4538T>A",
        "Protein Change":"p.Arg78Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000685%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77738840",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1147",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q82.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5438G>A",
        "Protein Change":"p.Ser267Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003971%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11214920",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1148",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q29.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7164T>C",
        "Protein Change":"p.Gly350Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006397%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77456925",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1149",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q35.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5026A>C",
        "Protein Change":"p.Ser159Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003402%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74535012",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1150",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q53.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5205C>C",
        "Protein Change":"p.Arg227Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008882%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70777000",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1151",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q30.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2813T>A",
        "Protein Change":"p.Arg287Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008523%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82124348",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1152",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q14.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4627T>T",
        "Protein Change":"p.Gln444Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006029%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75362334",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1153",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q19.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9989G>C",
        "Protein Change":"p.Ser413Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007291%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80375348",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1154",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q79.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8041A>T",
        "Protein Change":"p.Gln425Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007851%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45175642",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1155",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q57.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4472G>T",
        "Protein Change":"p.Ser242Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001231%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19474127",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1156",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q94.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4520G>A",
        "Protein Change":"p.Gln467Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004251%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74685678",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1157",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q58.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9609C>T",
        "Protein Change":"p.Leu317Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006691%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17979634",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1158",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q93.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6874A>G",
        "Protein Change":"p.Arg351Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002329%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45044425",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1159",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q16.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2145C>T",
        "Protein Change":"p.Leu82Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007606%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33939555",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1160",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q68.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8887A>C",
        "Protein Change":"p.Arg126Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000993%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25809866",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1161",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q4.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4086G>A",
        "Protein Change":"p.Pro203Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001098%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73348952",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1162",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q88.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3451C>G",
        "Protein Change":"p.Leu219Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009209%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52659109",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1163",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q35.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8297T>G",
        "Protein Change":"p.Gly416Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008749%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29733473",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1164",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q42.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3453A>G",
        "Protein Change":"p.Pro67Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004396%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36664777",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1165",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q35.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1977G>C",
        "Protein Change":"p.Leu424Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002961%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78611508",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1166",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q58.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.392A>A",
        "Protein Change":"p.Leu176Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00772%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46072634",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1167",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q28.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2590A>A",
        "Protein Change":"p.Gln256Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006353%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76614965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1168",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q85.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6245G>T",
        "Protein Change":"p.Gln212Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004964%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48737546",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1169",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q8.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6158A>C",
        "Protein Change":"p.Gly337Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003922%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30819661",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1170",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q67.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3858G>G",
        "Protein Change":"p.Gly69Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009985%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75751726",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1171",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q98.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9133T>C",
        "Protein Change":"p.Leu29Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007139%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57940295",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1172",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q84.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2407A>T",
        "Protein Change":"p.Ser452Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97279491",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1173",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q29.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8318G>T",
        "Protein Change":"p.Pro307Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00748%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18244131",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1174",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q58.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2855A>G",
        "Protein Change":"p.Ser83Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009371%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76000539",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1175",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q36.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8047T>A",
        "Protein Change":"p.Pro84Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001362%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66330931",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1176",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q18.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7966G>A",
        "Protein Change":"p.Leu24Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009429%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39334577",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1177",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q97.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2166G>G",
        "Protein Change":"p.Pro27Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003039%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89622042",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1178",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q24.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4122T>G",
        "Protein Change":"p.Gln48Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006144%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88824137",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1179",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q90.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.937T>A",
        "Protein Change":"p.Gly395Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007596%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91631854",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1180",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q37.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7115C>G",
        "Protein Change":"p.Pro215Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008045%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19485701",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1181",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q80.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8076G>T",
        "Protein Change":"p.Arg259Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002093%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86352315",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1182",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q90.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2172A>A",
        "Protein Change":"p.Ser113Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001315%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58579303",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1183",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q49.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4816G>C",
        "Protein Change":"p.Arg254Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001415%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92574420",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1184",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q31.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1876T>A",
        "Protein Change":"p.Gln179Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49334719",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1185",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q65.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1773A>A",
        "Protein Change":"p.Ser378Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005554%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49930116",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1186",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q61.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2155A>C",
        "Protein Change":"p.Leu323Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001104%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19770469",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1187",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q71.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7158A>G",
        "Protein Change":"p.Pro35Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008578%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41375805",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1188",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q41.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9299A>C",
        "Protein Change":"p.Pro236Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006198%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22495297",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1189",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q85.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5476G>T",
        "Protein Change":"p.Arg50Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005403%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10275241",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1190",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q93.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3353C>C",
        "Protein Change":"p.Gly354Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002897%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60471840",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1191",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q3.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8703T>A",
        "Protein Change":"p.Arg431Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003371%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91867222",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1192",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q77.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7682C>T",
        "Protein Change":"p.Gly494Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002314%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11992173",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1193",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q84.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4094A>A",
        "Protein Change":"p.Ser306Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002617%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95022198",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1194",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q55.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.198T>T",
        "Protein Change":"p.Arg84Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007361%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99193609",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1195",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q51.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6329T>C",
        "Protein Change":"p.Ser458Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00322%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42410608",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1196",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q47.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7626C>G",
        "Protein Change":"p.Ser86Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00378%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92605738",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1197",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q37.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1756C>C",
        "Protein Change":"p.Gly125Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001867%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33708118",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1198",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q24.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6116C>A",
        "Protein Change":"p.Gly12Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002508%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:40503809",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1199",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q55.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1179T>T",
        "Protein Change":"p.Ser135Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007521%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58545545",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1200",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q93.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5682G>T",
        "Protein Change":"p.Pro21Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002902%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58211393",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1201",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q21.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7127G>T",
        "Protein Change":"p.Ser254Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001999%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:79065276",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1202",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q33.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8836G>A",
        "Protein Change":"p.Arg138Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001539%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16790964",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1203",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q58.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7190G>A",
        "Protein Change":"p.Leu235Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009339%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88008515",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1204",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q36.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.940T>C",
        "Protein Change":"p.Gly236Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008874%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17482351",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1205",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q46.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2295T>G",
        "Protein Change":"p.Ser356Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00518%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48009566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1206",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q17.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4372T>G",
        "Protein Change":"p.Gln96Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004018%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97222580",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1207",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q20.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3045A>G",
        "Protein Change":"p.Gly177Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38525573",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1208",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q62.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9854C>T",
        "Protein Change":"p.Ser314Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004731%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59189658",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1209",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q72.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5788A>C",
        "Protein Change":"p.Gln353Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005505%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18331149",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1210",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q74.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4274C>C",
        "Protein Change":"p.Gln274Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004088%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82712883",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1211",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q5.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5694G>C",
        "Protein Change":"p.Arg115Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009435%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53320257",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1212",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q56.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6383C>T",
        "Protein Change":"p.Pro244Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00994%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37992160",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1213",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q78.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5378C>C",
        "Protein Change":"p.Ser463Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009743%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53229553",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1214",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q33.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1959A>C",
        "Protein Change":"p.Ser46Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005008%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88136932",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1215",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q15.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7382C>T",
        "Protein Change":"p.Pro36Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005036%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41215859",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1216",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q82.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8697G>C",
        "Protein Change":"p.Ser213Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0046%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79167353",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1217",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q65.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8413A>A",
        "Protein Change":"p.Pro295Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004652%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62957378",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1218",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q27.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6854C>C",
        "Protein Change":"p.Gly12Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005364%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20246965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1219",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q90.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5074T>A",
        "Protein Change":"p.Gln447Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004723%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58279136",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1220",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q94.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5624A>A",
        "Protein Change":"p.Gln482Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000416%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89730547",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1221",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q74.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9911T>A",
        "Protein Change":"p.Gln488Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00038%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65789862",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1222",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q35.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7706C>A",
        "Protein Change":"p.Gln234Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000923%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97925391",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1223",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q45.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8737A>G",
        "Protein Change":"p.Leu340Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001172%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39313395",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1224",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q21.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3367C>T",
        "Protein Change":"p.Ser418Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002617%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28222206",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1225",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q72.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7151C>A",
        "Protein Change":"p.Gln466Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005852%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28993673",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1226",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q22.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9351G>G",
        "Protein Change":"p.Pro476Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003565%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10531123",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1227",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q10.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6941T>G",
        "Protein Change":"p.Leu354Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003189%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32905104",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1228",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q15.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4733G>C",
        "Protein Change":"p.Leu434Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008082%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56001870",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1229",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q47.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3587G>G",
        "Protein Change":"p.Gln413Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000528%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60474031",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1230",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q70.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2019A>T",
        "Protein Change":"p.Pro216Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001372%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15804996",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1231",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q27.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3186G>G",
        "Protein Change":"p.Arg40Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006727%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50136793",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1232",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q39.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6441C>C",
        "Protein Change":"p.Gln16Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001299%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98798935",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1233",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q37.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1632A>C",
        "Protein Change":"p.Ser129Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003962%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73466601",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1234",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q3.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2101C>A",
        "Protein Change":"p.Arg260Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000238%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12842991",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1235",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q36.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6243A>T",
        "Protein Change":"p.Gln106Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000647%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34258446",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1236",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q39.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.555T>C",
        "Protein Change":"p.Gly239Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006801%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99992336",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1237",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q60.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.411G>G",
        "Protein Change":"p.Arg306Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009151%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39200335",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1238",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q14.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3645C>T",
        "Protein Change":"p.Gly436Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00079%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24092654",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1239",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q71.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3752G>A",
        "Protein Change":"p.Gln182Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009121%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13879494",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1240",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q16.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6977C>C",
        "Protein Change":"p.Gln409Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002056%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13890972",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1241",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q71.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6221A>T",
        "Protein Change":"p.Gly226Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00129%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99817740",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1242",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q99.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5192T>G",
        "Protein Change":"p.Arg267Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003315%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93197355",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1243",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q14.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4840A>C",
        "Protein Change":"p.Gln13Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001457%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49113951",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1244",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q53.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.762T>A",
        "Protein Change":"p.Leu40Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006085%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63332383",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1245",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q12.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.715C>G",
        "Protein Change":"p.Gln462Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00802%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15271278",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1246",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q30.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5445G>C",
        "Protein Change":"p.Pro333Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007987%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71929182",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1247",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q59.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2633C>C",
        "Protein Change":"p.Pro147Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0086%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92383363",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1248",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q54.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7932G>G",
        "Protein Change":"p.Ser25Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007287%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11750282",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1249",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q49.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6673A>T",
        "Protein Change":"p.Arg406Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005017%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10619924",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1250",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q31.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5301C>T",
        "Protein Change":"p.Gln103Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008512%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46055295",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1251",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q14.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6939G>T",
        "Protein Change":"p.Leu71Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006707%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35129928",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1252",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q44.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3064C>C",
        "Protein Change":"p.Gln191Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003585%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37740243",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1253",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q9.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6710C>T",
        "Protein Change":"p.Arg412Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002202%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25049535",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1254",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q84.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3088A>A",
        "Protein Change":"p.Arg283Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000343%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76026127",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1255",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q60.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4372G>G",
        "Protein Change":"p.Arg293Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009379%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76234607",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1256",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q77.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3515G>A",
        "Protein Change":"p.Pro197Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007977%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78532678",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1257",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q99.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6182A>C",
        "Protein Change":"p.Gln351Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00258%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42193196",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1258",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q86.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8761T>G",
        "Protein Change":"p.Gly201Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001256%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48490486",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1259",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q70.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1780T>G",
        "Protein Change":"p.Ser464Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003978%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33187507",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1260",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q70.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7879A>C",
        "Protein Change":"p.Leu236Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00885%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75271465",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1261",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q94.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4521C>A",
        "Protein Change":"p.Leu235Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001185%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44001756",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1262",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q34.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3637G>A",
        "Protein Change":"p.Leu87Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007913%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37817760",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1263",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q91.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8994G>G",
        "Protein Change":"p.Gly245Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000752%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13145974",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1264",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q57.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8973G>C",
        "Protein Change":"p.Gln52Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005469%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34112955",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1265",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q58.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.997G>G",
        "Protein Change":"p.Arg120Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001294%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20977178",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1266",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q2.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1628A>A",
        "Protein Change":"p.Gln452Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008768%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68090603",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1267",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q53.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.175C>T",
        "Protein Change":"p.Arg226Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001863%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35205443",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1268",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q39.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.664C>A",
        "Protein Change":"p.Pro344Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009635%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27346493",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1269",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q97.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4160A>C",
        "Protein Change":"p.Leu377Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005325%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31268871",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1270",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q30.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5129G>T",
        "Protein Change":"p.Gln94Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001543%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95827784",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1271",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q78.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4986T>T",
        "Protein Change":"p.Gly420Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007305%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82599961",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1272",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q25.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8435A>A",
        "Protein Change":"p.Ser480Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004371%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85417404",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1273",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q77.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4173C>G",
        "Protein Change":"p.Leu21Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00936%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88039596",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1274",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q91.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4620T>G",
        "Protein Change":"p.Gly291Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005958%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44489491",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1275",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q71.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9085A>T",
        "Protein Change":"p.Gly338Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008434%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98095581",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1276",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q67.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6056A>A",
        "Protein Change":"p.Gly24Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000147%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10459398",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1277",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q7.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8864T>A",
        "Protein Change":"p.Leu377Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009588%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57762579",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1278",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q24.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5850T>T",
        "Protein Change":"p.Pro101Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008806%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94868248",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1279",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q47.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8931T>A",
        "Protein Change":"p.Arg160Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009877%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67271889",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1280",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q42.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.341G>A",
        "Protein Change":"p.Pro374Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007165%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30764532",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1281",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q50.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2243T>C",
        "Protein Change":"p.Gln286Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005305%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77346397",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1282",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q89.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1954G>C",
        "Protein Change":"p.Ser400Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009228%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61426695",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1283",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q78.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7431T>T",
        "Protein Change":"p.Leu359Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002752%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60238352",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1284",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q97.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3323G>A",
        "Protein Change":"p.Gln456Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008868%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88131338",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1285",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q82.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.330A>T",
        "Protein Change":"p.Gly467Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00335%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73392340",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1286",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q93.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3901G>A",
        "Protein Change":"p.Leu392Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007059%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99271791",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1287",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q33.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.963T>T",
        "Protein Change":"p.Gly100Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00381%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68786399",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1288",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q89.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2467C>T",
        "Protein Change":"p.Leu264Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000863%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98332246",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1289",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q9.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4818C>G",
        "Protein Change":"p.Gln318Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00949%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54235759",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1290",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q67.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.611C>A",
        "Protein Change":"p.Gln322Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004716%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92285720",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1291",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q7.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5107G>C",
        "Protein Change":"p.Pro197Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000139%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39073744",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1292",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q97.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.169C>G",
        "Protein Change":"p.Gln112Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006737%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39905271",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1293",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q95.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5828G>T",
        "Protein Change":"p.Leu154Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000968%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13075803",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1294",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q35.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2552C>G",
        "Protein Change":"p.Ser9Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002324%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99214951",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1295",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q64.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5375G>A",
        "Protein Change":"p.Pro498Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001448%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75768569",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1296",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q38.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5013G>A",
        "Protein Change":"p.Arg469Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002681%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24083672",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1297",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q13.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4647C>C",
        "Protein Change":"p.Arg23Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005556%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90877407",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1298",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q50.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9805T>T",
        "Protein Change":"p.Gln420Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000893%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15304921",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1299",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q13.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9865A>A",
        "Protein Change":"p.Ser157Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007209%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56315200",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1300",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q97.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6199C>T",
        "Protein Change":"p.Gly483Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003198%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43438251",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1301",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q99.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1222T>A",
        "Protein Change":"p.Ser491Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000742%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29096861",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1302",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q15.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5552T>G",
        "Protein Change":"p.Gly353Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006821%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99470785",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1303",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q2.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4534A>A",
        "Protein Change":"p.Gly257Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30058419",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1304",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q31.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.844T>T",
        "Protein Change":"p.Arg142Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003285%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51866393",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1305",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q87.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2548A>T",
        "Protein Change":"p.Arg444Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001167%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30128971",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1306",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q44.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5475C>A",
        "Protein Change":"p.Pro272Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006139%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12877814",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1307",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q84.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6072T>G",
        "Protein Change":"p.Gln400Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006063%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84552768",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1308",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q53.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8729G>T",
        "Protein Change":"p.Gln143Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005882%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71980981",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1309",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q8.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8855T>T",
        "Protein Change":"p.Arg362Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005155%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64961241",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1310",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q19.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6304A>G",
        "Protein Change":"p.Leu309Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002331%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58919593",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1311",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q41.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1285T>C",
        "Protein Change":"p.Gln180Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000657%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50828840",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1312",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q25.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6663G>A",
        "Protein Change":"p.Pro370Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004269%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55325956",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1313",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q10.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7216T>G",
        "Protein Change":"p.Gln323Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007449%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88291590",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1314",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q34.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7556T>G",
        "Protein Change":"p.Gln167Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008282%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91192179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1315",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q33.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7457G>A",
        "Protein Change":"p.Pro405Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006071%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82195951",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1316",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q21.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8165T>G",
        "Protein Change":"p.Gly16Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008003%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14210628",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1317",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q94.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2583C>A",
        "Protein Change":"p.Ser59Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002245%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11729605",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1318",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q63.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7823G>A",
        "Protein Change":"p.Pro359Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000152%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68214760",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1319",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q43.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1186A>A",
        "Protein Change":"p.Gly58Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000774%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26327280",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1320",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q92.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2549C>C",
        "Protein Change":"p.Leu493Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001948%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71691773",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1321",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q96.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1151T>C",
        "Protein Change":"p.Leu13Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003545%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64245881",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1322",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q99.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1297G>A",
        "Protein Change":"p.Gly26Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007119%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84014603",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1323",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q38.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4761C>C",
        "Protein Change":"p.Leu435Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002404%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16760985",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1324",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q58.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9337T>A",
        "Protein Change":"p.Gly184Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003526%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23641996",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1325",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q51.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9857T>G",
        "Protein Change":"p.Leu306Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003626%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27268894",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1326",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q91.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8555G>T",
        "Protein Change":"p.Pro47Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005855%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33732872",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1327",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q14.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9560G>A",
        "Protein Change":"p.Gln360Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002095%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39400496",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1328",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q63.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2490G>G",
        "Protein Change":"p.Gly414Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008032%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60889628",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1329",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q6.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.298G>C",
        "Protein Change":"p.Pro497Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002649%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34951577",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1330",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q9.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3274T>T",
        "Protein Change":"p.Leu215Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002288%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76145880",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1331",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q64.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6742A>C",
        "Protein Change":"p.Pro146Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004456%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11917341",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1332",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q69.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1063A>C",
        "Protein Change":"p.Gly270Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00847%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89495050",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1333",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q97.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.868G>A",
        "Protein Change":"p.Gly254Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004168%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18339858",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1334",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q4.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.185A>T",
        "Protein Change":"p.Arg427Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008395%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52071795",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1335",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q23.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7461T>T",
        "Protein Change":"p.Gln250Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005056%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54163578",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1336",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q69.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2695C>A",
        "Protein Change":"p.Ser363Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00184%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19137759",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1337",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q71.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9330G>C",
        "Protein Change":"p.Arg430Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001098%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55020424",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1338",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q62.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5928G>A",
        "Protein Change":"p.Gln380Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001039%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23812048",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1339",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q86.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1782C>T",
        "Protein Change":"p.Ser181Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005728%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68310079",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1340",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q32.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2598T>A",
        "Protein Change":"p.Pro262Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000837%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:50512080",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1341",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q50.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8056A>A",
        "Protein Change":"p.Leu27Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003507%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21222713",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1342",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q95.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2910T>T",
        "Protein Change":"p.Gly124Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004919%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85807900",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1343",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q65.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5443T>T",
        "Protein Change":"p.Gly254Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003106%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89732513",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1344",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q15.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5684G>A",
        "Protein Change":"p.Leu356Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004049%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80800842",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1345",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q8.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4149A>T",
        "Protein Change":"p.Gln125Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009991%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64217158",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1346",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q63.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8903G>T",
        "Protein Change":"p.Pro66Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007123%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72687738",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1347",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q30.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8806T>T",
        "Protein Change":"p.Gly331Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005603%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58370492",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1348",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q89.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7090C>A",
        "Protein Change":"p.Ser320Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001722%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96555184",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1349",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q71.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9911T>C",
        "Protein Change":"p.Arg155Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004393%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36810589",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1350",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q72.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1226C>C",
        "Protein Change":"p.Pro15Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001189%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15725038",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1351",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q35.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4443C>C",
        "Protein Change":"p.Gln447Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009051%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52344036",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1352",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q48.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6773G>G",
        "Protein Change":"p.Gln149Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009161%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42553957",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1353",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q75.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3388C>A",
        "Protein Change":"p.Pro411Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000134%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17688060",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1354",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q46.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4771A>C",
        "Protein Change":"p.Gly471Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003601%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82411847",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1355",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q68.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5392T>C",
        "Protein Change":"p.Arg226Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002412%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:50407111",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1356",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q32.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2704C>G",
        "Protein Change":"p.Leu120Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007311%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92822244",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1357",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q9.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6531A>C",
        "Protein Change":"p.Pro353Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002575%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14344451",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1358",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q61.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8486G>C",
        "Protein Change":"p.Leu73Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008783%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71396505",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1359",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q20.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7247C>T",
        "Protein Change":"p.Ser496Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004483%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74589923",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1360",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q35.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.899T>C",
        "Protein Change":"p.Ser131Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008301%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80664885",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1361",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q60.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2460A>A",
        "Protein Change":"p.Leu32Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008349%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68785045",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1362",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q79.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6766G>C",
        "Protein Change":"p.Gly11Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002654%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67979915",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1363",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q29.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6687A>T",
        "Protein Change":"p.Arg465Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000843%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77560119",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1364",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q22.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5710C>A",
        "Protein Change":"p.Pro90Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003253%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31564571",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1365",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q23.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8507T>C",
        "Protein Change":"p.Pro75Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0012%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42415160",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1366",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q21.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.493A>A",
        "Protein Change":"p.Gly178Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007962%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66064721",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1367",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q23.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.311C>C",
        "Protein Change":"p.Ser131Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90538480",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1368",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q71.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8857T>G",
        "Protein Change":"p.Arg337Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008147%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49587949",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1369",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q4.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5894G>C",
        "Protein Change":"p.Arg314Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005562%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96457912",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1370",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q32.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.129G>T",
        "Protein Change":"p.Leu421Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005406%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23184684",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1371",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q77.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.835T>T",
        "Protein Change":"p.Arg39Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000984%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99393933",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1372",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q35.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5935T>T",
        "Protein Change":"p.Pro403Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005417%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94462553",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1373",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q51.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4770G>C",
        "Protein Change":"p.Pro381Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008304%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46616493",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1374",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q17.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4964G>A",
        "Protein Change":"p.Ser98Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006307%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75328766",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1375",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q41.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9564T>T",
        "Protein Change":"p.Arg314Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004971%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25689444",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1376",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q86.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4547A>A",
        "Protein Change":"p.Ser252Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008419%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95438590",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1377",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q21.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1337T>G",
        "Protein Change":"p.Gly121Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007312%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52844827",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1378",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q92.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6987G>A",
        "Protein Change":"p.Ser182Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007689%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40152804",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1379",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q18.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1789C>G",
        "Protein Change":"p.Arg296Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006531%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35421793",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1380",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q36.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2287C>A",
        "Protein Change":"p.Ser432Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005216%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37227475",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1381",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q40.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5436T>A",
        "Protein Change":"p.Leu260Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008826%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73184274",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1382",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q22.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5913G>T",
        "Protein Change":"p.Gly401Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00446%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35948671",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1383",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q97.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7334C>T",
        "Protein Change":"p.Pro133Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009473%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77861336",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1384",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q48.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.274C>A",
        "Protein Change":"p.Gln250Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006703%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78762540",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1385",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q44.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9401A>T",
        "Protein Change":"p.Leu321Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006895%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42892758",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1386",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q43.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6237C>T",
        "Protein Change":"p.Ser485Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00097%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40099659",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1387",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q10.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4067T>A",
        "Protein Change":"p.Gly90Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00096%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85624356",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1388",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q36.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8683A>G",
        "Protein Change":"p.Gln320Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004168%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71863199",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1389",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q68.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8677G>C",
        "Protein Change":"p.Leu237Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001786%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15403885",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1390",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q31.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5288A>T",
        "Protein Change":"p.Gly78Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009113%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39127563",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1391",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q47.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3826T>G",
        "Protein Change":"p.Gln363Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004979%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33304464",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1392",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q83.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3882A>G",
        "Protein Change":"p.Gly348Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005492%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12861118",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1393",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q36.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4183C>G",
        "Protein Change":"p.Leu441Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008571%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11713039",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1394",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q70.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5400C>C",
        "Protein Change":"p.Gln4Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006034%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99479672",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1395",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q95.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6959A>T",
        "Protein Change":"p.Arg121Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006958%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29674629",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1396",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q58.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7750G>A",
        "Protein Change":"p.Pro170Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001449%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39779824",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1397",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q75.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.603T>G",
        "Protein Change":"p.Gln22Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005285%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33829132",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1398",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q74.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7822C>G",
        "Protein Change":"p.Gly64Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008461%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64632419",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1399",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q20.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7173T>G",
        "Protein Change":"p.Leu118Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005561%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91541855",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1400",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q52.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4297T>C",
        "Protein Change":"p.Gly306Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006257%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44401324",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1401",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q29.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9531G>A",
        "Protein Change":"p.Arg150Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005266%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56862031",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1402",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q52.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6731G>A",
        "Protein Change":"p.Arg213Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007152%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37657247",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1403",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q50.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4607G>A",
        "Protein Change":"p.Leu221Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008055%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20398141",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1404",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q10.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9934C>G",
        "Protein Change":"p.Ser93Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007682%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54836455",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1405",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q2.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6965G>T",
        "Protein Change":"p.Gln166Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005333%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14655086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1406",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q91.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2009C>G",
        "Protein Change":"p.Arg493Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001923%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49507637",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1407",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q2.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3117G>A",
        "Protein Change":"p.Pro303Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004267%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93267028",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1408",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q64.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4360G>C",
        "Protein Change":"p.Gln25Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007697%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96771441",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1409",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q93.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1826A>G",
        "Protein Change":"p.Gly304Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001091%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42805078",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1410",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q44.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5337G>A",
        "Protein Change":"p.Pro478Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006287%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30771630",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1411",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q72.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6596T>T",
        "Protein Change":"p.Arg246Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003516%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35353626",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1412",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q89.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2291G>A",
        "Protein Change":"p.Leu473Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001409%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29421196",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1413",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q59.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7935T>G",
        "Protein Change":"p.Gln375Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005441%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12361904",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1414",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q73.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9340C>C",
        "Protein Change":"p.Arg42Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007129%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52312430",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1415",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q95.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9935C>G",
        "Protein Change":"p.Leu367Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009037%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:97368108",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1416",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q45.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8959G>C",
        "Protein Change":"p.Leu304Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004314%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78832592",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1417",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q39.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9853A>T",
        "Protein Change":"p.Gly199Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003026%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38327037",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1418",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q18.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.524G>G",
        "Protein Change":"p.Ser485Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006494%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10613446",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1419",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q80.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3501A>T",
        "Protein Change":"p.Arg69Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003309%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76154391",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1420",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q28.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3624G>C",
        "Protein Change":"p.Leu163Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009877%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11699248",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1421",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q86.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2566A>G",
        "Protein Change":"p.Pro427Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00783%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78966808",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1422",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q3.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6619A>A",
        "Protein Change":"p.Ser306Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006727%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55795483",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1423",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q15.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4585C>A",
        "Protein Change":"p.Ser228Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001029%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16977471",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1424",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q56.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2850T>A",
        "Protein Change":"p.Gln455Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008122%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86461887",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1425",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q70.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5913A>T",
        "Protein Change":"p.Gly407Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007863%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46719584",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1426",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q54.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1322G>T",
        "Protein Change":"p.Pro415Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006336%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73988953",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1427",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q82.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5789T>G",
        "Protein Change":"p.Leu44Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006998%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86567111",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1428",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q23.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1109C>A",
        "Protein Change":"p.Gly396Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006803%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26826246",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1429",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q90.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4655A>C",
        "Protein Change":"p.Pro44Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005381%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78137915",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1430",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q53.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.491G>G",
        "Protein Change":"p.Pro299Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005109%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59983982",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1431",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q87.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1919A>G",
        "Protein Change":"p.Leu60Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00793%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68532376",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1432",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q85.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.642C>C",
        "Protein Change":"p.Arg64Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002029%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50540529",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1433",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q97.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3533G>G",
        "Protein Change":"p.Ser261Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006298%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61364480",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1434",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q96.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9870G>C",
        "Protein Change":"p.Leu281Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002418%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57473371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1435",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q38.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7705T>A",
        "Protein Change":"p.Pro404Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007797%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30420321",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1436",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q71.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1537G>G",
        "Protein Change":"p.Arg323Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006016%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29590393",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1437",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q60.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7921T>A",
        "Protein Change":"p.Pro108Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00847%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35381081",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1438",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q34.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9848A>A",
        "Protein Change":"p.Ser148Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000946%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34214019",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1439",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q30.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6469G>A",
        "Protein Change":"p.Gln29Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009877%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82371829",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1440",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q85.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9757G>T",
        "Protein Change":"p.Leu389Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001759%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47576713",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1441",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q72.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9766A>A",
        "Protein Change":"p.Gly229Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001423%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92764630",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1442",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q57.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5414C>T",
        "Protein Change":"p.Gln493Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009817%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12807659",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1443",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q43.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3364G>A",
        "Protein Change":"p.Gly489Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009855%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23764148",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1444",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q88.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7383T>A",
        "Protein Change":"p.Pro6Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004769%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25259972",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1445",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q87.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4901G>T",
        "Protein Change":"p.Gln292Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009831%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22676706",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1446",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q25.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5531G>C",
        "Protein Change":"p.Ser439Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001344%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90663689",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1447",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q67.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3165G>C",
        "Protein Change":"p.Gln247Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002046%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59821229",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1448",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q93.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6428G>A",
        "Protein Change":"p.Ser181Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001844%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21724171",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1449",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q90.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6841A>T",
        "Protein Change":"p.Ser320Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00086%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14164398",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1450",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q14.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8780T>G",
        "Protein Change":"p.Arg258Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008766%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86846802",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1451",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q51.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7910T>T",
        "Protein Change":"p.Pro104Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009191%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78531396",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1452",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q38.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1060T>T",
        "Protein Change":"p.Gln113Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006796%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87434221",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1453",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q71.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4610A>A",
        "Protein Change":"p.Arg190Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00203%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88028496",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1454",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q63.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1513C>T",
        "Protein Change":"p.Gln65Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009485%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14327290",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1455",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q68.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9458A>A",
        "Protein Change":"p.Gln283Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008074%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65806708",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1456",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q57.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7951G>G",
        "Protein Change":"p.Pro97Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002306%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93413684",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1457",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q39.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6574G>A",
        "Protein Change":"p.Ser282Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004055%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32734794",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1458",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q62.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8191A>G",
        "Protein Change":"p.Gly244Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004133%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24654954",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1459",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q76.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3611C>A",
        "Protein Change":"p.Gln452Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002725%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35651161",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1460",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q28.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8478A>T",
        "Protein Change":"p.Arg486Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009914%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56160413",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1461",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q50.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1788T>C",
        "Protein Change":"p.Gly36Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007474%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43317995",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1462",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q83.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1851G>T",
        "Protein Change":"p.Pro200Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000996%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46433366",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1463",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q5.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1999T>G",
        "Protein Change":"p.Arg99Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007652%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97150374",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1464",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q12.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6907C>G",
        "Protein Change":"p.Pro492Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005278%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99769118",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1465",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q71.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6535T>C",
        "Protein Change":"p.Gly243Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002579%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44459693",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1466",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q10.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1555A>C",
        "Protein Change":"p.Pro56Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007969%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11278972",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1467",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q73.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9705C>G",
        "Protein Change":"p.Ser41Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005097%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79036100",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1468",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q21.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8996A>T",
        "Protein Change":"p.Gln464Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004123%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21107059",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1469",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q81.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2992A>T",
        "Protein Change":"p.Ser321Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005327%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55467364",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1470",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q19.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4888C>T",
        "Protein Change":"p.Pro236Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006881%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94835805",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1471",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q52.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1192C>A",
        "Protein Change":"p.Gly335Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000972%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59939589",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1472",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q51.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6952G>G",
        "Protein Change":"p.Ser458Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002833%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58959626",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1473",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q21.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9498T>T",
        "Protein Change":"p.Pro421Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009112%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60488156",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1474",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q66.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4146T>T",
        "Protein Change":"p.Gly468Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00386%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31172848",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1475",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q79.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5335C>G",
        "Protein Change":"p.Ser70Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000177%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88101925",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1476",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q35.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2245A>G",
        "Protein Change":"p.Arg118Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009274%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39144544",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1477",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q90.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3420A>G",
        "Protein Change":"p.Leu214Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00353%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72751495",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1478",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q83.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8562T>T",
        "Protein Change":"p.Gln247Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00403%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89497905",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1479",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q10.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.672C>C",
        "Protein Change":"p.Pro291Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000981%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95698199",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1480",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q57.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1373G>A",
        "Protein Change":"p.Pro399Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001139%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37512295",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1481",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q29.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5457C>G",
        "Protein Change":"p.Leu175Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007802%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25086144",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1482",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q47.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3575A>C",
        "Protein Change":"p.Leu176Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92457734",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1483",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q46.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.476C>A",
        "Protein Change":"p.Arg294Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00828%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45922802",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1484",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q31.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2775A>G",
        "Protein Change":"p.Gln194Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003497%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18125963",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1485",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q37.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7017A>C",
        "Protein Change":"p.Gln74Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000531%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69799990",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1486",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q81.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.785T>G",
        "Protein Change":"p.Arg497Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003967%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71970559",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1487",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q82.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5216T>C",
        "Protein Change":"p.Gln170Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001986%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56319124",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1488",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q40.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5172G>A",
        "Protein Change":"p.Ser467Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000998%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35097600",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1489",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q36.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2514T>C",
        "Protein Change":"p.Leu306Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000407%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13177612",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1490",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q51.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8054A>C",
        "Protein Change":"p.Gly342Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005826%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16504007",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1491",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q16.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8928G>T",
        "Protein Change":"p.Gln320Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009277%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76775945",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1492",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q91.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1488T>A",
        "Protein Change":"p.Leu322Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001929%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97531050",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1493",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q9.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1622A>G",
        "Protein Change":"p.Gly375Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002817%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24731113",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1494",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q44.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.158G>C",
        "Protein Change":"p.Gly134Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007306%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97319761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1495",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q67.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7988G>G",
        "Protein Change":"p.Ser298Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001889%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55774725",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1496",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q76.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8727G>A",
        "Protein Change":"p.Gly31Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007076%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60033320",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1497",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q17.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9373A>C",
        "Protein Change":"p.Arg485Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007208%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29464202",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1498",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q76.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2198A>G",
        "Protein Change":"p.Gly141Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003205%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18527785",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1499",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q63.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1083T>A",
        "Protein Change":"p.Gln91Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003466%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12405093",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1500",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q57.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6803G>G",
        "Protein Change":"p.Pro475Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004285%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36112860",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1501",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q72.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5829G>T",
        "Protein Change":"p.Gln80Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00392%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35404743",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1502",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q25.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9508T>G",
        "Protein Change":"p.Pro198Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006346%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:90142709",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1503",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q71.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7675T>T",
        "Protein Change":"p.Leu417Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006523%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40336305",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1504",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q56.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3335G>C",
        "Protein Change":"p.Gln454Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004584%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64589543",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1505",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q33.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7905C>A",
        "Protein Change":"p.Pro285Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003051%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71501758",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1506",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q19.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9021T>G",
        "Protein Change":"p.Ser341Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000396%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12478092",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1507",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q78.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6184G>T",
        "Protein Change":"p.Gln108Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009481%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71111922",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1508",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q85.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8285T>G",
        "Protein Change":"p.Leu432Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37978627",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1509",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q67.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3330C>C",
        "Protein Change":"p.Leu328Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005489%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28784390",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1510",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q99.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8872A>C",
        "Protein Change":"p.Gln64Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000796%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14230550",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1511",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q26.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4569G>G",
        "Protein Change":"p.Gln35Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003618%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33090145",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1512",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q35.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8277C>A",
        "Protein Change":"p.Ser372Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001614%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20164397",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1513",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q21.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9141T>A",
        "Protein Change":"p.Arg315Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006908%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32082334",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1514",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q29.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8641C>G",
        "Protein Change":"p.Arg280Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002351%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58446502",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1515",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q77.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9142G>G",
        "Protein Change":"p.Gln237Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002808%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71508145",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1516",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q74.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1613C>G",
        "Protein Change":"p.Ser166Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009484%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88309231",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1517",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q94.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2052G>A",
        "Protein Change":"p.Arg15Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003455%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37362080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1518",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q1.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1399C>C",
        "Protein Change":"p.Gly145Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004252%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55788703",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1519",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q94.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8927A>T",
        "Protein Change":"p.Pro333Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008698%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44487734",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1520",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q35.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2771A>A",
        "Protein Change":"p.Ser157Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009833%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15546791",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1521",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q1.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9313A>C",
        "Protein Change":"p.Leu193Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17924775",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1522",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q61.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3364T>A",
        "Protein Change":"p.Ser127Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007574%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22202531",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1523",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q66.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1013C>C",
        "Protein Change":"p.Gln293Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005702%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68399597",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1524",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q26.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2037C>A",
        "Protein Change":"p.Gln78Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004931%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19670400",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1525",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q37.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5355G>C",
        "Protein Change":"p.Ser281Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009701%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98069468",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1526",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q24.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2741A>C",
        "Protein Change":"p.Arg395Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001835%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33750618",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1527",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q52.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3593A>T",
        "Protein Change":"p.Gly216Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001008%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24920108",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1528",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q79.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4075T>G",
        "Protein Change":"p.Gln185Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009771%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66598308",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1529",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q85.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2876T>G",
        "Protein Change":"p.Gly203Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007011%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46400594",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1530",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q21.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4076C>T",
        "Protein Change":"p.Gln449Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005781%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67320841",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1531",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q57.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.391G>G",
        "Protein Change":"p.Pro151Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002814%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15292491",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1532",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q13.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.219G>A",
        "Protein Change":"p.Arg197Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001554%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61646932",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1533",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q39.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6358A>A",
        "Protein Change":"p.Gly68Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008287%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81121094",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1534",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q7.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3587A>C",
        "Protein Change":"p.Pro375Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009067%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77642991",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1535",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q72.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7292A>T",
        "Protein Change":"p.Gly491Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009504%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65970174",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1536",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q96.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2587C>G",
        "Protein Change":"p.Gly272Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002691%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83144265",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1537",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q60.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6683A>G",
        "Protein Change":"p.Arg150Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004984%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88077544",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1538",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q97.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9124C>G",
        "Protein Change":"p.Gly301Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007923%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35604287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1539",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q30.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9860G>G",
        "Protein Change":"p.Gly134Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001101%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33828377",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1540",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q38.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7689G>A",
        "Protein Change":"p.Arg412Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002334%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29382860",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1541",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q62.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9781C>T",
        "Protein Change":"p.Gly167Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000238%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77483854",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1542",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q36.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3882T>T",
        "Protein Change":"p.Arg289Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002196%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19047371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1543",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q22.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5101C>T",
        "Protein Change":"p.Pro480Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002301%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70903296",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1544",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q37.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3323C>A",
        "Protein Change":"p.Pro322Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001721%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81060555",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1545",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q79.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4564C>G",
        "Protein Change":"p.Gly342Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004114%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11211001",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1546",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q94.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1421G>G",
        "Protein Change":"p.Arg143Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006116%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80684121",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1547",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q44.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4031T>T",
        "Protein Change":"p.Arg230Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006894%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64415410",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1548",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q10.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3089T>A",
        "Protein Change":"p.Leu58Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007838%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49596874",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1549",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q21.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3546T>A",
        "Protein Change":"p.Arg68Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007818%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66469827",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1550",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q84.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6823A>C",
        "Protein Change":"p.Leu435Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00204%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80609052",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1551",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q23.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2024G>G",
        "Protein Change":"p.Pro144Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00134%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18645092",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1552",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q56.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2104C>C",
        "Protein Change":"p.Arg78Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005865%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36228378",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1553",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q66.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4413C>T",
        "Protein Change":"p.Gly209Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007864%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87332162",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1554",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q70.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4589A>G",
        "Protein Change":"p.Arg64Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007784%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32538978",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1555",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q26.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2142G>T",
        "Protein Change":"p.Arg295Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007284%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21201522",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1556",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q7.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2316C>T",
        "Protein Change":"p.Gln339Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003979%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17543780",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1557",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q96.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7116G>C",
        "Protein Change":"p.Leu144Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003138%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24721093",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1558",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q6.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1018G>A",
        "Protein Change":"p.Arg6Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002678%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90938431",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1559",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q36.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9487A>C",
        "Protein Change":"p.Gln348Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001258%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98828836",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1560",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q84.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4520T>A",
        "Protein Change":"p.Ser104Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009289%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87465847",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1561",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q7.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.444C>T",
        "Protein Change":"p.Arg85Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009773%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33518225",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1562",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q22.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1273A>A",
        "Protein Change":"p.Pro115Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00628%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25465616",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1563",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q55.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1576A>A",
        "Protein Change":"p.Leu339Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006771%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36852558",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1564",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q77.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3479A>A",
        "Protein Change":"p.Leu186Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009702%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73201096",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1565",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q14.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4496T>G",
        "Protein Change":"p.Gln294Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005709%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57241143",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1566",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q8.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.844G>T",
        "Protein Change":"p.Ser437Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007424%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54607927",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1567",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q45.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2617C>C",
        "Protein Change":"p.Arg426Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002532%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13001271",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1568",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q14.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5093C>C",
        "Protein Change":"p.Gly462Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002452%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95098345",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1569",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q45.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6319T>C",
        "Protein Change":"p.Pro402Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006968%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99287099",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1570",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q3.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8143C>T",
        "Protein Change":"p.Ser184Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008169%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39669863",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1571",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q20.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5293C>C",
        "Protein Change":"p.Gln415Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002633%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49764030",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1572",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q55.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6079A>T",
        "Protein Change":"p.Ser226Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00059%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24784831",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1573",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q55.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3010G>A",
        "Protein Change":"p.Arg335Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003691%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45994896",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1574",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q48.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4362G>T",
        "Protein Change":"p.Ser467Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004247%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82506766",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1575",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q38.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1497G>T",
        "Protein Change":"p.Gln426Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001836%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50382340",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1576",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q72.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4971G>A",
        "Protein Change":"p.Gly22Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007646%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93825196",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1577",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q48.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8763T>T",
        "Protein Change":"p.Gly210Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008756%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68426799",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1578",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q97.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8213T>C",
        "Protein Change":"p.Gln113Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00261%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75423833",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1579",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q74.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8002A>T",
        "Protein Change":"p.Pro287Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000964%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15179495",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1580",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q14.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1839G>T",
        "Protein Change":"p.Gln23Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003337%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92035920",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1581",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q90.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4339G>G",
        "Protein Change":"p.Gln396Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008435%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19097142",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1582",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q97.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1093A>G",
        "Protein Change":"p.Gly150Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009916%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96160343",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1583",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q94.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7491T>C",
        "Protein Change":"p.Leu436Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00074%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68428151",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1584",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q35.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3124T>A",
        "Protein Change":"p.Pro192Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007969%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26395752",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1585",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q80.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8530G>G",
        "Protein Change":"p.Gly60Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006402%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59249429",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1586",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q14.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3665T>G",
        "Protein Change":"p.Gly380Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006775%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99152419",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1587",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q5.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2718C>C",
        "Protein Change":"p.Gly279Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002643%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87805017",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1588",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q90.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3584C>A",
        "Protein Change":"p.Gln332Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006469%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70652437",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1589",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q1.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5828C>T",
        "Protein Change":"p.Arg196Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005703%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62434655",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1590",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q23.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2266A>C",
        "Protein Change":"p.Ser246Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004533%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94064828",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1591",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q48.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9488A>A",
        "Protein Change":"p.Gln146Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002425%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51848574",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1592",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q93.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2663G>T",
        "Protein Change":"p.Leu437Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009642%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10463329",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1593",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q64.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3187A>C",
        "Protein Change":"p.Gly332Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008978%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64161723",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1594",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q46.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4466T>A",
        "Protein Change":"p.Gln289Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00033%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25298450",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1595",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q16.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9249C>A",
        "Protein Change":"p.Gln74Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005583%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57148280",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1596",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q60.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.259A>T",
        "Protein Change":"p.Ser283Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005135%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16159176",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1597",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q18.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8532G>T",
        "Protein Change":"p.Leu188Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004154%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31268507",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1598",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q70.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8960A>G",
        "Protein Change":"p.Gly280Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000947%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18967514",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1599",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q99.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7869G>G",
        "Protein Change":"p.Leu396Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006644%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83368555",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1600",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q91.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.683G>G",
        "Protein Change":"p.Gln419Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003109%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74351191",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1601",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q64.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3504C>G",
        "Protein Change":"p.Pro16Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69987650",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1602",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q21.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8842A>A",
        "Protein Change":"p.Arg327Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008165%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78658069",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1603",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q63.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8066A>A",
        "Protein Change":"p.Pro362Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005447%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85360302",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1604",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q6.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4815T>A",
        "Protein Change":"p.Arg202Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001646%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79783703",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1605",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q96.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.802G>A",
        "Protein Change":"p.Gln35Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00401%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38157995",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1606",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q62.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2689A>A",
        "Protein Change":"p.Gly22Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000544%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92742650",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1607",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q15.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2917A>T",
        "Protein Change":"p.Gln287Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009274%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84986101",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1608",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q55.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8820T>A",
        "Protein Change":"p.Pro217Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007422%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20813457",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1609",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q62.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.439C>A",
        "Protein Change":"p.Gln488Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007817%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51575394",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1610",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q22.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1317G>T",
        "Protein Change":"p.Pro181Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005553%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21047787",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1611",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q31.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4597G>C",
        "Protein Change":"p.Arg328Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005232%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87526400",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1612",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q4.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9722T>T",
        "Protein Change":"p.Gln52Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000413%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11051695",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1613",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q1.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9805C>C",
        "Protein Change":"p.Pro18Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004388%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36155593",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1614",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q98.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2580C>C",
        "Protein Change":"p.Arg246Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007061%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66939066",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1615",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q67.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3722A>T",
        "Protein Change":"p.Ser333Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006637%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89578120",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1616",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q10.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6156A>C",
        "Protein Change":"p.Gln217Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003939%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37816536",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1617",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q63.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4276C>C",
        "Protein Change":"p.Gly221Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007953%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74681761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1618",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q82.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3737G>T",
        "Protein Change":"p.Ser189Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009617%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12186149",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1619",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q29.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8351T>G",
        "Protein Change":"p.Pro331Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006167%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16345994",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1620",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q32.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7743C>T",
        "Protein Change":"p.Leu106Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008063%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42483090",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1621",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q32.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5280A>T",
        "Protein Change":"p.Pro496Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005517%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32396869",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1622",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q44.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6322T>G",
        "Protein Change":"p.Arg398Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005733%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81307990",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1623",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q82.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8471G>G",
        "Protein Change":"p.Ser471Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007194%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42083009",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1624",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q61.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9515C>A",
        "Protein Change":"p.Leu339Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008654%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95193826",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1625",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q63.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7881A>T",
        "Protein Change":"p.Ser220Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007155%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46151380",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1626",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q29.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7392C>G",
        "Protein Change":"p.Pro33Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005939%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19687440",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1627",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q88.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1792G>C",
        "Protein Change":"p.Arg202Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008761%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36584238",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1628",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q59.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4900A>G",
        "Protein Change":"p.Leu158Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001415%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68150358",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1629",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q65.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8940C>C",
        "Protein Change":"p.Gln291Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00428%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91241574",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1630",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q7.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9570T>A",
        "Protein Change":"p.Gln305Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004808%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71329790",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1631",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q27.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.940T>C",
        "Protein Change":"p.Gln157Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005757%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14999320",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1632",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q95.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3635T>T",
        "Protein Change":"p.Pro361Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005032%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34630396",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1633",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q17.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.815A>C",
        "Protein Change":"p.Pro396Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002857%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70462107",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1634",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q53.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3969C>G",
        "Protein Change":"p.Gly312Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003158%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37302676",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1635",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q25.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8815T>T",
        "Protein Change":"p.Leu289Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008912%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70428709",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1636",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q67.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5218G>T",
        "Protein Change":"p.Gln295Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008772%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52576456",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1637",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q39.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3535C>G",
        "Protein Change":"p.Gly350Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002923%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14454611",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1638",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q9.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6468T>A",
        "Protein Change":"p.Gln172Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008174%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94460308",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1639",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q25.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9246C>C",
        "Protein Change":"p.Arg201Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004061%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57090348",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1640",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q6.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3265A>T",
        "Protein Change":"p.Arg352Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004786%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83028288",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1641",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q56.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8042G>T",
        "Protein Change":"p.Gln185Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006791%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26553851",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1642",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q93.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5009A>A",
        "Protein Change":"p.Leu364Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00294%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48870095",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1643",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q18.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4337C>T",
        "Protein Change":"p.Arg80Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006469%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76764804",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1644",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q29.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4272A>C",
        "Protein Change":"p.Gly435Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000391%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33208412",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1645",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q29.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8228G>T",
        "Protein Change":"p.Gln241Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000186%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55920927",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1646",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q14.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5477A>C",
        "Protein Change":"p.Arg370Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001952%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54718433",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1647",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q27.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8572C>C",
        "Protein Change":"p.Arg405Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008098%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74563879",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1648",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q87.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6758A>G",
        "Protein Change":"p.Leu468Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009422%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30625261",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1649",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q71.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3213G>T",
        "Protein Change":"p.Ser313Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001973%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20498046",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1650",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q88.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5069A>A",
        "Protein Change":"p.Leu174Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000539%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31251707",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1651",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q95.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2365T>A",
        "Protein Change":"p.Gln236Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009005%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46117296",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1652",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q95.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1716A>G",
        "Protein Change":"p.Gln435Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003389%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96939717",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1653",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q72.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3230T>T",
        "Protein Change":"p.Ser360Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006591%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16417487",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1654",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q41.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9880T>A",
        "Protein Change":"p.Leu441Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00874%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75831481",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1655",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q80.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1412T>A",
        "Protein Change":"p.Gly495Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002095%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78447819",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1656",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q87.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1211G>T",
        "Protein Change":"p.Ser149Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007129%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10480289",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1657",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q82.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5253T>T",
        "Protein Change":"p.Arg331Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002635%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70052643",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1658",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q65.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1411A>G",
        "Protein Change":"p.Pro67Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008883%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20231140",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1659",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q49.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8826T>G",
        "Protein Change":"p.Gln254Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003698%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69738338",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1660",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q43.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9413T>A",
        "Protein Change":"p.Pro222Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004192%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60687834",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1661",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q88.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6153C>G",
        "Protein Change":"p.Pro265Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0009%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39900865",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1662",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q96.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6121T>C",
        "Protein Change":"p.Gln9Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000661%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98933289",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1663",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q11.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.511T>G",
        "Protein Change":"p.Leu492Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002598%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29037790",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1664",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q85.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4696G>C",
        "Protein Change":"p.Pro338Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006673%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38997133",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1665",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q32.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7819A>G",
        "Protein Change":"p.Gln445Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009583%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73465365",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1666",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q74.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7750T>A",
        "Protein Change":"p.Leu82Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009257%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52986430",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1667",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q55.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9584T>G",
        "Protein Change":"p.Leu391Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0037%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21184372",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1668",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q55.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6172C>A",
        "Protein Change":"p.Gln372Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000346%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88919742",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1669",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q50.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9189T>T",
        "Protein Change":"p.Ser175Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002431%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32700132",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1670",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q30.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2725G>C",
        "Protein Change":"p.Leu218Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004025%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22924320",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1671",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q51.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9429T>A",
        "Protein Change":"p.Pro399Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004528%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59963891",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1672",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q14.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8758C>A",
        "Protein Change":"p.Gln418Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008504%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90145539",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1673",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q38.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3930G>G",
        "Protein Change":"p.Gly276Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008163%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70977718",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1674",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q33.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.897G>A",
        "Protein Change":"p.Leu110Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000568%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18696891",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1675",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q45.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1357G>A",
        "Protein Change":"p.Pro487Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003988%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94298522",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1676",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q36.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1342G>C",
        "Protein Change":"p.Arg455Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0034%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28830301",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1677",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q91.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5801G>C",
        "Protein Change":"p.Gln83Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000525%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91693525",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1678",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q14.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1358T>T",
        "Protein Change":"p.Ser358Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006035%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83982608",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1679",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q48.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9364T>G",
        "Protein Change":"p.Gly282Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0073%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31526632",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1680",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q65.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4743G>A",
        "Protein Change":"p.Gln120Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000845%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31026204",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1681",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q27.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6722G>G",
        "Protein Change":"p.Leu336Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003067%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71642876",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1682",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q96.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1946T>T",
        "Protein Change":"p.Arg84Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002675%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90048640",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1683",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q57.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8304T>A",
        "Protein Change":"p.Pro256Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003391%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19702588",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1684",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q33.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1238G>T",
        "Protein Change":"p.Gln415Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006633%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35715546",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1685",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q40.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3287T>G",
        "Protein Change":"p.Leu417Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009014%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44044668",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1686",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q3.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1644T>A",
        "Protein Change":"p.Gln26Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008096%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11344679",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1687",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q46.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3215T>T",
        "Protein Change":"p.Arg313Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005343%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25184483",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1688",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q53.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5385T>G",
        "Protein Change":"p.Arg270Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001164%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18056439",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1689",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q69.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8931G>T",
        "Protein Change":"p.Gln88Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007416%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39298163",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1690",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q67.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6327C>C",
        "Protein Change":"p.Gln218Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000968%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55471941",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1691",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q63.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5886G>G",
        "Protein Change":"p.Arg462Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007684%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31639334",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1692",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q23.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1895G>A",
        "Protein Change":"p.Ser192Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009718%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68664544",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1693",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q71.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.943T>C",
        "Protein Change":"p.Gln417Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008147%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28995000",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1694",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q47.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7322T>C",
        "Protein Change":"p.Gln39Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003565%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81417129",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1695",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q69.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9875A>T",
        "Protein Change":"p.Pro110Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002949%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36874640",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1696",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q85.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4280T>T",
        "Protein Change":"p.Leu314Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002544%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36299520",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1697",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q14.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7065T>G",
        "Protein Change":"p.Arg29Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009919%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31838093",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1698",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q10.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.172G>G",
        "Protein Change":"p.Arg101Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67839805",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1699",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q62.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4407C>C",
        "Protein Change":"p.Leu31Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007633%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11062712",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1700",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q28.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8659C>A",
        "Protein Change":"p.Gly32Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006666%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13670538",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1701",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q62.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3781T>G",
        "Protein Change":"p.Arg319Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001726%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23972421",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1702",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q47.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9411G>T",
        "Protein Change":"p.Leu22Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007436%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94708167",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1703",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q61.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9468C>T",
        "Protein Change":"p.Pro324Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000778%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:96347479",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1704",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q96.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4577C>A",
        "Protein Change":"p.Gln140Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008736%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32195745",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1705",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q4.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6309A>T",
        "Protein Change":"p.Ser456Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005121%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87210915",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1706",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q82.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3320C>T",
        "Protein Change":"p.Gly274Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000444%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86533329",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1707",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q85.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2590C>A",
        "Protein Change":"p.Gln82Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00055%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16575442",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1708",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q74.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.160A>G",
        "Protein Change":"p.Pro272Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00243%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28033223",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1709",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q21.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.738T>C",
        "Protein Change":"p.Ser410Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000371%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86785048",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1710",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q5.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1876T>G",
        "Protein Change":"p.Gln139Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007181%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47989595",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1711",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q54.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1889G>T",
        "Protein Change":"p.Gln344Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005337%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16008617",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1712",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q89.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1585C>C",
        "Protein Change":"p.Ser126Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006289%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85723107",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1713",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q60.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4396G>T",
        "Protein Change":"p.Gly352Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009941%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60333783",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1714",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q7.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.512T>C",
        "Protein Change":"p.Gln24Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006915%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30282044",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1715",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q24.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9405C>G",
        "Protein Change":"p.Gln151Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005936%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26382517",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1716",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q28.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8181A>G",
        "Protein Change":"p.Arg471Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004837%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35783501",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1717",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q18.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3410C>C",
        "Protein Change":"p.Gln157Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001085%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59228848",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1718",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q69.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.964C>G",
        "Protein Change":"p.Ser194Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008976%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36884642",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1719",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q20.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8952T>T",
        "Protein Change":"p.Pro447Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008386%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22830457",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1720",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q77.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1106C>T",
        "Protein Change":"p.Pro330Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003594%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81622392",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1721",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q58.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9337A>A",
        "Protein Change":"p.Ser489Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00304%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21779309",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1722",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q21.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5400A>C",
        "Protein Change":"p.Gln222Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005878%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97873589",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1723",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q99.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2112C>A",
        "Protein Change":"p.Arg196Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007382%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41031624",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1724",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q13.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1836A>T",
        "Protein Change":"p.Leu10Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006729%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84774850",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1725",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q69.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.892G>T",
        "Protein Change":"p.Leu26Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000928%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18380420",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1726",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q50.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4498T>G",
        "Protein Change":"p.Pro9Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009043%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75296077",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1727",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q20.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6521C>T",
        "Protein Change":"p.Arg384Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004991%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19553782",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1728",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q24.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6835C>C",
        "Protein Change":"p.Arg53Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003307%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66946337",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1729",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q99.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2504T>A",
        "Protein Change":"p.Leu216Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000238%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76963048",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1730",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q39.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6043G>T",
        "Protein Change":"p.Arg262Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005504%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47974185",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1731",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q17.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9907G>T",
        "Protein Change":"p.Gly360Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00046%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49221503",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1732",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q17.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7699C>C",
        "Protein Change":"p.Leu144Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008664%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11210047",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1733",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q77.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3011G>A",
        "Protein Change":"p.Gly75Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000525%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51268371",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1734",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q47.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1581C>T",
        "Protein Change":"p.Arg315Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002469%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11369314",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1735",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q17.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7926C>A",
        "Protein Change":"p.Ser486Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004688%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63033461",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1736",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q3.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.376G>G",
        "Protein Change":"p.Pro367Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008539%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87994389",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1737",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q2.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9019G>A",
        "Protein Change":"p.Gln191Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002295%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51849537",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1738",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q65.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6167G>A",
        "Protein Change":"p.Ser242Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009868%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91497371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1739",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q45.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4861C>A",
        "Protein Change":"p.Gln140Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001389%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61449718",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1740",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q51.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2323C>G",
        "Protein Change":"p.Gln453Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008907%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75750290",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1741",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q76.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2349A>C",
        "Protein Change":"p.Gln57Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003902%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27398236",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1742",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q26.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5000C>G",
        "Protein Change":"p.Pro52Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007973%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57868141",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1743",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q70.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3446A>T",
        "Protein Change":"p.Ser429Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009419%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32675136",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1744",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q98.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9763G>C",
        "Protein Change":"p.Leu184Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004621%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79792995",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1745",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q43.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4763A>A",
        "Protein Change":"p.Gly324Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005805%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22826522",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1746",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q45.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2305C>T",
        "Protein Change":"p.Leu130Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00059%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61105895",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1747",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q96.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.444G>T",
        "Protein Change":"p.Gly28Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006843%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76297206",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1748",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q79.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6364T>C",
        "Protein Change":"p.Pro447Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001691%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45779468",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1749",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q99.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7648G>T",
        "Protein Change":"p.Arg179Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004332%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83856070",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1750",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q83.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2559T>C",
        "Protein Change":"p.Ser489Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001087%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49972659",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1751",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q87.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2950C>C",
        "Protein Change":"p.Gly449Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009943%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48967963",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1752",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q20.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5981G>T",
        "Protein Change":"p.Arg156Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005778%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95471953",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1753",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q79.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7648C>T",
        "Protein Change":"p.Arg452Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007648%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83996744",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1754",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q73.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8769C>T",
        "Protein Change":"p.Gly374Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005578%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18251174",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1755",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q40.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8053A>C",
        "Protein Change":"p.Arg200Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001502%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38237054",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1756",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q42.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2938G>T",
        "Protein Change":"p.Ser422Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006195%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69026203",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1757",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q67.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3463A>A",
        "Protein Change":"p.Gln216Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008492%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41996019",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1758",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q79.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8008G>A",
        "Protein Change":"p.Pro302Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007201%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76441410",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1759",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q78.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6067T>G",
        "Protein Change":"p.Arg398Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004787%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75966019",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1760",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q49.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5587C>C",
        "Protein Change":"p.Gly127Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005432%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25495050",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1761",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q4.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8468A>C",
        "Protein Change":"p.Gly341Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003438%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91520121",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1762",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q79.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1777A>G",
        "Protein Change":"p.Ser269Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0072%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25321882",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1763",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q12.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2440T>C",
        "Protein Change":"p.Leu430Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005485%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20909377",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1764",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q4.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4342T>G",
        "Protein Change":"p.Leu460Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003364%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20827584",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1765",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q27.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5191A>A",
        "Protein Change":"p.Gly285Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002109%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38611111",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1766",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q94.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6961T>T",
        "Protein Change":"p.Leu109Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003525%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62166412",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1767",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q78.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5830A>G",
        "Protein Change":"p.Gln137Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000894%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18832888",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1768",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q28.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3363A>G",
        "Protein Change":"p.Ser161Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003126%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55911589",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1769",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q97.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9223G>G",
        "Protein Change":"p.Leu198Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41512366",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1770",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q93.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2556A>A",
        "Protein Change":"p.Gly56Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009669%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45549916",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1771",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q32.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6220T>G",
        "Protein Change":"p.Leu423Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008749%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31516013",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1772",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q53.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3980T>C",
        "Protein Change":"p.Gln390Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000259%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48305278",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1773",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q75.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1731G>A",
        "Protein Change":"p.Gln278Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007839%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24038901",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1774",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q87.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8953G>A",
        "Protein Change":"p.Pro41Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008191%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92706524",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1775",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q16.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5457C>G",
        "Protein Change":"p.Arg42Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003657%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52022066",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1776",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q83.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7819A>C",
        "Protein Change":"p.Gly321Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001974%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74649581",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1777",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q67.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9303A>G",
        "Protein Change":"p.Ser84Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000467%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57988860",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1778",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q93.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2456A>G",
        "Protein Change":"p.Leu64Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009865%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80733382",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1779",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q29.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4393C>A",
        "Protein Change":"p.Arg90Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008027%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95974883",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1780",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q67.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7078A>T",
        "Protein Change":"p.Gln86Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00563%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76623228",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1781",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q92.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5680T>C",
        "Protein Change":"p.Ser4Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009776%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44419063",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1782",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q23.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7664G>T",
        "Protein Change":"p.Gln105Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00733%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32616044",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1783",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q94.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1986A>A",
        "Protein Change":"p.Arg301Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000559%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65211331",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1784",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q70.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3364G>T",
        "Protein Change":"p.Gln86Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009118%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88870352",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1785",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q21.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5680C>C",
        "Protein Change":"p.Leu150Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000685%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38893416",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1786",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q81.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5932A>C",
        "Protein Change":"p.Gln271Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003509%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31949071",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1787",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q32.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3596T>T",
        "Protein Change":"p.Gly270Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009464%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34060164",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1788",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q27.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9217C>C",
        "Protein Change":"p.Ser453Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007204%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18481219",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1789",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q67.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7883A>G",
        "Protein Change":"p.Gln141Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006086%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29478315",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1790",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q48.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1783G>C",
        "Protein Change":"p.Pro167Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009346%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77380129",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1791",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q90.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3788A>A",
        "Protein Change":"p.Pro180Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007818%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38214212",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1792",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q96.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.317T>T",
        "Protein Change":"p.Leu296Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003232%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66750474",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1793",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q66.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1074G>C",
        "Protein Change":"p.Leu450Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000625%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10271324",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1794",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q17.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4460G>G",
        "Protein Change":"p.Gln153Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008822%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59630459",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1795",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q19.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.879A>G",
        "Protein Change":"p.Gly310Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009057%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32825977",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1796",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q45.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4449T>T",
        "Protein Change":"p.Gly230Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007323%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35230427",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1797",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q55.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9257T>G",
        "Protein Change":"p.Ser280Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001589%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45085321",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1798",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q58.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3076T>A",
        "Protein Change":"p.Leu135Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00786%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22124767",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1799",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q48.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6757G>G",
        "Protein Change":"p.Ser478Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006531%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11899722",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1800",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q38.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4930T>A",
        "Protein Change":"p.Gly205Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008282%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76493024",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1801",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q82.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8634C>C",
        "Protein Change":"p.Gln292Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000148%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88044581",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1802",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q82.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3220G>G",
        "Protein Change":"p.Gly173Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008647%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56052582",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1803",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q98.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6480A>T",
        "Protein Change":"p.Gly120Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005874%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15384279",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1804",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q94.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5248G>C",
        "Protein Change":"p.Gln160Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000437%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38799304",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1805",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q45.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3303C>A",
        "Protein Change":"p.Leu19Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007425%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49899906",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1806",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q8.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2176A>T",
        "Protein Change":"p.Arg387Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007663%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15911661",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1807",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q68.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4244C>G",
        "Protein Change":"p.Arg372Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000183%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66002132",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1808",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q28.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.407T>G",
        "Protein Change":"p.Ser241Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00025%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45990513",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1809",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q3.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4995C>A",
        "Protein Change":"p.Pro352Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008986%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33099740",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1810",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q6.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4128C>T",
        "Protein Change":"p.Leu186Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003962%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27922998",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1811",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q44.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4155C>G",
        "Protein Change":"p.Ser80Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001269%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98688976",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1812",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q39.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3614G>C",
        "Protein Change":"p.Gly414Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007778%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91092130",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1813",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q54.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2244T>G",
        "Protein Change":"p.Gln267Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007208%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87150078",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1814",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q45.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2617T>C",
        "Protein Change":"p.Gly271Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008469%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72232972",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1815",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q73.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7308G>G",
        "Protein Change":"p.Pro47Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001377%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72447381",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1816",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q41.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7378G>T",
        "Protein Change":"p.Leu459Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000635%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83272920",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1817",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q42.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8464C>G",
        "Protein Change":"p.Ser359Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009585%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67757830",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1818",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q41.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5947A>A",
        "Protein Change":"p.Gly428Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008646%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92922718",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1819",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q74.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.891C>G",
        "Protein Change":"p.Ser1Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002322%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11487226",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1820",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q61.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4524C>T",
        "Protein Change":"p.Pro182Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009618%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89692326",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1821",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q78.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.483G>T",
        "Protein Change":"p.Ser302Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003582%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29635278",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1822",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q81.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5531G>G",
        "Protein Change":"p.Pro499Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000652%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82634326",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1823",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q20.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3291T>C",
        "Protein Change":"p.Leu268Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002226%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34274509",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1824",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q36.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.834T>G",
        "Protein Change":"p.Arg336Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005446%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54330003",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1825",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q49.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8988T>G",
        "Protein Change":"p.Gly256Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004778%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97919174",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1826",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q94.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.286A>A",
        "Protein Change":"p.Gln39Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004596%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60580072",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1827",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q61.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8968G>C",
        "Protein Change":"p.Arg16Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004115%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65543837",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1828",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q94.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8865G>T",
        "Protein Change":"p.Gln477Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006988%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29600434",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1829",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q29.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4521A>C",
        "Protein Change":"p.Leu417Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006662%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71635761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1830",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q17.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3066G>A",
        "Protein Change":"p.Ser318Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00018%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72482372",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1831",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q6.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8548G>T",
        "Protein Change":"p.Pro60Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006883%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58440632",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1832",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q7.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6783A>T",
        "Protein Change":"p.Arg259Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005562%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71684536",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1833",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q28.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.363A>A",
        "Protein Change":"p.Leu41Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008727%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80827690",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1834",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q1.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3242G>T",
        "Protein Change":"p.Gly329Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008693%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55878134",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1835",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q19.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3622C>G",
        "Protein Change":"p.Gln112Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009709%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38547886",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1836",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q28.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5477G>C",
        "Protein Change":"p.Ser238Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008483%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16857992",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1837",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q32.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2796G>T",
        "Protein Change":"p.Pro303Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000147%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40562591",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1838",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q56.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5498G>C",
        "Protein Change":"p.Gln407Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007921%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95814528",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1839",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q72.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9672T>G",
        "Protein Change":"p.Gly274Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005536%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71250358",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1840",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q77.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5121C>G",
        "Protein Change":"p.Gln167Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000396%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50996058",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1841",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q51.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2422T>T",
        "Protein Change":"p.Pro132Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009652%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73896929",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1842",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q71.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1394A>T",
        "Protein Change":"p.Ser445Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005274%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40343374",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1843",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q18.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6024G>G",
        "Protein Change":"p.Gln70Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006242%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59414911",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1844",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q51.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4433G>G",
        "Protein Change":"p.Ser324Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003392%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13105346",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1845",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q59.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6535A>A",
        "Protein Change":"p.Ser67Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007156%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39978364",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1846",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q38.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.889A>A",
        "Protein Change":"p.Gln64Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005902%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95419637",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1847",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q2.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5869G>C",
        "Protein Change":"p.Leu78Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000783%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86202182",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1848",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q96.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9146G>C",
        "Protein Change":"p.Arg8Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00678%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59334936",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1849",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q19.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9731T>T",
        "Protein Change":"p.Leu286Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000178%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10243884",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1850",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q3.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9797A>G",
        "Protein Change":"p.Gly214Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009769%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67668406",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1851",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q59.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6212C>G",
        "Protein Change":"p.Arg459Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006474%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73940799",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1852",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q72.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.132G>A",
        "Protein Change":"p.Arg148Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006303%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91593760",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1853",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q63.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3042G>G",
        "Protein Change":"p.Gln91Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004206%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51773496",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1854",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q32.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7871T>C",
        "Protein Change":"p.Pro319Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006428%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38159654",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1855",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q90.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4930C>A",
        "Protein Change":"p.Gly159Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00522%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:57188503",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1856",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q1.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6356G>A",
        "Protein Change":"p.Arg274Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005296%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75901679",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1857",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q1.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8344C>T",
        "Protein Change":"p.Leu64Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17177949",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1858",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q45.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7649A>A",
        "Protein Change":"p.Leu494Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005859%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64104233",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1859",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q14.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5293C>A",
        "Protein Change":"p.Pro115Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00837%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34580987",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1860",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q32.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5832T>G",
        "Protein Change":"p.Gln36Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009374%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36478566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1861",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q26.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9163C>C",
        "Protein Change":"p.Ser270Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008065%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40077466",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1862",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q61.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7840C>C",
        "Protein Change":"p.Arg428Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007049%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23615901",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1863",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q25.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6268T>G",
        "Protein Change":"p.Pro254Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002408%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78069454",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1864",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q49.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7698A>G",
        "Protein Change":"p.Leu17Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001609%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69430453",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1865",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q73.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3373T>T",
        "Protein Change":"p.Ser259Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005407%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29269130",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1866",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q35.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4574T>G",
        "Protein Change":"p.Gln40Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00345%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37977533",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1867",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q33.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2104G>G",
        "Protein Change":"p.Gly388Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009247%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67346810",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1868",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q39.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8145T>C",
        "Protein Change":"p.Pro259Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00042%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40403831",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1869",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q33.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9113G>C",
        "Protein Change":"p.Gln346Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009788%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23602439",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1870",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q92.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6102C>C",
        "Protein Change":"p.Ser190Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005945%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54671076",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1871",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q96.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.639G>G",
        "Protein Change":"p.Ser21Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004414%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25626518",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1872",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q4.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2512A>C",
        "Protein Change":"p.Gln420Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004896%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97410592",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1873",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q22.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.458G>G",
        "Protein Change":"p.Gly454Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005987%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17608951",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1874",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q50.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5883G>C",
        "Protein Change":"p.Pro147Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003076%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82523831",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1875",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q87.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5325A>G",
        "Protein Change":"p.Gln204Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003406%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98016417",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1876",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q79.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1991T>A",
        "Protein Change":"p.Arg165Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005736%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81621321",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1877",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q51.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1078G>C",
        "Protein Change":"p.Pro478Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005434%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27469632",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1878",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q54.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1802G>T",
        "Protein Change":"p.Pro432Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007953%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49963122",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1879",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q57.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4455C>T",
        "Protein Change":"p.Gly197Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008736%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80620249",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1880",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q89.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1684G>T",
        "Protein Change":"p.Ser394Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008135%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95075485",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1881",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q88.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8602C>G",
        "Protein Change":"p.Gly455Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009319%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72987608",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1882",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q94.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1329C>A",
        "Protein Change":"p.Leu482Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006631%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33555290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1883",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q52.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7013G>A",
        "Protein Change":"p.Gln430Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009912%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42965546",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1884",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q73.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2939A>A",
        "Protein Change":"p.Arg343Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004925%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20307807",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1885",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q26.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9481C>T",
        "Protein Change":"p.Arg110Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008783%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75384917",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1886",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q12.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8620C>T",
        "Protein Change":"p.Ser92Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004909%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19861907",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1887",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q30.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3015A>A",
        "Protein Change":"p.Pro472Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000887%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63827088",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1888",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q42.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2797G>A",
        "Protein Change":"p.Ser96Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007315%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26243582",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1889",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q98.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2686A>G",
        "Protein Change":"p.Arg215Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00346%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45988819",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1890",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q27.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3187C>A",
        "Protein Change":"p.Pro125Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003006%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91914403",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1891",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q73.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4882G>A",
        "Protein Change":"p.Pro410Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00831%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50423862",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1892",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q2.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3578G>A",
        "Protein Change":"p.Gly453Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003184%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38766369",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1893",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q43.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4867G>C",
        "Protein Change":"p.Ser484Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003597%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64797156",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1894",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q64.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8874T>A",
        "Protein Change":"p.Pro110Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005085%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83944518",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1895",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q42.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7142T>C",
        "Protein Change":"p.Gln384Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007014%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76679665",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1896",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q59.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6928T>C",
        "Protein Change":"p.Arg71Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000387%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67127762",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1897",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q39.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7877T>G",
        "Protein Change":"p.Leu381Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11980962",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1898",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q70.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9253T>A",
        "Protein Change":"p.Leu488Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009909%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13986315",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1899",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q77.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.779A>C",
        "Protein Change":"p.Ser115Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00077%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64521718",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1900",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q15.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7877C>T",
        "Protein Change":"p.Arg132Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006014%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86160791",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1901",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q80.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7611G>C",
        "Protein Change":"p.Arg498Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004631%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74843115",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1902",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q70.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3937C>A",
        "Protein Change":"p.Pro100Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002198%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43303909",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1903",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q87.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7056T>T",
        "Protein Change":"p.Arg393Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005439%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39559996",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1904",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q80.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7957C>A",
        "Protein Change":"p.Leu439Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00266%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65749830",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1905",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q58.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.959G>C",
        "Protein Change":"p.Gly455Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005659%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27691138",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1906",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q26.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8308A>A",
        "Protein Change":"p.Leu248Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006236%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55141213",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1907",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q23.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3067G>G",
        "Protein Change":"p.Gly494Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004508%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69133244",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1908",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q58.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7766C>A",
        "Protein Change":"p.Pro54Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005271%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86533688",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1909",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q16.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7612G>C",
        "Protein Change":"p.Gln315Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002735%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37125982",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1910",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q94.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9353A>A",
        "Protein Change":"p.Ser250Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000293%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14875161",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1911",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q12.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5292G>C",
        "Protein Change":"p.Gly171Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000537%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26258138",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1912",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q44.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8031A>C",
        "Protein Change":"p.Gly48Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005076%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12368505",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1913",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q7.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7783T>A",
        "Protein Change":"p.Gly165Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001287%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53547886",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1914",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q42.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4546C>G",
        "Protein Change":"p.Gln438Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007351%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30889844",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1915",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q22.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6990A>G",
        "Protein Change":"p.Pro317Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007683%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29431020",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1916",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q33.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9106T>A",
        "Protein Change":"p.Gln484Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002353%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93976388",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1917",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q31.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1745A>T",
        "Protein Change":"p.Gln116Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000388%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28052153",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1918",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q74.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4390C>C",
        "Protein Change":"p.Leu486Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005899%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67429367",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1919",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q75.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3547G>A",
        "Protein Change":"p.Leu455Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007972%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92638937",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1920",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q74.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5118G>C",
        "Protein Change":"p.Gly199Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003913%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51792425",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1921",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q39.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2586T>G",
        "Protein Change":"p.Arg404Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003757%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61114081",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1922",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q76.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3648C>A",
        "Protein Change":"p.Leu292Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000624%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72809039",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1923",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q42.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3722G>A",
        "Protein Change":"p.Ser67Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005852%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47317637",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1924",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q4.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3317G>C",
        "Protein Change":"p.Ser231Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005966%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24791173",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1925",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q76.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3720G>A",
        "Protein Change":"p.Gly292Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009273%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39857901",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1926",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q74.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.187C>A",
        "Protein Change":"p.Gly258Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007973%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32500274",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1927",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q72.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2434C>T",
        "Protein Change":"p.Ser77Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006436%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35502998",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1928",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q57.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6929T>A",
        "Protein Change":"p.Pro211Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009212%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14690246",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1929",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q10.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5267T>C",
        "Protein Change":"p.Gly421Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006661%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53140364",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1930",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q69.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3299T>G",
        "Protein Change":"p.Gln305Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00761%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51894376",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1931",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q10.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.834A>C",
        "Protein Change":"p.Gln195Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007267%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:10156110",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1932",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q47.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5503G>T",
        "Protein Change":"p.Gly485Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002583%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30970643",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1933",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q5.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7523G>C",
        "Protein Change":"p.Gly242Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008923%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64482032",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1934",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q60.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.706A>C",
        "Protein Change":"p.Ser166Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002644%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63410001",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1935",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q89.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2060T>T",
        "Protein Change":"p.Ser302Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002684%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68140548",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1936",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q74.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2154G>G",
        "Protein Change":"p.Pro429Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001011%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95829818",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1937",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q51.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5518A>T",
        "Protein Change":"p.Ser186Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00925%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34978764",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1938",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q68.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6605T>G",
        "Protein Change":"p.Leu199Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001495%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71513962",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1939",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q45.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9128G>A",
        "Protein Change":"p.Ser258Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005356%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50342544",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1940",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q86.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3769C>G",
        "Protein Change":"p.Leu324Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008668%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46286919",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1941",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q41.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9910C>T",
        "Protein Change":"p.Leu293Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002815%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30743259",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1942",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q10.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5860G>G",
        "Protein Change":"p.Gln453Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008521%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68795295",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1943",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q34.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3984G>A",
        "Protein Change":"p.Pro85Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003732%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74332765",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1944",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q33.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9576C>T",
        "Protein Change":"p.Pro331Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004277%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68009367",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1945",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q49.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3138C>G",
        "Protein Change":"p.Arg478Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000318%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59892770",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1946",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q54.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6637A>C",
        "Protein Change":"p.Pro150Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002391%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81944558",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1947",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q9.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5235T>A",
        "Protein Change":"p.Ser348Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006005%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32752933",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1948",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q10.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4168C>G",
        "Protein Change":"p.Gln492Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00391%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82439556",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1949",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q91.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7147A>A",
        "Protein Change":"p.Pro374Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009541%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15351134",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1950",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q54.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8532G>T",
        "Protein Change":"p.Leu167Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005684%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55678759",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1951",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q48.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2150G>G",
        "Protein Change":"p.Arg179Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002011%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53116108",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1952",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q11.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5373C>T",
        "Protein Change":"p.Pro450Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002037%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59897840",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1953",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q24.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9412A>C",
        "Protein Change":"p.Leu370Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0061%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56320858",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1954",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q80.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7660G>G",
        "Protein Change":"p.Ser51Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006533%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92719290",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1955",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q60.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9698C>G",
        "Protein Change":"p.Leu59Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00831%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90366195",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1956",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q88.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6354C>G",
        "Protein Change":"p.Pro231Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008725%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49668620",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1957",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q62.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2964G>C",
        "Protein Change":"p.Ser470Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007692%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75592772",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1958",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q91.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2149C>G",
        "Protein Change":"p.Leu292Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001088%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25361319",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1959",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q62.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5501A>A",
        "Protein Change":"p.Leu157Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000908%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18577287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1960",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q86.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7247T>A",
        "Protein Change":"p.Leu391Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007897%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32051384",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1961",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q40.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8483T>G",
        "Protein Change":"p.Pro410Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003778%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92732775",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1962",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q96.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3807G>G",
        "Protein Change":"p.Gly324Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003678%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36836764",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1963",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q54.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8285G>G",
        "Protein Change":"p.Leu140Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009967%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22418015",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1964",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q14.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3835A>A",
        "Protein Change":"p.Ser92Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006473%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39786703",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1965",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q65.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3094G>C",
        "Protein Change":"p.Arg60Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002698%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14891068",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1966",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q43.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4947C>A",
        "Protein Change":"p.Ser127Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005067%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32586867",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1967",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q63.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.286T>G",
        "Protein Change":"p.Pro103Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00763%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40073539",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1968",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q16.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6492C>A",
        "Protein Change":"p.Pro151Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002231%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45827192",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1969",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q50.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.849C>G",
        "Protein Change":"p.Gly453Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001803%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:38106814",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1970",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q23.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8010G>T",
        "Protein Change":"p.Ser481Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004566%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51863004",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1971",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q37.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6039G>C",
        "Protein Change":"p.Leu121Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003915%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78232426",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1972",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q56.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8554G>G",
        "Protein Change":"p.Arg64Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009379%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71114164",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1973",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q57.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.459G>G",
        "Protein Change":"p.Gln178Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009317%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88278761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1974",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q80.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7980G>T",
        "Protein Change":"p.Gln56Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008027%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85013631",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1975",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q46.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4438G>A",
        "Protein Change":"p.Pro292Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009366%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81644978",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1976",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q34.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7613C>G",
        "Protein Change":"p.Gln343Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005768%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77659904",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1977",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q10.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3624C>G",
        "Protein Change":"p.Leu73Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005967%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10686298",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1978",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q84.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2662T>G",
        "Protein Change":"p.Arg411Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003012%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39858036",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1979",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q61.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3132G>A",
        "Protein Change":"p.Leu6Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002239%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16112732",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1980",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q44.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2357T>T",
        "Protein Change":"p.Pro112Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00492%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97186417",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1981",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q66.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6777C>T",
        "Protein Change":"p.Arg286Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006786%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47466519",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1982",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q21.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.659G>C",
        "Protein Change":"p.Leu16Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000587%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87705991",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1983",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q67.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9962C>G",
        "Protein Change":"p.Arg174Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000648%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82654536",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1984",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q24.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5433A>G",
        "Protein Change":"p.Gly446Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005626%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61087194",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1985",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q71.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6071G>A",
        "Protein Change":"p.Pro372Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006949%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67265128",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1986",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q49.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.316G>G",
        "Protein Change":"p.Leu319Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00495%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15555834",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1987",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q16.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3737C>A",
        "Protein Change":"p.Pro478Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008219%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13358741",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1988",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q46.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4311T>A",
        "Protein Change":"p.Gly375Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000685%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18276158",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1989",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q40.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2743G>A",
        "Protein Change":"p.Ser27Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009996%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82712195",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1990",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q43.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8435C>A",
        "Protein Change":"p.Arg24Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000688%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53544788",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1991",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q16.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4754T>T",
        "Protein Change":"p.Ser313Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003675%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22009499",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1992",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q10.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8153A>A",
        "Protein Change":"p.Gly429Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006884%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59101293",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT1993",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q44.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5359A>T",
        "Protein Change":"p.Pro212Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00432%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92935079",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1994",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q80.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6621T>T",
        "Protein Change":"p.Gln381Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001782%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37284834",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1995",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q45.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2614G>T",
        "Protein Change":"p.Leu126Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006518%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25214383",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT1996",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q58.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9886G>G",
        "Protein Change":"p.Ser410Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000769%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76299444",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1997",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q3.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4088A>C",
        "Protein Change":"p.Arg259Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008927%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30262588",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1998",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q87.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8582A>G",
        "Protein Change":"p.Ser330Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002065%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18771448",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT1999",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q26.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9654T>T",
        "Protein Change":"p.Gln87Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001691%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28173449",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2000",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q26.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.562C>T",
        "Protein Change":"p.Pro378Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007211%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89691502",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2001",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q76.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9911G>G",
        "Protein Change":"p.Pro300Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008939%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65577534",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2002",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q14.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6813C>C",
        "Protein Change":"p.Gly232Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009349%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52098124",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2003",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q20.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6104G>T",
        "Protein Change":"p.Gln337Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000312%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67372558",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2004",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q89.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4273G>C",
        "Protein Change":"p.Ser16Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007603%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20752200",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2005",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q9.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8821A>A",
        "Protein Change":"p.Gln58Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007255%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96457127",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2006",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q70.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5614G>A",
        "Protein Change":"p.Leu211Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002936%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32195990",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2007",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q82.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8693G>A",
        "Protein Change":"p.Pro441Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002908%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88121756",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2008",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q35.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1347G>G",
        "Protein Change":"p.Pro237Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000308%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67260460",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2009",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q76.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3463G>G",
        "Protein Change":"p.Pro178Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001159%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91672380",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2010",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q13.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8043T>C",
        "Protein Change":"p.Leu68Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007953%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67403204",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2011",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q17.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2634C>G",
        "Protein Change":"p.Gly315Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007131%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19947071",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2012",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q31.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2326A>T",
        "Protein Change":"p.Arg256Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002965%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31408394",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2013",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q6.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6756G>G",
        "Protein Change":"p.Gln486Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000735%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76650230",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2014",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q8.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6713G>G",
        "Protein Change":"p.Gln456Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006185%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28975325",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2015",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q53.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1235C>T",
        "Protein Change":"p.Gln27Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008585%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36294848",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2016",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q66.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3743C>G",
        "Protein Change":"p.Arg265Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004779%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43630360",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2017",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q75.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7881G>T",
        "Protein Change":"p.Arg124Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009479%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77215311",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2018",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q40.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3189C>G",
        "Protein Change":"p.Gln372Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007728%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64505878",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2019",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q58.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9152G>G",
        "Protein Change":"p.Gly225Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005952%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36409149",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2020",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q64.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9655T>G",
        "Protein Change":"p.Arg488Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004005%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65268944",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2021",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q48.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9232C>G",
        "Protein Change":"p.Pro477Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000273%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30808049",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2022",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q89.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.810A>A",
        "Protein Change":"p.Ser358Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005075%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99224962",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2023",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q26.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.771G>A",
        "Protein Change":"p.Gln481Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008655%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47806069",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2024",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q79.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8712G>T",
        "Protein Change":"p.Gln299Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002637%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36379462",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2025",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q77.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2773A>G",
        "Protein Change":"p.Leu20Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001517%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59628442",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2026",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q5.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5257C>C",
        "Protein Change":"p.Leu267Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004585%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74137563",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2027",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q94.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9211A>G",
        "Protein Change":"p.Gly350Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000936%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14024005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2028",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q93.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.382C>A",
        "Protein Change":"p.Gly194Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002314%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94604970",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2029",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q54.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2504C>A",
        "Protein Change":"p.Arg272Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002543%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15272030",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2030",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q81.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2268G>C",
        "Protein Change":"p.Gln305Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006418%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65214692",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2031",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q69.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.508C>A",
        "Protein Change":"p.Leu42Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002478%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49934222",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2032",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q25.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3777T>G",
        "Protein Change":"p.Gln227Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009016%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51889114",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2033",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q36.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8371T>G",
        "Protein Change":"p.Ser16Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008942%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17241776",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2034",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q81.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5308G>C",
        "Protein Change":"p.Pro227Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000914%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20427301",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2035",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q47.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9359C>G",
        "Protein Change":"p.Gln326Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007825%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41661131",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2036",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q12.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3810A>A",
        "Protein Change":"p.Gly217Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002252%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:24984566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2037",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q45.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1303A>T",
        "Protein Change":"p.Arg370Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005029%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99792907",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2038",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q51.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9768G>C",
        "Protein Change":"p.Gly20Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009952%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94303621",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2039",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q41.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9870T>T",
        "Protein Change":"p.Gln498Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002394%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62140546",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2040",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q12.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3237T>G",
        "Protein Change":"p.Arg108Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009441%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60740053",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2041",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q12.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1871A>T",
        "Protein Change":"p.Gln276Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000662%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88480788",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2042",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q51.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6933C>A",
        "Protein Change":"p.Ser491Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004547%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69918158",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2043",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q53.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9157A>C",
        "Protein Change":"p.Pro476Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002354%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57717299",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2044",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q84.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.888G>G",
        "Protein Change":"p.Leu88Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005085%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44933931",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2045",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q13.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.726T>A",
        "Protein Change":"p.Leu306Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007495%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18740502",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2046",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q22.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7987C>T",
        "Protein Change":"p.Arg239Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78858326",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2047",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q36.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6370G>C",
        "Protein Change":"p.Pro330Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005636%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51238505",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2048",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q15.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5377G>T",
        "Protein Change":"p.Gln311Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000882%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78705207",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2049",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q50.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3041C>T",
        "Protein Change":"p.Gly178Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00511%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62648249",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2050",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q44.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.289C>T",
        "Protein Change":"p.Pro133Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001987%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76228893",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2051",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q77.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6949A>G",
        "Protein Change":"p.Ser165Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006638%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34260204",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2052",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q62.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3811T>G",
        "Protein Change":"p.Gln439Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001293%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26791910",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2053",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q37.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1983C>G",
        "Protein Change":"p.Arg352Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001047%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31174078",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2054",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q42.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6711G>T",
        "Protein Change":"p.Pro395Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007349%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20976863",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2055",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q7.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2791T>C",
        "Protein Change":"p.Gly136Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00893%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99920030",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2056",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q75.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3315A>C",
        "Protein Change":"p.Leu386Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008727%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64342487",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2057",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q33.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2408A>C",
        "Protein Change":"p.Arg133Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002895%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12569983",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2058",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q6.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6211G>A",
        "Protein Change":"p.Gln397Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001974%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92886357",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2059",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q17.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5496G>A",
        "Protein Change":"p.Ser245Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008249%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92547325",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2060",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q51.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3281G>G",
        "Protein Change":"p.Pro414Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004015%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26864906",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2061",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q23.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4183A>C",
        "Protein Change":"p.Arg117Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002382%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43730643",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2062",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q1.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2136G>G",
        "Protein Change":"p.Pro165Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27658985",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2063",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q90.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3206C>T",
        "Protein Change":"p.Pro487Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00824%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26063863",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2064",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q47.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6963C>T",
        "Protein Change":"p.Arg158Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000525%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34804578",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2065",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q35.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3862C>G",
        "Protein Change":"p.Ser254Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006634%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84569714",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2066",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q18.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4363G>G",
        "Protein Change":"p.Pro485Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004233%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58681523",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2067",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q85.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2810C>G",
        "Protein Change":"p.Leu201Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000359%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75698955",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2068",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q94.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8283G>T",
        "Protein Change":"p.Arg243Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007544%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92407767",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2069",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q46.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5518T>G",
        "Protein Change":"p.Arg290Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009243%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81551875",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2070",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q55.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6948T>C",
        "Protein Change":"p.Gly389Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000326%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67581732",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2071",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q27.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2609G>C",
        "Protein Change":"p.Leu118Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003504%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53735737",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2072",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q38.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9501T>C",
        "Protein Change":"p.Leu374Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001995%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75561344",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2073",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q90.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6815C>C",
        "Protein Change":"p.Gln286Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004634%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47135475",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2074",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q3.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9467A>G",
        "Protein Change":"p.Pro316Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006294%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19967454",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2075",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q53.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7115T>T",
        "Protein Change":"p.Leu320Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007343%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48364828",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2076",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q33.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1032A>A",
        "Protein Change":"p.Pro222Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004274%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83651388",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2077",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q2.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.301G>G",
        "Protein Change":"p.Gln47Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005671%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63054935",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2078",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q5.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2772T>C",
        "Protein Change":"p.Arg41Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001653%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52355422",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2079",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q65.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8183A>C",
        "Protein Change":"p.Leu192Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004235%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47789098",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2080",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q67.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4023C>T",
        "Protein Change":"p.Gly172Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000955%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59438092",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2081",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q11.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3616C>A",
        "Protein Change":"p.Leu417Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002106%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50368983",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2082",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q69.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.217T>T",
        "Protein Change":"p.Gly144Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002312%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39953243",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2083",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q47.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1174A>T",
        "Protein Change":"p.Gly409Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00851%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86719021",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2084",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q35.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.678A>T",
        "Protein Change":"p.Arg360Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005049%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36522412",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2085",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q48.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8416G>G",
        "Protein Change":"p.Pro161Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000651%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84774399",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2086",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q95.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5580T>A",
        "Protein Change":"p.Gly312Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009581%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52293255",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2087",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q61.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5521A>T",
        "Protein Change":"p.Gln203Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004315%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89731103",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2088",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q84.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4823T>T",
        "Protein Change":"p.Leu159Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003603%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32399152",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2089",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q46.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4924G>G",
        "Protein Change":"p.Leu268Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000483%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71410334",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2090",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q72.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3415C>T",
        "Protein Change":"p.Gln19Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006274%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44518960",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2091",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q30.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7588T>G",
        "Protein Change":"p.Ser270Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006703%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72385845",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2092",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q35.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7470C>T",
        "Protein Change":"p.Gly162Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004229%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71442164",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2093",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q32.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3932A>C",
        "Protein Change":"p.Leu30Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006377%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51496182",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2094",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q32.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8173T>T",
        "Protein Change":"p.Gly370Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000624%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30162317",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2095",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q89.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5369C>T",
        "Protein Change":"p.Gly47Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009219%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84721393",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2096",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q30.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1181C>T",
        "Protein Change":"p.Leu87Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00764%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60333929",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2097",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q92.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5567C>G",
        "Protein Change":"p.Gly489Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001015%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88736798",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2098",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q32.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2679T>A",
        "Protein Change":"p.Gly90Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005121%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79774632",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2099",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q23.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.525T>A",
        "Protein Change":"p.Gln355Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005293%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16878681",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2100",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q2.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5625G>T",
        "Protein Change":"p.Gly485Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00893%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49056127",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2101",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q64.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1088A>G",
        "Protein Change":"p.Ser345Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00482%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21778869",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2102",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q36.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8898A>C",
        "Protein Change":"p.Gly386Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006839%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12357559",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2103",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q4.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.853C>G",
        "Protein Change":"p.Pro67Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009226%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88104653",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2104",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q69.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7616G>C",
        "Protein Change":"p.Ser197Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00978%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62746496",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2105",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q98.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6027C>C",
        "Protein Change":"p.Arg343Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004162%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74166361",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2106",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q90.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1311T>C",
        "Protein Change":"p.Arg388Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004091%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18285499",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2107",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q43.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7626G>T",
        "Protein Change":"p.Gly294Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005709%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45654622",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2108",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q76.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8851A>T",
        "Protein Change":"p.Gln365Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001395%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42326878",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2109",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q92.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5461T>T",
        "Protein Change":"p.Pro49Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003048%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62841093",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2110",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q33.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.615A>T",
        "Protein Change":"p.Pro107Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002937%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86887799",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2111",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q30.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6162G>T",
        "Protein Change":"p.Gln36Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008371%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54940162",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2112",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q37.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7256A>T",
        "Protein Change":"p.Leu21Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004712%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22699026",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2113",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q85.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6187C>T",
        "Protein Change":"p.Pro444Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003858%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44146937",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2114",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q48.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3398T>C",
        "Protein Change":"p.Pro452Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00972%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21461554",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2115",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q3.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6556A>T",
        "Protein Change":"p.Leu121Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005545%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62155362",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2116",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q2.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7912T>G",
        "Protein Change":"p.Ser336Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006389%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86962065",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2117",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q6.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3191T>C",
        "Protein Change":"p.Leu220Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007792%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17841086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2118",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q32.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6678A>G",
        "Protein Change":"p.Leu154Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000221%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57713072",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2119",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q66.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.806C>A",
        "Protein Change":"p.Arg371Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005262%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36977246",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2120",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q99.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8153A>G",
        "Protein Change":"p.Pro113Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000746%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99256999",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2121",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q18.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1253A>T",
        "Protein Change":"p.Arg168Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001009%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42878788",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2122",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q37.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6943G>A",
        "Protein Change":"p.Gly454Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004752%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78983029",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2123",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q39.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7284A>A",
        "Protein Change":"p.Pro362Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004095%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57192629",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2124",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q14.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4639G>A",
        "Protein Change":"p.Gln391Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004684%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75879360",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2125",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q99.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9326G>T",
        "Protein Change":"p.Leu339Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002312%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30417094",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2126",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q94.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6770A>A",
        "Protein Change":"p.Pro182Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003721%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31604812",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2127",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q79.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7347G>T",
        "Protein Change":"p.Gln381Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007171%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51790471",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2128",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q73.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6419A>T",
        "Protein Change":"p.Gly363Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000867%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20445566",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2129",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q21.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3797C>G",
        "Protein Change":"p.Gln393Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002882%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76477229",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2130",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q50.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8549C>T",
        "Protein Change":"p.Pro48Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0023%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19448049",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2131",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q41.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2493C>A",
        "Protein Change":"p.Pro423Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00836%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45203903",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2132",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q43.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3227C>T",
        "Protein Change":"p.Arg435Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00684%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72413523",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2133",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q16.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7664T>T",
        "Protein Change":"p.Pro361Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00392%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78162542",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2134",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q71.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.643G>G",
        "Protein Change":"p.Gly66Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007274%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37695396",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2135",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q86.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2284A>A",
        "Protein Change":"p.Gly392Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007537%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98910517",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2136",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q76.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9752T>T",
        "Protein Change":"p.Pro122Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006209%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41335977",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2137",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q81.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7019C>A",
        "Protein Change":"p.Leu95Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008036%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21810768",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2138",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q91.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8750C>A",
        "Protein Change":"p.Arg56Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00651%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:90518071",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2139",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q86.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3191A>T",
        "Protein Change":"p.Pro487Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004754%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59650792",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2140",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q73.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5377A>G",
        "Protein Change":"p.Pro327Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009351%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:29321316",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2141",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q72.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8760C>G",
        "Protein Change":"p.Ser165Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004138%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45719811",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2142",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q1.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8097C>T",
        "Protein Change":"p.Pro482Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001793%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64326633",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2143",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q41.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7204A>A",
        "Protein Change":"p.Gly248Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005947%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36796984",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2144",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q50.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8669C>T",
        "Protein Change":"p.Pro27Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002231%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67276292",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2145",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q50.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2600G>T",
        "Protein Change":"p.Arg402Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007931%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65744526",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2146",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q42.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6853G>T",
        "Protein Change":"p.Leu190Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009965%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44548801",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2147",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q41.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4596A>A",
        "Protein Change":"p.Ser430Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008171%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57759932",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2148",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q21.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5354T>G",
        "Protein Change":"p.Gly419Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001628%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60364689",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2149",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q49.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6009A>C",
        "Protein Change":"p.Pro358Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008864%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54323546",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2150",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q61.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7532A>C",
        "Protein Change":"p.Arg458Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007181%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73997886",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2151",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q36.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5569A>G",
        "Protein Change":"p.Pro468Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002829%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52207908",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2152",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q96.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1391T>C",
        "Protein Change":"p.Leu336Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004462%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49930929",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2153",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q25.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.166C>C",
        "Protein Change":"p.Pro196Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005893%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54736970",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2154",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q97.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2363G>A",
        "Protein Change":"p.Leu95Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006534%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17438878",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2155",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q64.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1420C>C",
        "Protein Change":"p.Arg297Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000202%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19427930",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2156",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q51.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5572G>G",
        "Protein Change":"p.Gly450Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002887%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43116739",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2157",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q42.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3481A>G",
        "Protein Change":"p.Ser441Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005146%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91818164",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2158",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q34.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2057C>G",
        "Protein Change":"p.Arg107Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006544%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59454584",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2159",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q26.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3624G>G",
        "Protein Change":"p.Gln390Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001732%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60115626",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2160",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q66.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7452C>G",
        "Protein Change":"p.Arg470Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003701%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:26663687",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2161",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q31.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2419A>T",
        "Protein Change":"p.Gln302Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000963%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23451780",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2162",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q59.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3202T>G",
        "Protein Change":"p.Pro481Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008028%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51457070",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2163",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q92.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2145T>T",
        "Protein Change":"p.Pro415Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000921%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16776846",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2164",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q15.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.385G>T",
        "Protein Change":"p.Gln253Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00317%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89473996",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2165",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q57.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1633A>T",
        "Protein Change":"p.Arg207Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009258%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46187164",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2166",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q8.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6333G>A",
        "Protein Change":"p.Pro460Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00509%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21338121",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2167",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q55.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1954G>A",
        "Protein Change":"p.Arg349Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006727%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:80540943",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2168",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q33.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6618T>C",
        "Protein Change":"p.Gln136Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002818%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63856005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2169",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q63.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7417T>G",
        "Protein Change":"p.Ser162Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009184%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96642940",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2170",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q24.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2107T>G",
        "Protein Change":"p.Arg486Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006121%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59037593",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2171",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q93.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.233C>G",
        "Protein Change":"p.Gly170Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006003%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34499914",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2172",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q7.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3478C>T",
        "Protein Change":"p.Gly168Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00925%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70740902",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2173",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q28.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5844T>G",
        "Protein Change":"p.Gly481Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008872%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73271958",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2174",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q82.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6876G>A",
        "Protein Change":"p.Leu309Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00388%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72738119",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2175",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q13.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9396G>A",
        "Protein Change":"p.Gly440Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006438%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67737053",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2176",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q22.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5159G>T",
        "Protein Change":"p.Ser216Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007916%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92652747",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2177",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q23.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1780G>C",
        "Protein Change":"p.Arg256Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00135%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49229450",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2178",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q83.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8627A>T",
        "Protein Change":"p.Gly417Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003054%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35730729",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2179",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q37.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8460A>C",
        "Protein Change":"p.Ser259Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006125%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90727138",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2180",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q54.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6323T>A",
        "Protein Change":"p.Gln158Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005218%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74639106",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2181",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q5.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8878T>G",
        "Protein Change":"p.Gln455Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008137%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35244953",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2182",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q6.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7945C>A",
        "Protein Change":"p.Pro20Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007345%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23115804",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2183",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q73.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3495C>T",
        "Protein Change":"p.Gln170Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009252%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11641737",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2184",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q70.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3660A>C",
        "Protein Change":"p.Ser375Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007212%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13234449",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2185",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q98.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5520C>T",
        "Protein Change":"p.Arg210Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007668%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56908287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2186",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q4.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7830C>C",
        "Protein Change":"p.Arg332Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004367%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29513044",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2187",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q97.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8918T>T",
        "Protein Change":"p.Leu29Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007819%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57608340",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2188",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q1.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1718T>C",
        "Protein Change":"p.Arg431Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00517%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28782052",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2189",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q75.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5389C>G",
        "Protein Change":"p.Leu344Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007803%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12963426",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2190",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q50.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7816C>C",
        "Protein Change":"p.Arg474Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004497%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30797183",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2191",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q33.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1058G>T",
        "Protein Change":"p.Pro488Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00091%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61817751",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2192",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q33.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4535T>C",
        "Protein Change":"p.Ser244Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00729%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67688676",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2193",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q86.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1810T>A",
        "Protein Change":"p.Pro270Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003218%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94408353",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2194",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q11.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9149A>A",
        "Protein Change":"p.Arg265Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001619%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79786962",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2195",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q76.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7112T>T",
        "Protein Change":"p.Gln272Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000492%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98244628",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2196",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q19.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1135C>A",
        "Protein Change":"p.Gly127Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000948%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26192066",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2197",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q93.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6520A>A",
        "Protein Change":"p.Arg256Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004988%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65041663",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2198",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q68.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9465C>G",
        "Protein Change":"p.Arg454Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004134%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13001900",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2199",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q45.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2647A>G",
        "Protein Change":"p.Leu182Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002111%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:92244232",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2200",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q63.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9492T>G",
        "Protein Change":"p.Gln253Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006917%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10476770",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2201",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q14.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8216A>T",
        "Protein Change":"p.Leu360Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000973%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43538553",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2202",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q52.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4580A>C",
        "Protein Change":"p.Pro231Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004975%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:68867720",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2203",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q17.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5892T>G",
        "Protein Change":"p.Pro363Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004221%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82000889",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2204",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q60.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6151G>A",
        "Protein Change":"p.Gly15Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005124%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61917895",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2205",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q77.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.656T>C",
        "Protein Change":"p.Leu28Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006119%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:27219161",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2206",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q99.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4618C>C",
        "Protein Change":"p.Ser301Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001515%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59965513",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2207",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q70.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7872T>T",
        "Protein Change":"p.Gly243Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007693%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98742844",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2208",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q16.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1300T>A",
        "Protein Change":"p.Arg52Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007648%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62858842",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2209",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q67.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1560T>T",
        "Protein Change":"p.Gly445Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003555%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:90112503",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2210",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q8.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8722C>G",
        "Protein Change":"p.Leu488Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008471%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:40973926",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2211",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q51.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7248C>G",
        "Protein Change":"p.Gln223Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00373%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74039112",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2212",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"17q83.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6734C>G",
        "Protein Change":"p.Arg471Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00721%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25848489",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2213",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q70.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1891C>T",
        "Protein Change":"p.Gly133Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008375%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58070112",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2214",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q49.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9065C>A",
        "Protein Change":"p.Gly80Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008916%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:55337377",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2215",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q25.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6237C>T",
        "Protein Change":"p.Gln138Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008667%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52830204",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2216",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q3.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5928A>G",
        "Protein Change":"p.Leu442Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00074%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15607420",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2217",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q17.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.223A>C",
        "Protein Change":"p.Leu183Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000558%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87057804",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2218",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q26.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1829T>C",
        "Protein Change":"p.Gly14Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004158%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23634463",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2219",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q15.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4450C>C",
        "Protein Change":"p.Leu39Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008574%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72545022",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2220",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q28.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.714T>A",
        "Protein Change":"p.Gly59Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001261%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94610908",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2221",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q68.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6478G>A",
        "Protein Change":"p.Arg106Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006125%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74172864",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2222",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q71.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5796T>G",
        "Protein Change":"p.Arg349Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003868%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57004361",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2223",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q36.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4097C>T",
        "Protein Change":"p.Pro188Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002402%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25075958",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2224",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q7.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1420G>C",
        "Protein Change":"p.Arg154Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003191%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91784596",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2225",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q95.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7965A>T",
        "Protein Change":"p.Leu424Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007708%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43894704",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2226",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q25.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6204G>A",
        "Protein Change":"p.Gly437Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001116%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89043336",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2227",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q14.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7848G>C",
        "Protein Change":"p.Pro196Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001864%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57476302",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2228",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q53.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9889T>C",
        "Protein Change":"p.Pro251Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00364%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45143353",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2229",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q78.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8720A>T",
        "Protein Change":"p.Leu104Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002045%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81332030",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2230",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q51.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6931G>T",
        "Protein Change":"p.Gln377Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003781%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80820828",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2231",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q64.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5334A>A",
        "Protein Change":"p.Gly172Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003169%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53541875",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2232",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q75.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1692G>A",
        "Protein Change":"p.Gly181Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004358%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90423902",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2233",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q49.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.850C>T",
        "Protein Change":"p.Ser120Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004337%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:93492007",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2234",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q41.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.406G>A",
        "Protein Change":"p.Leu266Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002527%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74337820",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2235",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q86.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1753T>G",
        "Protein Change":"p.Pro279Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006509%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74819681",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2236",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q68.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8803C>A",
        "Protein Change":"p.Gln164Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002662%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70522420",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2237",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q96.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.842A>T",
        "Protein Change":"p.Arg261Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00171%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56714642",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2238",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q2.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7096C>C",
        "Protein Change":"p.Gln359Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000216%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37556198",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2239",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q84.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1564C>G",
        "Protein Change":"p.Ser107Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000123%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87615305",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2240",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q16.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2329G>T",
        "Protein Change":"p.Pro468Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004065%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71150873",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2241",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q60.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3145A>G",
        "Protein Change":"p.Ser490Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001258%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12919823",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2242",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q63.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1444A>A",
        "Protein Change":"p.Gln100Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00822%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15258519",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2243",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"8q82.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3803T>C",
        "Protein Change":"p.Gln243Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005612%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88986741",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2244",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q20.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3885G>T",
        "Protein Change":"p.Ser74Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008997%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63316047",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2245",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q48.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3751C>G",
        "Protein Change":"p.Pro151Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006309%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78812179",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2246",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q90.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9002T>C",
        "Protein Change":"p.Pro192Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009582%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69536797",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2247",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q48.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2361G>C",
        "Protein Change":"p.Leu214Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003022%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33366896",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2248",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q16.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6102C>G",
        "Protein Change":"p.Leu140Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007714%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13842841",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2249",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q75.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6402A>G",
        "Protein Change":"p.Arg205Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009196%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58177068",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2250",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q68.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3384T>T",
        "Protein Change":"p.Ser60Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003021%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39134386",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2251",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q60.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4270A>C",
        "Protein Change":"p.Gly255Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001864%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87159239",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2252",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q46.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8433T>A",
        "Protein Change":"p.Gln344Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009148%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20560586",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2253",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q56.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7209A>C",
        "Protein Change":"p.Gln478Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00586%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33072656",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2254",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q29.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5740C>A",
        "Protein Change":"p.Pro217Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009504%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82774526",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2255",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q54.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5250A>C",
        "Protein Change":"p.Gln362Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008837%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96454237",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2256",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q44.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2551G>G",
        "Protein Change":"p.Arg403Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007741%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95421740",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2257",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q51.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7068G>G",
        "Protein Change":"p.Leu388Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006292%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56951427",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2258",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q22.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2395C>C",
        "Protein Change":"p.Gln142Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001875%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60747300",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2259",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q6.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2536G>G",
        "Protein Change":"p.Leu250Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003843%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27524939",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2260",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q35.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8518G>C",
        "Protein Change":"p.Pro310Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003162%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:50885615",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2261",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q49.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6922T>A",
        "Protein Change":"p.Gly390Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009989%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56010368",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2262",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q62.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5832C>G",
        "Protein Change":"p.Ser267Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007378%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49755362",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2263",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q67.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5280G>A",
        "Protein Change":"p.Arg292Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006296%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59903983",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2264",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q85.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7772T>C",
        "Protein Change":"p.Pro164Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003935%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82292441",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2265",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q30.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4267G>C",
        "Protein Change":"p.Pro257Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009253%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33281375",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2266",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q18.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7281T>C",
        "Protein Change":"p.Gln209Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009526%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13913186",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2267",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q59.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8563C>T",
        "Protein Change":"p.Gln240Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008579%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26483051",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2268",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q76.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.597T>G",
        "Protein Change":"p.Leu350Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00975%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77897387",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2269",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"18q12.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5912A>T",
        "Protein Change":"p.Leu470Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007524%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70825782",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2270",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q41.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.546G>C",
        "Protein Change":"p.Leu45Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004234%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96184044",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2271",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q99.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1173G>A",
        "Protein Change":"p.Pro139Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007089%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88665660",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2272",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q39.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8835A>G",
        "Protein Change":"p.Gln452Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006815%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80505814",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2273",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q89.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4581T>A",
        "Protein Change":"p.Ser471Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006724%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12826490",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2274",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q67.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1849C>T",
        "Protein Change":"p.Gly26Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002169%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42298759",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2275",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q13.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6142G>G",
        "Protein Change":"p.Pro401Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009168%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48780849",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2276",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q84.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9730T>T",
        "Protein Change":"p.Gly438Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004201%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78668948",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2277",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q31.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7971T>C",
        "Protein Change":"p.Leu371Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003785%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47454833",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2278",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q37.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8612A>G",
        "Protein Change":"p.Gly385Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009998%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40175301",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2279",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q75.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.594A>A",
        "Protein Change":"p.Leu400Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006496%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66985671",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2280",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q39.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5679C>A",
        "Protein Change":"p.Gln379Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003764%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:68694156",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2281",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q49.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.657A>G",
        "Protein Change":"p.Ser183Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001396%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36729901",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2282",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q60.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8208G>C",
        "Protein Change":"p.Gln345Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008071%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36500521",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2283",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q89.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3776C>T",
        "Protein Change":"p.Gly492Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002964%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13981231",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2284",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q1.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5490C>T",
        "Protein Change":"p.Leu85Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002394%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80174150",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2285",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q78.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7519T>A",
        "Protein Change":"p.Pro265Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009287%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:21652118",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2286",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q20.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5958T>A",
        "Protein Change":"p.Gly400Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006399%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69412308",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2287",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q40.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2683G>C",
        "Protein Change":"p.Leu105Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006499%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57393617",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2288",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q27.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3434T>T",
        "Protein Change":"p.Gln357Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006171%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24933076",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2289",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q95.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2011C>C",
        "Protein Change":"p.Leu220Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006824%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81367973",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2290",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q8.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7881A>A",
        "Protein Change":"p.Gly324Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005444%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96978470",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2291",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q45.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5384G>G",
        "Protein Change":"p.Ser200Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003576%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80375454",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2292",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q1.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6395A>G",
        "Protein Change":"p.Leu223Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008539%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59154270",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2293",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q28.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8564G>G",
        "Protein Change":"p.Ser450Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005597%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26864322",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2294",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q19.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9026T>T",
        "Protein Change":"p.Leu296Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00462%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51443407",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2295",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q99.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2357G>A",
        "Protein Change":"p.Leu288Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005232%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93862444",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2296",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q36.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1217G>T",
        "Protein Change":"p.Pro65Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007109%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66677725",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2297",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q75.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.186A>A",
        "Protein Change":"p.Pro129Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003892%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73805934",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2298",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q25.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5371T>A",
        "Protein Change":"p.Gly180Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000178%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60959918",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2299",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q44.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2214T>A",
        "Protein Change":"p.Leu243Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007025%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:17709126",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2300",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q12.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2161T>T",
        "Protein Change":"p.Leu297Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004378%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39693262",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2301",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q45.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7753T>G",
        "Protein Change":"p.Pro355Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008928%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31285091",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2302",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q19.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6702G>C",
        "Protein Change":"p.Gly184Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00706%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84405799",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2303",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q44.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5972G>T",
        "Protein Change":"p.Arg247Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001946%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85971369",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2304",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q38.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9414T>G",
        "Protein Change":"p.Leu215Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00896%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84769864",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2305",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q75.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.360G>G",
        "Protein Change":"p.Gly91Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000976%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41643792",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2306",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q43.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3320A>G",
        "Protein Change":"p.Gln54Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00704%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85664941",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2307",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q79.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1671C>T",
        "Protein Change":"p.Ser163Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003901%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32857378",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2308",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q54.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.958C>A",
        "Protein Change":"p.Pro146Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004911%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60471406",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2309",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q64.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8468T>C",
        "Protein Change":"p.Arg275Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009614%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61001419",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2310",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q95.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8340G>T",
        "Protein Change":"p.Gln348Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002318%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54278256",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2311",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q90.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.612T>A",
        "Protein Change":"p.Arg130Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00033%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46666813",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2312",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"5q71.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1806A>G",
        "Protein Change":"p.Leu475Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001893%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82263467",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2313",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q18.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6359C>G",
        "Protein Change":"p.Arg104Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002851%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53009649",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2314",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q33.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6072T>G",
        "Protein Change":"p.Leu233Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003283%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28474041",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2315",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q65.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4851G>A",
        "Protein Change":"p.Gly284Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003627%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30363276",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2316",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q25.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2695A>A",
        "Protein Change":"p.Leu96Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009191%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84330949",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2317",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q58.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3172A>G",
        "Protein Change":"p.Leu406Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003969%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13872932",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2318",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q51.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.207A>T",
        "Protein Change":"p.Ser307Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00969%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94033595",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2319",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q28.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6375T>C",
        "Protein Change":"p.Leu394Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007848%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54492129",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2320",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q53.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4493T>C",
        "Protein Change":"p.Gln266Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007129%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:59632173",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2321",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q57.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4638C>C",
        "Protein Change":"p.Gln477Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008054%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83452576",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2322",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q1.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9937T>G",
        "Protein Change":"p.Arg316Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006499%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94567028",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2323",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q22.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2066T>G",
        "Protein Change":"p.Arg438Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002928%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34054139",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2324",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q93.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5120T>A",
        "Protein Change":"p.Leu116Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001391%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32222216",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2325",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q53.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.175A>T",
        "Protein Change":"p.Gly364Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001431%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26735884",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2326",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q20.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9893C>A",
        "Protein Change":"p.Gln316Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002056%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56198011",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2327",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q6.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8366T>T",
        "Protein Change":"p.Leu409Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009494%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97143958",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2328",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q14.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9059T>G",
        "Protein Change":"p.Ser494Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006832%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:77073797",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2329",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q50.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9807A>T",
        "Protein Change":"p.Pro137Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000328%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74101880",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2330",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q73.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7204C>G",
        "Protein Change":"p.Arg52Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002067%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97757991",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2331",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q78.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5960T>C",
        "Protein Change":"p.Gln310Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007134%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76544480",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2332",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q98.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5058T>C",
        "Protein Change":"p.Arg141Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008865%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36064037",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2333",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q34.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2266C>G",
        "Protein Change":"p.Arg113Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002302%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31316854",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2334",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"13q37.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5694T>C",
        "Protein Change":"p.Arg482Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001765%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75463321",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2335",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q97.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4298G>A",
        "Protein Change":"p.Leu427Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007971%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15208566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2336",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q65.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1143A>A",
        "Protein Change":"p.Gln382Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00421%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85120137",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2337",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q81.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3803A>A",
        "Protein Change":"p.Pro79Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000603%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:40221007",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2338",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q49.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8819G>C",
        "Protein Change":"p.Gln299Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004111%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47773248",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2339",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q8.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3501G>T",
        "Protein Change":"p.Ser119Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005379%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56859728",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2340",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q25.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2855C>A",
        "Protein Change":"p.Pro157Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005446%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84826383",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2341",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q17.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.435G>T",
        "Protein Change":"p.Gly37Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009233%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32918602",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2342",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q13.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9885G>C",
        "Protein Change":"p.Ser379Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007872%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82187172",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2343",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q83.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7948G>A",
        "Protein Change":"p.Gly165Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003543%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52969324",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2344",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q55.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8090T>T",
        "Protein Change":"p.Pro120Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005888%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13110591",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2345",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q86.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.583A>C",
        "Protein Change":"p.Leu389Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009938%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59085422",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2346",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q6.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5594C>C",
        "Protein Change":"p.Gly98Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007522%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45718819",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2347",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q39.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6773C>T",
        "Protein Change":"p.Arg404Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009369%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54598055",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2348",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q33.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7958T>G",
        "Protein Change":"p.Arg431Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00893%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83618080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2349",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q65.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7591G>T",
        "Protein Change":"p.Pro448Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001816%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72558386",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2350",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q66.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.810C>G",
        "Protein Change":"p.Arg55Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001378%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93144951",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2351",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q19.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9262T>C",
        "Protein Change":"p.Gln4Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00232%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11027535",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2352",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q60.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4689G>A",
        "Protein Change":"p.Gly356Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001662%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54185565",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2353",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q92.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2376G>A",
        "Protein Change":"p.Pro137Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001585%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31607823",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2354",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q69.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6124G>C",
        "Protein Change":"p.Gly117Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001855%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49733745",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2355",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q29.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4823A>T",
        "Protein Change":"p.Gln459Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008758%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62322013",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2356",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q98.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1806G>C",
        "Protein Change":"p.Gln247Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007556%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84721460",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2357",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q37.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5368G>T",
        "Protein Change":"p.Pro114Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007658%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78332144",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2358",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q3.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.494T>G",
        "Protein Change":"p.Gly260Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00812%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16574062",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2359",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q56.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7376T>T",
        "Protein Change":"p.Pro448Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009584%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89053854",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2360",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q68.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9656A>A",
        "Protein Change":"p.Pro49Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003112%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28824441",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2361",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q64.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1337C>A",
        "Protein Change":"p.Arg216Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001621%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82746548",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2362",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q45.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3509T>G",
        "Protein Change":"p.Leu441Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009163%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:50151893",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2363",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q79.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1448A>G",
        "Protein Change":"p.Ser210Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009742%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39629504",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2364",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q77.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7994T>C",
        "Protein Change":"p.Gly331Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004053%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18053114",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2365",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q32.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3348C>C",
        "Protein Change":"p.Ser35Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009512%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81696717",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2366",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q97.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9494A>T",
        "Protein Change":"p.Pro200Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001614%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19783095",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2367",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q23.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2544A>G",
        "Protein Change":"p.Pro324Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008739%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69619175",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2368",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q95.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1829T>G",
        "Protein Change":"p.Leu148Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004252%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44515231",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2369",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q34.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5690A>T",
        "Protein Change":"p.Gly399Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001127%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16823150",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2370",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q10.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8622A>A",
        "Protein Change":"p.Arg112Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009434%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13786965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2371",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q35.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3359C>T",
        "Protein Change":"p.Gly28Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000567%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43928448",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2372",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q96.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4545C>T",
        "Protein Change":"p.Gln280Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009768%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15635514",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2373",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q85.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9760A>T",
        "Protein Change":"p.Gln52Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00015%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28349773",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2374",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q25.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1138T>A",
        "Protein Change":"p.Gln15Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003143%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:26351613",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2375",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q51.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9013G>T",
        "Protein Change":"p.Gly155Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006537%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53470626",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2376",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q64.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2838C>C",
        "Protein Change":"p.Gly184Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008687%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20300684",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2377",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q98.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4354T>A",
        "Protein Change":"p.Gly175Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00668%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:98398570",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2378",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q29.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3742A>A",
        "Protein Change":"p.Ser144Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000387%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11590822",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2379",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q33.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4596C>G",
        "Protein Change":"p.Ser130Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006985%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69985093",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2380",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q29.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6589T>C",
        "Protein Change":"p.Arg477Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00781%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24207112",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2381",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q63.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5732G>T",
        "Protein Change":"p.Arg129Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00333%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:75483021",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2382",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q85.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2112C>G",
        "Protein Change":"p.Pro392Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001289%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11766465",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2383",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q88.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6318G>C",
        "Protein Change":"p.Leu421Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005453%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11679454",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2384",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q76.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5512T>T",
        "Protein Change":"p.Leu244Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009492%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72478341",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2385",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q66.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5013C>T",
        "Protein Change":"p.Pro492Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002707%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77974084",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2386",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q30.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4938C>C",
        "Protein Change":"p.Ser444Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006467%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80598630",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2387",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q50.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2816G>T",
        "Protein Change":"p.Arg182Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00547%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12719697",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2388",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q7.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7640A>C",
        "Protein Change":"p.Arg118Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00574%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69191260",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2389",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q28.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.194C>G",
        "Protein Change":"p.Gln472Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002287%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20397444",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2390",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q59.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2677G>T",
        "Protein Change":"p.Gly301Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001918%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82457675",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2391",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q69.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6081T>A",
        "Protein Change":"p.Gln33Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0078%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69794071",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2392",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q42.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6398A>T",
        "Protein Change":"p.Gly293Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003249%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91057088",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2393",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q11.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4610A>C",
        "Protein Change":"p.Arg326Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009485%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86560778",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2394",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q28.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.866G>C",
        "Protein Change":"p.Ser254Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009683%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87468622",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2395",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q80.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1107T>C",
        "Protein Change":"p.Arg49Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000601%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65976014",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2396",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q80.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9147C>G",
        "Protein Change":"p.Leu217Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86604023",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2397",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"14q1.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4524A>A",
        "Protein Change":"p.Pro409Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008247%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:34659002",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2398",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q56.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6238C>G",
        "Protein Change":"p.Pro61Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002154%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55457006",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2399",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q54.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1793G>A",
        "Protein Change":"p.Ser18Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004177%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85404251",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2400",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q15.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4549T>A",
        "Protein Change":"p.Gly170Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00066%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49959016",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2401",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q75.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1363G>A",
        "Protein Change":"p.Gly480Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005181%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85431227",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2402",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q30.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4519G>A",
        "Protein Change":"p.Pro98Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003619%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64532132",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2403",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q64.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6181G>T",
        "Protein Change":"p.Pro386Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001482%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17820066",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2404",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q50.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.597G>C",
        "Protein Change":"p.Gln368Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002687%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39362508",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2405",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q49.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8712C>C",
        "Protein Change":"p.Gly427Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003848%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49608681",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2406",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q49.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5366C>T",
        "Protein Change":"p.Leu95Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005016%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64533364",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2407",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q67.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1207G>C",
        "Protein Change":"p.Gly312Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005445%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40821000",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2408",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q87.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5856A>G",
        "Protein Change":"p.Arg185Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009411%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15728924",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2409",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q44.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5708C>T",
        "Protein Change":"p.Ser474Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001911%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84572253",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2410",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q62.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1545C>T",
        "Protein Change":"p.Pro482Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00267%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21920087",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2411",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q91.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4048T>T",
        "Protein Change":"p.Gly26Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007027%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:15181812",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2412",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q21.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5085A>A",
        "Protein Change":"p.Pro95Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009881%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43487522",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2413",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q47.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5855A>T",
        "Protein Change":"p.Leu189Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001815%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45426817",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2414",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q74.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.995A>C",
        "Protein Change":"p.Ser160Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000322%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30137380",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2415",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q96.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8857C>G",
        "Protein Change":"p.Pro162Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009561%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12739904",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2416",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q45.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6053A>T",
        "Protein Change":"p.Arg205Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004016%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35009277",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2417",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q84.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1959C>T",
        "Protein Change":"p.Arg212Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007188%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91010226",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2418",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q26.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5722G>A",
        "Protein Change":"p.Ser87Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00453%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83497039",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2419",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q33.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7126T>G",
        "Protein Change":"p.Gln358Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00804%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40841494",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2420",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q61.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.953T>G",
        "Protein Change":"p.Leu271Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000724%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49992167",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2421",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q18.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1559T>T",
        "Protein Change":"p.Gln462Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0073%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33280466",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2422",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q54.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.578T>C",
        "Protein Change":"p.Ser330Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003795%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76409430",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2423",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q13.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6489C>G",
        "Protein Change":"p.Pro267Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005966%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94187525",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2424",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q27.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3161G>G",
        "Protein Change":"p.Gln442Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000141%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21374587",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2425",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q34.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9847C>C",
        "Protein Change":"p.Ser164Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004692%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55866007",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2426",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q57.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5327A>C",
        "Protein Change":"p.Leu17Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009708%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37167892",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2427",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q45.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6782A>A",
        "Protein Change":"p.Ser63Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001418%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10335559",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2428",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q99.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2284C>C",
        "Protein Change":"p.Gly7Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006912%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49742805",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2429",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q35.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9830C>A",
        "Protein Change":"p.Arg325Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001415%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80215097",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2430",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q52.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5960T>C",
        "Protein Change":"p.Leu260Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003097%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:69371083",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2431",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q67.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8882A>A",
        "Protein Change":"p.Arg112Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00678%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74683730",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2432",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q5.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2751C>A",
        "Protein Change":"p.Gly445Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001203%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81076770",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2433",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q42.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8688C>G",
        "Protein Change":"p.Leu30Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00428%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16751779",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2434",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q47.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9245G>G",
        "Protein Change":"p.Leu337Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001302%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73912113",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2435",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q23.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6818C>C",
        "Protein Change":"p.Gly430Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009414%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71151688",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2436",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"20q5.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3415G>C",
        "Protein Change":"p.Pro377Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000626%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37173377",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2437",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"8q89.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2626C>A",
        "Protein Change":"p.Gly126Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002025%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42384969",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2438",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"19q61.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3359T>A",
        "Protein Change":"p.Ser379Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007492%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69536693",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2439",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q71.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5831G>G",
        "Protein Change":"p.Leu285Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008026%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12704993",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2440",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q38.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3265G>T",
        "Protein Change":"p.Ser150Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008216%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28593715",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2441",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q68.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.204T>G",
        "Protein Change":"p.Gln207Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009457%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23522081",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2442",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q80.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1984C>C",
        "Protein Change":"p.Arg328Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002499%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78241496",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2443",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q60.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1442G>C",
        "Protein Change":"p.Pro235Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003777%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95761727",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2444",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q25.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8840C>C",
        "Protein Change":"p.Gly487Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009816%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61615788",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2445",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q78.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4257G>G",
        "Protein Change":"p.Gly491Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93903762",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2446",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q33.3",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6604C>G",
        "Protein Change":"p.Leu129Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008613%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:31788004",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2447",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q12.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6270G>T",
        "Protein Change":"p.Leu105Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005216%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11527818",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2448",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q76.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8372A>G",
        "Protein Change":"p.Leu417Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003003%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32721199",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2449",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q52.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7215C>C",
        "Protein Change":"p.Gln331Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005265%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49378421",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2450",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q57.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1989C>A",
        "Protein Change":"p.Pro495Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005387%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85722996",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2451",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q78.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2248T>G",
        "Protein Change":"p.Pro292Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004001%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72927598",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2452",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q62.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7099T>C",
        "Protein Change":"p.Pro179Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00811%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24888784",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2453",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q5.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7408T>G",
        "Protein Change":"p.Arg440Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005507%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94564170",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2454",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q66.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2739G>A",
        "Protein Change":"p.Leu187Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008249%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76899583",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2455",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q63.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1945G>A",
        "Protein Change":"p.Gly18Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000896%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15343890",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2456",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q12.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3886G>A",
        "Protein Change":"p.Ser120Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005056%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93080793",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2457",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q59.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7653G>T",
        "Protein Change":"p.Ser413Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006045%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13228341",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2458",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q3.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1258T>C",
        "Protein Change":"p.Pro493Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002653%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66633700",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2459",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q51.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2452G>A",
        "Protein Change":"p.Gln208Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005617%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46017624",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2460",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q51.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1505T>C",
        "Protein Change":"p.Gly124Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006228%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90885534",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2461",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q62.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4403C>G",
        "Protein Change":"p.Pro375Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00168%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49862189",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2462",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q69.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.217C>T",
        "Protein Change":"p.Pro177Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002633%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66371499",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2463",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q44.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5237C>T",
        "Protein Change":"p.Ser233Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12831661",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2464",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q12.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.353C>C",
        "Protein Change":"p.Arg125Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008712%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:86559428",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2465",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q93.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6759A>C",
        "Protein Change":"p.Arg395Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000251%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:87170633",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2466",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q10.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8670A>A",
        "Protein Change":"p.Ser200Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001188%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62986323",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2467",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q52.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2487T>G",
        "Protein Change":"p.Pro271Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00139%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83811741",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2468",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q95.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3917G>C",
        "Protein Change":"p.Ser472Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001165%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42066975",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2469",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q24.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3672C>A",
        "Protein Change":"p.Leu452Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008433%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24465390",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2470",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q5.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4232G>C",
        "Protein Change":"p.Leu340Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003345%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18958260",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2471",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q83.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4718A>T",
        "Protein Change":"p.Gln34Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007048%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85884492",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2472",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q8.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3733T>T",
        "Protein Change":"p.Leu331Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00782%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10261986",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2473",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q85.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7426G>C",
        "Protein Change":"p.Arg159Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00799%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53157032",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2474",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q53.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9989T>A",
        "Protein Change":"p.Gln178Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00808%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61678780",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2475",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q61.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2710A>T",
        "Protein Change":"p.Arg391Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000763%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82489700",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2476",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q49.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7051T>G",
        "Protein Change":"p.Gly327Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008226%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:45763998",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2477",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q92.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2726A>T",
        "Protein Change":"p.Ser384Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009884%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83448392",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2478",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q67.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3942C>C",
        "Protein Change":"p.Pro431Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007027%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47916725",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2479",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q33.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2934A>G",
        "Protein Change":"p.Leu220Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006743%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72774307",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2480",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q13.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7321C>G",
        "Protein Change":"p.Gln341Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00376%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:53515990",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2481",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q17.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3761T>T",
        "Protein Change":"p.Gln339Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007883%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:78328014",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2482",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q93.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5237C>A",
        "Protein Change":"p.Leu452Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002422%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32165770",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2483",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q62.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8374G>A",
        "Protein Change":"p.Leu51Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009809%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86898685",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2484",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q40.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.204A>C",
        "Protein Change":"p.Gln152Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003232%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91343287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2485",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q78.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3595A>G",
        "Protein Change":"p.Pro428Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005876%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:18137837",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2486",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q93.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8753T>C",
        "Protein Change":"p.Leu204Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00483%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:62251992",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2487",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q74.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5348T>A",
        "Protein Change":"p.Ser151Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004205%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28993729",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2488",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q9.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.870T>G",
        "Protein Change":"p.Leu274Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002255%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92295594",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2489",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q68.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7946C>A",
        "Protein Change":"p.Pro31Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00452%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28197488",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2490",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q60.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4906T>C",
        "Protein Change":"p.Pro60Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007187%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19091365",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2491",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q87.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9578T>G",
        "Protein Change":"p.Gly327Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002817%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65597742",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2492",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q23.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2353A>A",
        "Protein Change":"p.Leu391Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005006%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88272342",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2493",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q32.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4497G>G",
        "Protein Change":"p.Arg179Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007835%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:48999047",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2494",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q67.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3854T>A",
        "Protein Change":"p.Ser440Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002061%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:51569154",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2495",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q3.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8822C>G",
        "Protein Change":"p.Arg17Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001961%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40331072",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2496",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q16.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8337C>T",
        "Protein Change":"p.Leu448Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007091%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89512901",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2497",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q17.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3980G>A",
        "Protein Change":"p.Arg98Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003179%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45107449",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2498",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q37.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3267T>C",
        "Protein Change":"p.Leu128Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002082%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:70454031",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2499",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q67.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3024A>A",
        "Protein Change":"p.Pro341Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002191%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:78793196",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2500",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q72.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6360G>C",
        "Protein Change":"p.Ser238Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002908%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32360502",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2501",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q31.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4317C>A",
        "Protein Change":"p.Gln381Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00086%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74685969",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2502",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q28.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.602G>G",
        "Protein Change":"p.Gly293Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005011%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63315503",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2503",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q43.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7370A>A",
        "Protein Change":"p.Arg163Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006927%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11734791",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2504",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q39.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6530G>C",
        "Protein Change":"p.Gln182Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004462%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70440290",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2505",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q58.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3456C>A",
        "Protein Change":"p.Arg10Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006202%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97967954",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2506",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q64.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3672T>A",
        "Protein Change":"p.Leu14Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002504%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:80618606",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2507",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q51.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4050G>A",
        "Protein Change":"p.Ser207Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004895%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22276322",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2508",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q99.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7147G>C",
        "Protein Change":"p.Ser289Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005299%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28580685",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2509",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"12q75.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7088T>A",
        "Protein Change":"p.Leu65Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009534%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:14333475",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2510",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q2.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3610C>T",
        "Protein Change":"p.Leu125Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004881%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:38104760",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2511",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q21.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.647A>C",
        "Protein Change":"p.Ser379Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001449%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66181554",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2512",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q10.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5349G>C",
        "Protein Change":"p.Arg9Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008874%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94346235",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2513",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"3q41.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2049G>G",
        "Protein Change":"p.Ser355Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003731%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83144692",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2514",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"15q9.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8040A>A",
        "Protein Change":"p.Arg400Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002567%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:99502742",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2515",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q77.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.131G>T",
        "Protein Change":"p.Gln54Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003568%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65111382",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2516",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q15.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9296T>G",
        "Protein Change":"p.Pro384Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003129%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78961080",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2517",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q41.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1162T>G",
        "Protein Change":"p.Pro245Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003421%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34150145",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2518",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q78.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5946T>T",
        "Protein Change":"p.Gly474Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006049%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64175211",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2519",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q21.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2584C>A",
        "Protein Change":"p.Gly247Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008313%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96641775",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2520",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q1.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7120C>A",
        "Protein Change":"p.Leu225Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00495%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46512005",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2521",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q20.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.290T>C",
        "Protein Change":"p.Leu484Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004634%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85146525",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2522",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q78.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5533C>T",
        "Protein Change":"p.Gly209Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002342%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:76597263",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2523",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q94.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9516T>T",
        "Protein Change":"p.Ser500Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000269%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:73048662",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2524",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q38.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2187T>A",
        "Protein Change":"p.Arg152Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008842%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:27942348",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2525",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q79.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8656T>A",
        "Protein Change":"p.Leu485Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004688%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88120674",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2526",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q32.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5276T>C",
        "Protein Change":"p.Gln31Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00854%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44124866",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2527",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q40.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4675A>C",
        "Protein Change":"p.Arg367Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004896%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54231957",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2528",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q61.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8394G>C",
        "Protein Change":"p.Pro138Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006995%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55911241",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2529",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q80.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7109A>G",
        "Protein Change":"p.Gly289Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007269%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20081123",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2530",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q64.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6413G>T",
        "Protein Change":"p.Gln387Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004354%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30746709",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2531",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"22q55.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6907G>A",
        "Protein Change":"p.Pro349Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005692%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23205675",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2532",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q38.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2881T>C",
        "Protein Change":"p.Leu342Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004162%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98339971",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2533",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q11.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3144C>C",
        "Protein Change":"p.Ser200Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004555%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84937107",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2534",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q64.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1503A>A",
        "Protein Change":"p.Gly410Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008707%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96051175",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2535",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q76.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7819T>T",
        "Protein Change":"p.Arg476Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009658%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35238515",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2536",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q99.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.528G>T",
        "Protein Change":"p.Gln267Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008258%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10937504",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2537",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q50.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1329T>T",
        "Protein Change":"p.Gln424Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002681%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14119336",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2538",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q65.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4984C>G",
        "Protein Change":"p.Gly467Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007819%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65189399",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2539",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q71.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1961G>C",
        "Protein Change":"p.Gln488Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007148%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86155968",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2540",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q43.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9030A>G",
        "Protein Change":"p.Pro348Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000199%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25838082",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2541",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q49.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6313C>G",
        "Protein Change":"p.Gly157Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000467%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81808413",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2542",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q74.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9622C>C",
        "Protein Change":"p.Arg425Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008695%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11713423",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2543",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q78.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1714C>C",
        "Protein Change":"p.Gln402Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004342%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48675477",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2544",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q34.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3547C>A",
        "Protein Change":"p.Leu429Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00266%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56778450",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2545",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q45.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3508G>G",
        "Protein Change":"p.Ser451Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000348%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35704433",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2546",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q63.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5349C>C",
        "Protein Change":"p.Pro253Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00058%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47076353",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2547",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q23.4",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5197C>C",
        "Protein Change":"p.Arg157Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007812%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79315563",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2548",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q95.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6802T>A",
        "Protein Change":"p.Leu73Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000484%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60509368",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2549",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q67.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.245C>A",
        "Protein Change":"p.Ser393Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000906%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14370014",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2550",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"8q3.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5267A>G",
        "Protein Change":"p.Gln477Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005356%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51580222",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2551",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q97.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.186G>C",
        "Protein Change":"p.Ser56Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002146%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61588710",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2552",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q84.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1926G>A",
        "Protein Change":"p.Arg225Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001939%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15113892",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2553",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"11q61.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4403A>A",
        "Protein Change":"p.Arg423Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005807%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91513092",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2554",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"21q70.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9679C>A",
        "Protein Change":"p.Gly496Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000143%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49888885",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2555",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q45.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.293G>C",
        "Protein Change":"p.Gln338Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005332%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21474741",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2556",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q25.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1308A>A",
        "Protein Change":"p.Leu214Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002935%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95746197",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2557",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q44.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5630T>G",
        "Protein Change":"p.Ser168Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008372%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19822563",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2558",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q18.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9690A>G",
        "Protein Change":"p.Gln272Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008871%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18571975",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2559",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q59.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1861C>T",
        "Protein Change":"p.Ser275Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002867%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29540480",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2560",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q80.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3972G>G",
        "Protein Change":"p.Gln253Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006611%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54005988",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2561",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q84.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4489C>G",
        "Protein Change":"p.Ser236Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:61892137",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2562",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q12.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3821T>T",
        "Protein Change":"p.Leu74Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009346%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25134467",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2563",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q59.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8565C>T",
        "Protein Change":"p.Leu229Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001197%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:43963590",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2564",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q21.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2924G>A",
        "Protein Change":"p.Gly192Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002763%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89464532",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2565",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q6.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9224A>A",
        "Protein Change":"p.Ser139Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000368%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:85199376",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2566",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q56.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.761A>T",
        "Protein Change":"p.Gly354Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009063%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41415216",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2567",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q73.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5365A>A",
        "Protein Change":"p.Gln328Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007629%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80975393",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2568",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q26.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9253C>T",
        "Protein Change":"p.Pro146Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004191%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22835586",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2569",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q44.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4700C>C",
        "Protein Change":"p.Leu218Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006724%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18782473",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2570",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q90.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2638A>C",
        "Protein Change":"p.Leu466Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000286%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95608571",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2571",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q53.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8428T>A",
        "Protein Change":"p.Leu461Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002378%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:71119347",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2572",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q90.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9197A>T",
        "Protein Change":"p.Gln149Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005085%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44229168",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2573",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q6.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3858C>A",
        "Protein Change":"p.Arg485Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007662%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:88721177",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2574",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q52.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4601G>G",
        "Protein Change":"p.Gln314Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007074%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83393571",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2575",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q55.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2776A>T",
        "Protein Change":"p.Gly73Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000349%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78246506",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2576",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q78.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6080T>A",
        "Protein Change":"p.Arg409Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00029%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74602587",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2577",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q73.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7698G>C",
        "Protein Change":"p.Gln195Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003551%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33613600",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2578",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q3.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2892C>T",
        "Protein Change":"p.Gly471Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002054%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43617337",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2579",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q90.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4423T>C",
        "Protein Change":"p.Gly1Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009716%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:67715794",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2580",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q20.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7155G>G",
        "Protein Change":"p.Arg222Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006798%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62748008",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2581",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q81.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7027C>A",
        "Protein Change":"p.Pro443Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005074%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30249818",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2582",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q65.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2491G>C",
        "Protein Change":"p.Gly302Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004016%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70036967",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2583",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q92.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.553C>C",
        "Protein Change":"p.Arg371Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005851%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57406769",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2584",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q23.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3236A>T",
        "Protein Change":"p.Gly154Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00933%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76428109",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2585",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q14.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1271A>T",
        "Protein Change":"p.Ser38Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009936%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56929215",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2586",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q61.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2534A>A",
        "Protein Change":"p.Leu439Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008296%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70511285",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2587",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q44.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2285A>T",
        "Protein Change":"p.Gln166Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000391%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:21867332",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2588",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q83.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2571A>G",
        "Protein Change":"p.Leu96Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001981%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46012554",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2589",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q11.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3673A>A",
        "Protein Change":"p.Pro29Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000821%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:40188882",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2590",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q43.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2227T>G",
        "Protein Change":"p.Ser56Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001827%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:48134926",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2591",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q2.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6732T>C",
        "Protein Change":"p.Gln230Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007494%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83493054",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2592",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q21.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2735T>G",
        "Protein Change":"p.Arg499Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005551%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39985320",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2593",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q45.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1983T>A",
        "Protein Change":"p.Leu353Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004362%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66198274",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2594",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q15.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9951T>A",
        "Protein Change":"p.Ser91Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000798%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40817730",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2595",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q21.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6325A>C",
        "Protein Change":"p.Arg305Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000477%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10919165",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2596",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"7q22.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9524T>T",
        "Protein Change":"p.Leu377Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005761%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10823021",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2597",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q68.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8278A>G",
        "Protein Change":"p.Pro3Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001159%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:38784711",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2598",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q52.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1334G>G",
        "Protein Change":"p.Pro221Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008782%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23163798",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2599",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q10.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2380C>A",
        "Protein Change":"p.Arg174Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001515%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:78129228",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2600",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q88.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2758C>G",
        "Protein Change":"p.Ser230Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009498%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45568937",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2601",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q73.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1679G>A",
        "Protein Change":"p.Gly183Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005842%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55551883",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2602",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q1.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7943A>A",
        "Protein Change":"p.Gln215Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001517%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52484712",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2603",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q40.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7278G>G",
        "Protein Change":"p.Ser347Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007262%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:54401149",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2604",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"13q28.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.308C>A",
        "Protein Change":"p.Gly316Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002844%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64818680",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2605",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q78.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.582G>C",
        "Protein Change":"p.Pro13Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008142%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29240609",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2606",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q16.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.689G>G",
        "Protein Change":"p.Gln339Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009125%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45417172",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2607",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"8q48.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8722T>C",
        "Protein Change":"p.Gln326Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003258%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95841763",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2608",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q97.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5229A>A",
        "Protein Change":"p.Arg367Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005059%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52493583",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2609",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q32.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6038C>A",
        "Protein Change":"p.Gln199Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003607%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83218172",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2610",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q20.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3002A>C",
        "Protein Change":"p.Leu439Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00321%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:22847401",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2611",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q67.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7056T>G",
        "Protein Change":"p.Arg313Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006834%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:28352739",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2612",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q12.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3324T>T",
        "Protein Change":"p.Pro102Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007944%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87018704",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2613",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q25.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6205C>C",
        "Protein Change":"p.Gln368Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00714%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59943501",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2614",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q23.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5517A>A",
        "Protein Change":"p.Arg325Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009833%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:37292113",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2615",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q88.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2036G>A",
        "Protein Change":"p.Pro265Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000576%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:98535979",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2616",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q91.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3259G>A",
        "Protein Change":"p.Leu104Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004644%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:98679185",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2617",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q67.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1492T>T",
        "Protein Change":"p.Ser125Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007739%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69942984",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2618",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q98.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2742A>T",
        "Protein Change":"p.Leu405Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001846%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:80779186",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2619",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q28.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7423T>T",
        "Protein Change":"p.Leu363Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007521%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96318941",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2620",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q38.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4233G>T",
        "Protein Change":"p.Arg263Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000117%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:81106737",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2621",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q99.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3125C>C",
        "Protein Change":"p.Pro306Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00979%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:60548782",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2622",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q84.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3899C>C",
        "Protein Change":"p.Gly116Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009184%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:77798464",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2623",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"17q37.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7865T>C",
        "Protein Change":"p.Leu94Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00818%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59307721",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2624",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q84.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3971G>G",
        "Protein Change":"p.Gly343Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007795%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47180195",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2625",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q44.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5507T>C",
        "Protein Change":"p.Leu124Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000306%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:42751272",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2626",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q13.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3780G>C",
        "Protein Change":"p.Gly357Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000559%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:57878164",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2627",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q81.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7499G>A",
        "Protein Change":"p.Arg160Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006663%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85627548",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2628",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q70.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9339A>T",
        "Protein Change":"p.Arg72Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006109%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29602642",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2629",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q26.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9109C>A",
        "Protein Change":"p.Pro22Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001195%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:20673045",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2630",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q85.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7906G>A",
        "Protein Change":"p.Gln55Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003154%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34366251",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2631",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"22q71.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5882G>C",
        "Protein Change":"p.Pro236Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007533%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27350814",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2632",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q42.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4288T>C",
        "Protein Change":"p.Ser269Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000345%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:20486404",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2633",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q77.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3361C>T",
        "Protein Change":"p.Leu273Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00582%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:29146669",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2634",
        "Gene Name":"CDH1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q92.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1078C>G",
        "Protein Change":"p.Ser402Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005397%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20487421",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2635",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q91.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6582C>A",
        "Protein Change":"p.Gln116Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007964%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39256705",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2636",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q19.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1305A>T",
        "Protein Change":"p.Ser261Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002271%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41897598",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2637",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q28.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5881T>T",
        "Protein Change":"p.Arg401Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003481%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27191833",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2638",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q49.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.905A>A",
        "Protein Change":"p.Ser456Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004964%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23707719",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2639",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q85.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6792G>G",
        "Protein Change":"p.Arg239Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000125%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66646596",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2640",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q6.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5832T>A",
        "Protein Change":"p.Ser196Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005335%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:35111727",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2641",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q81.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1905T>G",
        "Protein Change":"p.Pro145Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009731%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45904419",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2642",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q46.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8798A>G",
        "Protein Change":"p.Arg269Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001494%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:17722071",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2643",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q55.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6102A>A",
        "Protein Change":"p.Leu10Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009166%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24200869",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2644",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q42.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5677T>A",
        "Protein Change":"p.Leu150Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00481%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:65596316",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2645",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q39.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3960A>G",
        "Protein Change":"p.Arg229Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006527%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63543387",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2646",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q97.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5971T>A",
        "Protein Change":"p.Pro7Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009622%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:96142259",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2647",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q66.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8976A>T",
        "Protein Change":"p.Gln192Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003988%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94298878",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2648",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q6.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9358T>C",
        "Protein Change":"p.Leu145Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009635%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:67741052",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2649",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q74.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1791T>C",
        "Protein Change":"p.Arg451Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00044%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46141137",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2650",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q68.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6244A>C",
        "Protein Change":"p.Gln122Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00573%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:65664008",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2651",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q3.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2519A>C",
        "Protein Change":"p.Leu181Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001204%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11812225",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2652",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q99.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9618G>C",
        "Protein Change":"p.Pro343Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00026%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89110293",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2653",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q66.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5435G>C",
        "Protein Change":"p.Arg400Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006884%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52536734",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2654",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q51.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1269A>T",
        "Protein Change":"p.Pro431Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002653%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60172845",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2655",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q20.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3942T>A",
        "Protein Change":"p.Arg497Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004426%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61242013",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2656",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q23.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1076A>T",
        "Protein Change":"p.Leu88Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004506%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33795644",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2657",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q73.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7185C>G",
        "Protein Change":"p.Ser415Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004513%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71247181",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2658",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q79.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4825A>G",
        "Protein Change":"p.Ser128Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004645%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51465048",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2659",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q95.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.436G>A",
        "Protein Change":"p.Pro33Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002884%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87296147",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2660",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q36.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5871T>C",
        "Protein Change":"p.Leu4Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005539%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27170574",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2661",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"3q85.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3173C>T",
        "Protein Change":"p.Pro18Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001691%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79436605",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2662",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q34.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5708A>A",
        "Protein Change":"p.Pro345Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006161%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92289012",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2663",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q57.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3510C>G",
        "Protein Change":"p.Arg455Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005291%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95892699",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2664",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q87.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2772T>G",
        "Protein Change":"p.Arg491Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007733%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:58593104",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2665",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q44.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3629A>G",
        "Protein Change":"p.Gln65Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003038%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56139423",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2666",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q85.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7531C>G",
        "Protein Change":"p.Leu103Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005472%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:43076627",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2667",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q81.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5955C>T",
        "Protein Change":"p.Gly90Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000637%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72781278",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2668",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"10q35.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8755G>C",
        "Protein Change":"p.Gly209Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002092%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77037897",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2669",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q59.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4537C>A",
        "Protein Change":"p.Gln244Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001631%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45775025",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2670",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q20.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.712A>G",
        "Protein Change":"p.Leu388Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004534%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47340691",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2671",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"15q51.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3831A>C",
        "Protein Change":"p.Leu11Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007219%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20766333",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2672",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q65.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2777C>A",
        "Protein Change":"p.Arg169Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006846%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72917882",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2673",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"6q78.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2135G>C",
        "Protein Change":"p.Gln210Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006994%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52703876",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2674",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q90.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8372T>C",
        "Protein Change":"p.Gln189Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009387%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:58020165",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2675",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q13.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8550C>A",
        "Protein Change":"p.Gly83Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005978%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95780193",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2676",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q37.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4331T>T",
        "Protein Change":"p.Pro266Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008671%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93367287",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2677",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q35.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6892C>A",
        "Protein Change":"p.Leu6Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00887%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44968815",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2678",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q19.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3803T>G",
        "Protein Change":"p.Gln406Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006639%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75818454",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2679",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q68.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.967A>T",
        "Protein Change":"p.Gln146Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003768%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:31573238",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2680",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q31.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4630C>A",
        "Protein Change":"p.Gln373Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003891%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51826534",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2681",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q4.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4697T>G",
        "Protein Change":"p.Pro160Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004737%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62016189",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2682",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q38.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9777A>C",
        "Protein Change":"p.Gln476Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007333%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86993796",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2683",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q98.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5665G>T",
        "Protein Change":"p.Gln46Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001793%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51700424",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2684",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q61.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9208C>G",
        "Protein Change":"p.Gly387Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003595%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36820901",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2685",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q45.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7570A>C",
        "Protein Change":"p.Arg426Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008621%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25233721",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2686",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q35.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1668G>T",
        "Protein Change":"p.Arg467Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006847%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41062915",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2687",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q65.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2733T>G",
        "Protein Change":"p.Gly62Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005483%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:41761182",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2688",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q47.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7800C>A",
        "Protein Change":"p.Gly55Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00571%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96108384",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2689",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q28.8",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3102C>T",
        "Protein Change":"p.Gln138Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006573%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:18128147",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2690",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q51.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6773G>G",
        "Protein Change":"p.Arg149Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009899%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:46851964",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2691",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q20.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.663T>A",
        "Protein Change":"p.Ser50Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004023%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16957327",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2692",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q85.7",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3893G>A",
        "Protein Change":"p.Gln351Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009575%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52019962",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2693",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q20.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3541G>A",
        "Protein Change":"p.Ser428Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004346%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:13091206",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2694",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q11.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4849C>C",
        "Protein Change":"p.Arg45Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001125%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19592766",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2695",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q16.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1298C>C",
        "Protein Change":"p.Pro7Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007915%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63222725",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2696",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q28.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.900T>C",
        "Protein Change":"p.Leu228Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009103%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47743289",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2697",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q80.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7192A>C",
        "Protein Change":"p.Gln113Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009584%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87145105",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2698",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q68.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1949A>C",
        "Protein Change":"p.Arg477Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002118%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45624302",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2699",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q24.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3758T>G",
        "Protein Change":"p.Arg394Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008314%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22517513",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2700",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q16.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7258C>C",
        "Protein Change":"p.Gly203Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008036%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84438085",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2701",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q58.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2949C>T",
        "Protein Change":"p.Gly370Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002456%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88561127",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2702",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q71.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8726C>T",
        "Protein Change":"p.Leu227Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000717%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63225199",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2703",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q44.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2936C>C",
        "Protein Change":"p.Arg40Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007217%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88907983",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2704",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q58.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4917C>C",
        "Protein Change":"p.Pro125Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007845%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63521289",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2705",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q24.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2888C>T",
        "Protein Change":"p.Leu415Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009984%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32452124",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2706",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q65.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7407G>G",
        "Protein Change":"p.Ser313Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00915%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42242616",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2707",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q93.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5691C>T",
        "Protein Change":"p.Gln293Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004889%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:85116302",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2708",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q21.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1578T>A",
        "Protein Change":"p.Gln263Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004349%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59429524",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2709",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"3q29.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6217T>G",
        "Protein Change":"p.Gln492Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002921%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:15460253",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2710",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q37.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.259C>T",
        "Protein Change":"p.Pro411Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008034%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23626001",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2711",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"20q40.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4040A>T",
        "Protein Change":"p.Pro237Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008009%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89864534",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2712",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q10.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5780C>T",
        "Protein Change":"p.Gly315Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003505%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88174306",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2713",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"8q94.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4111C>A",
        "Protein Change":"p.Ser161Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002761%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:88703633",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2714",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"9q26.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1998A>T",
        "Protein Change":"p.Pro11Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002533%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44596356",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2715",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q21.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1753C>G",
        "Protein Change":"p.Pro285Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002115%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25879323",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2716",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q97.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2222A>G",
        "Protein Change":"p.Arg463Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009363%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23698982",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2717",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"21q72.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9573T>C",
        "Protein Change":"p.Gln282Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002811%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89255058",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2718",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q8.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8573T>T",
        "Protein Change":"p.Gly356Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008734%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59476086",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2719",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q53.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8916G>C",
        "Protein Change":"p.Gln255Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00081%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86535357",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2720",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q39.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5762A>A",
        "Protein Change":"p.Leu88Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008503%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33027834",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2721",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q90.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9891G>T",
        "Protein Change":"p.Gly70Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000176%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:75820994",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2722",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q84.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8245G>G",
        "Protein Change":"p.Ser311Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006694%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:35219402",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2723",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q66.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6873C>C",
        "Protein Change":"p.Leu227Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000182%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39261988",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2724",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"3q51.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6318G>G",
        "Protein Change":"p.Ser358Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005064%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33786490",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2725",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q69.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4187A>A",
        "Protein Change":"p.Pro13Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002374%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72146269",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2726",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q87.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6895T>A",
        "Protein Change":"p.Leu293Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:47879496",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2727",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q53.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1506A>G",
        "Protein Change":"p.Pro400Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005692%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82278414",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2728",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q59.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.346C>T",
        "Protein Change":"p.Leu286Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001368%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74587305",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2729",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q40.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8242C>A",
        "Protein Change":"p.Gln448Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003174%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:56143060",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2730",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q30.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3750G>T",
        "Protein Change":"p.Leu17Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007245%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43346451",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2731",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q56.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8574A>T",
        "Protein Change":"p.Gly428Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003446%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30212810",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2732",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q68.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2952C>G",
        "Protein Change":"p.Ser235Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000404%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92844759",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2733",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q71.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4967G>G",
        "Protein Change":"p.Pro489Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001309%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:96442798",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2734",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q78.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8974T>A",
        "Protein Change":"p.Ser76Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003474%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:95260613",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2735",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q82.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9816A>T",
        "Protein Change":"p.Gly173Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000716%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:91414827",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2736",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q67.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5292A>A",
        "Protein Change":"p.Gly375Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008801%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:22137291",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2737",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q87.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.376C>C",
        "Protein Change":"p.Gln283Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003655%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44582227",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2738",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q2.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2405A>G",
        "Protein Change":"p.Ser131Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00519%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69173954",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2739",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q26.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9242A>G",
        "Protein Change":"p.Pro391Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004566%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55420317",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2740",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q63.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6563G>T",
        "Protein Change":"p.Pro500Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008374%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:99507395",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2741",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q10.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1584T>A",
        "Protein Change":"p.Gln402Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003932%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53004935",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2742",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"9q62.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6471G>A",
        "Protein Change":"p.Gln29Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002631%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33484811",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2743",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q55.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.559T>A",
        "Protein Change":"p.Gly302Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003024%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:73890972",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2744",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q66.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9177A>G",
        "Protein Change":"p.Arg58Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007832%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11769227",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2745",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q57.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9915C>A",
        "Protein Change":"p.Gln344Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003131%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13629751",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2746",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"15q7.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8940A>C",
        "Protein Change":"p.Ser487Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007092%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11606667",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2747",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q34.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8495C>G",
        "Protein Change":"p.Gln113Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008894%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10562438",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2748",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q65.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7773T>A",
        "Protein Change":"p.Arg465Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008354%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:10529943",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2749",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q9.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6977T>C",
        "Protein Change":"p.Gln459Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005423%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46108278",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2750",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q26.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8371T>G",
        "Protein Change":"p.Pro111Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003181%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44994363",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2751",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q49.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8575T>T",
        "Protein Change":"p.Gln217Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001568%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:82981132",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2752",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q52.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1639C>T",
        "Protein Change":"p.Gln53Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003567%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13092905",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2753",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q11.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7252T>T",
        "Protein Change":"p.Pro383Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002665%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:25538877",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2754",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"20q24.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8190A>A",
        "Protein Change":"p.Ser385Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008994%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36127838",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2755",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q68.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6670T>T",
        "Protein Change":"p.Pro113Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002125%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60331667",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2756",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q79.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3455C>T",
        "Protein Change":"p.Gln151Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005965%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:79594291",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2757",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q96.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.697A>T",
        "Protein Change":"p.Gln282Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004807%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:97177352",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2758",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q59.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2641T>G",
        "Protein Change":"p.Leu391Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009634%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44505492",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2759",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q55.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2453G>C",
        "Protein Change":"p.Ser319Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001104%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42501562",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2760",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q98.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1778A>T",
        "Protein Change":"p.Gly484Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003385%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:33483549",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2761",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q50.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2343A>G",
        "Protein Change":"p.Gly333Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000953%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86385243",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2762",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q15.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7409A>T",
        "Protein Change":"p.Pro130Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003355%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:63471828",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2763",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"10q42.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9807T>T",
        "Protein Change":"p.Arg173Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004743%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:24107522",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2764",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q8.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.111C>C",
        "Protein Change":"p.Leu223Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009636%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:24430918",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2765",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q61.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2963C>C",
        "Protein Change":"p.Leu99Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003891%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:72255983",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2766",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q27.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3800C>C",
        "Protein Change":"p.Pro61Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002258%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:91013826",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2767",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q23.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4740A>A",
        "Protein Change":"p.Arg426Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000974%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52275255",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2768",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q95.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2143A>T",
        "Protein Change":"p.Gln441Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007044%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84130489",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2769",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"6q72.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8911G>G",
        "Protein Change":"p.Ser225Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006519%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:93033747",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2770",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q24.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3986G>T",
        "Protein Change":"p.Arg96Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004722%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74523113",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2771",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q77.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9045C>T",
        "Protein Change":"p.Ser472Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003387%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:16709611",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2772",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q96.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9048C>C",
        "Protein Change":"p.Pro369Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000404%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:42395605",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2773",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"11q50.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7741G>C",
        "Protein Change":"p.Pro224Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001777%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97575092",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2774",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"4q57.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9267C>G",
        "Protein Change":"p.Arg425Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005416%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94639087",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2775",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q11.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6730C>A",
        "Protein Change":"p.Pro64Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0059%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69518541",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2776",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q90.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1329T>G",
        "Protein Change":"p.Pro147Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006849%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:25567610",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2777",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q34.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5781C>A",
        "Protein Change":"p.Arg274Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009205%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:97195878",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2778",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q97.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1446C>A",
        "Protein Change":"p.Ser474Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004644%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:97167879",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2779",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q60.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9145A>A",
        "Protein Change":"p.Gly197Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001856%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:69633635",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2780",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"18q71.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8242A>G",
        "Protein Change":"p.Arg129Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00455%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62544473",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2781",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q86.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9656G>C",
        "Protein Change":"p.Pro382Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005815%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91336018",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2782",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q90.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2150T>A",
        "Protein Change":"p.Leu186Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006082%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:19484265",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2783",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q93.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9632G>T",
        "Protein Change":"p.Gly89Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008637%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36062749",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2784",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q58.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4247T>A",
        "Protein Change":"p.Leu197Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005142%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:12170023",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2785",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q5.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9053A>A",
        "Protein Change":"p.Gln483Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00754%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:14947186",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2786",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"22q87.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8682A>A",
        "Protein Change":"p.Pro327Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005804%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51329525",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2787",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q91.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2733T>C",
        "Protein Change":"p.Leu378Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006248%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:36652828",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2788",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"8q36.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8598C>G",
        "Protein Change":"p.Ser398Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006717%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51711592",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2789",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q36.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6825T>C",
        "Protein Change":"p.Gly174Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005731%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68495370",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2790",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q47.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6755C>T",
        "Protein Change":"p.Gly346Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005784%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90316012",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2791",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q53.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2173A>C",
        "Protein Change":"p.Pro59Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002603%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66089722",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2792",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q85.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8167G>C",
        "Protein Change":"p.Leu477Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007318%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22756765",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2793",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"13q75.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8205A>A",
        "Protein Change":"p.Ser347Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009399%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34434874",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2794",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q71.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3342C>C",
        "Protein Change":"p.Gly488Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001972%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:28533558",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2795",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q24.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.123G>T",
        "Protein Change":"p.Ser176Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00657%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:40638726",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2796",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q39.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5659C>C",
        "Protein Change":"p.Gln422Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009814%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83746578",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2797",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q83.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8094T>G",
        "Protein Change":"p.Arg98Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000781%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10866389",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2798",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q73.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6307C>C",
        "Protein Change":"p.Pro372Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007731%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44493348",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2799",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q82.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4869G>G",
        "Protein Change":"p.Gly173Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000735%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:92201713",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2800",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q99.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6971C>T",
        "Protein Change":"p.Arg406Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004012%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:32646316",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2801",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q58.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9076G>A",
        "Protein Change":"p.Leu434Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006714%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63535518",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2802",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"21q88.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3110C>C",
        "Protein Change":"p.Ser258Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005196%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:41784826",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2803",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q21.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7231A>T",
        "Protein Change":"p.Arg184Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006625%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36271961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2804",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q89.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8182T>C",
        "Protein Change":"p.Pro493Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002526%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:64562776",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2805",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"5q69.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3197G>G",
        "Protein Change":"p.Gln210Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0023%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:64461376",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2806",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"19q48.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9934T>G",
        "Protein Change":"p.Pro99Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009825%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:55163319",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2807",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q70.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2647C>A",
        "Protein Change":"p.Pro298Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000265%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:60575616",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2808",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"1q46.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3253C>T",
        "Protein Change":"p.Pro450Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00791%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29832930",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2809",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q91.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7776T>C",
        "Protein Change":"p.Arg37Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005625%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49674676",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2810",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q77.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.105A>C",
        "Protein Change":"p.Pro137Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000959%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33822025",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2811",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q37.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3624T>T",
        "Protein Change":"p.Gly146Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007047%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54551385",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2812",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q59.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2646C>A",
        "Protein Change":"p.Gln390Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000405%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41407883",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2813",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q51.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4924A>C",
        "Protein Change":"p.Ser306Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006815%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95732760",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2814",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q64.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5451T>T",
        "Protein Change":"p.Gly72Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000886%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25866362",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2815",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q35.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7482C>G",
        "Protein Change":"p.Gln112Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006445%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:93816234",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2816",
        "Gene Name":"TP53",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q38.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.536T>T",
        "Protein Change":"p.Pro62Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007477%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:37709117",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2817",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"16q6.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3861T>T",
        "Protein Change":"p.Pro172Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008923%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66700371",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2818",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q34.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5958T>T",
        "Protein Change":"p.Gly467Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005577%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11934437",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2819",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q2.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3429G>C",
        "Protein Change":"p.Leu438Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004858%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:23462393",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2820",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"14q55.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9294A>C",
        "Protein Change":"p.Ser401Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00102%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:97176411",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2821",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q71.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8137G>T",
        "Protein Change":"p.Arg242Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001587%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:79062416",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2822",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q21.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.544A>G",
        "Protein Change":"p.Pro242Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000869%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49525255",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2823",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"10q60.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3720G>T",
        "Protein Change":"p.Leu355Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001796%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:53332320",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2824",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q57.2",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8429G>C",
        "Protein Change":"p.Ser67Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000456%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45942907",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2825",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q86.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.742G>G",
        "Protein Change":"p.Gln431Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008779%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:72548554",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2826",
        "Gene Name":"BRCA2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q78.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9784G>T",
        "Protein Change":"p.Gly78Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009294%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:23835603",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2827",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q94.5",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.117A>A",
        "Protein Change":"p.Gln5Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007389%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29493525",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2828",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q81.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7645C>A",
        "Protein Change":"p.Ser398Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009617%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22299462",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2829",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"12q18.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7248C>G",
        "Protein Change":"p.Ser439Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004275%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:26933472",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2830",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"9q59.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8168T>C",
        "Protein Change":"p.Arg350Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001788%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12571326",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2831",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q43.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.227A>T",
        "Protein Change":"p.Ser262Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005445%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89519934",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2832",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q41.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7176A>A",
        "Protein Change":"p.Pro66Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002245%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:61226891",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2833",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q57.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4619T>T",
        "Protein Change":"p.Gly135Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007224%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:89853749",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2834",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q32.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7009T>T",
        "Protein Change":"p.Ser136Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003174%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:30932717",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2835",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"21q21.4",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8035T>C",
        "Protein Change":"p.Gly294Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00361%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12122758",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2836",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q18.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2017C>A",
        "Protein Change":"p.Gln254Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005207%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:87943928",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2837",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q35.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5092T>G",
        "Protein Change":"p.Arg439Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002167%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:30921939",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2838",
        "Gene Name":"BRCA2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q25.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1429A>C",
        "Protein Change":"p.Pro290Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004102%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:54154745",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2839",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q63.7",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7449G>C",
        "Protein Change":"p.Leu90Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00239%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:42098633",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2840",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"6q15.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3054C>G",
        "Protein Change":"p.Ser248Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006936%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:63058871",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2841",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q10.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9786T>C",
        "Protein Change":"p.Pro306Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00923%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:33100110",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2842",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"17q30.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.512T>G",
        "Protein Change":"p.Pro267Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000807%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10585442",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2843",
        "Gene Name":"BRCA2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"4q74.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.336C>C",
        "Protein Change":"p.Ser43Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000358%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89235403",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2844",
        "Gene Name":"PTEN",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"2q14.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4915A>T",
        "Protein Change":"p.Arg288Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001431%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:23375019",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2845",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q92.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6290A>A",
        "Protein Change":"p.Gly222Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007409%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:86937419",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2846",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"12q64.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7225T>T",
        "Protein Change":"p.Gly27Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005427%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:65608542",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2847",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"16q40.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7659C>C",
        "Protein Change":"p.Arg105Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000238%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91088656",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2848",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q16.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5676C>C",
        "Protein Change":"p.Pro22Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009734%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:51696829",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2849",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q10.9",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.453G>T",
        "Protein Change":"p.Gln45Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000172%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99207600",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2850",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q82.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4763T>A",
        "Protein Change":"p.Ser55Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000354%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:36778382",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2851",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q57.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7715C>G",
        "Protein Change":"p.Gly367Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003263%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85276043",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2852",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q18.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3488G>A",
        "Protein Change":"p.Gln448Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009699%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76320050",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2853",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q96.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1238G>G",
        "Protein Change":"p.Arg364Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00313%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:21047693",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2854",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"14q60.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1620G>A",
        "Protein Change":"p.Leu326Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006689%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66127052",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2855",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"1q93.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7688G>G",
        "Protein Change":"p.Gln179Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003978%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56908351",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2856",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q44.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7834T>T",
        "Protein Change":"p.Arg124Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003408%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:49306332",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2857",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q93.8",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1628G>C",
        "Protein Change":"p.Gly62Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003679%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70764029",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2858",
        "Gene Name":"ERBB2",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q1.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6868T>A",
        "Protein Change":"p.Gly165Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003406%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83801042",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2859",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"18q97.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5938T>C",
        "Protein Change":"p.Gln3Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002243%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:77292045",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2860",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q52.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.154C>T",
        "Protein Change":"p.Arg482Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002616%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:32111695",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2861",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q31.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4282T>G",
        "Protein Change":"p.Arg33Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004352%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94349574",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2862",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q20.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8917C>G",
        "Protein Change":"p.Pro488Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005018%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:22190132",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2863",
        "Gene Name":"AKT1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"9q39.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2931C>G",
        "Protein Change":"p.Ser256Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000175%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:54759053",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2864",
        "Gene Name":"GATA3",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"10q42.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1083T>T",
        "Protein Change":"p.Gln417Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009011%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13294464",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2865",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q85.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4013C>T",
        "Protein Change":"p.Gly191Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003546%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71660949",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2866",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q94.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6625G>G",
        "Protein Change":"p.Arg349Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007882%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:84003027",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2867",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q8.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4919G>A",
        "Protein Change":"p.Ser177Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001469%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89007141",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2868",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q96.2",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3818C>A",
        "Protein Change":"p.Gln435Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000499%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:62411442",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2869",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"6q20.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7055T>G",
        "Protein Change":"p.Arg193Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001079%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:56226994",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2870",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q32.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8278T>C",
        "Protein Change":"p.Leu441Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005631%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:49614166",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2871",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q10.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5483G>T",
        "Protein Change":"p.Gly429Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000895%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28724787",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2872",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"6q82.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.539T>C",
        "Protein Change":"p.Ser71Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006736%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92716271",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2873",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"4q90.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2452A>G",
        "Protein Change":"p.Arg231Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002487%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46736736",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2874",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q39.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2874G>A",
        "Protein Change":"p.Gln226Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008817%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:49808965",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2875",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q44.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8026G>T",
        "Protein Change":"p.Gln477Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003005%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:52154388",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2876",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"11q17.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.577T>C",
        "Protein Change":"p.Gln500Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008312%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:73988426",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2877",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q12.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9833G>G",
        "Protein Change":"p.Ser377Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005406%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:34564353",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2878",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"3q43.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.209C>C",
        "Protein Change":"p.Ser223Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004334%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:84344830",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2879",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q53.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4838A>T",
        "Protein Change":"p.Pro69Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008593%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:19402904",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2880",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"8q50.4",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2204C>G",
        "Protein Change":"p.Leu298Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002442%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74819562",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2881",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"4q68.6",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2438T>C",
        "Protein Change":"p.Arg394Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007289%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:83134234",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2882",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q44.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1216G>G",
        "Protein Change":"p.Arg467Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000681%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:55006566",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2883",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q97.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.180G>T",
        "Protein Change":"p.Gln366Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000758%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:87912740",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2884",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"19q61.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4331C>A",
        "Protein Change":"p.Pro459Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009597%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:94515015",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2885",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"7q26.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.195C>C",
        "Protein Change":"p.Leu460Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.008775%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:15522761",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2886",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"4q26.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1188A>A",
        "Protein Change":"p.Leu18Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004006%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94163423",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2887",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"10q11.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.500T>C",
        "Protein Change":"p.Arg257Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00882%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:11799388",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2888",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"11q32.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9556T>G",
        "Protein Change":"p.Gln209Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004865%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31532566",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2889",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"19q61.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8936G>A",
        "Protein Change":"p.Gln328Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004975%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69292738",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2890",
        "Gene Name":"ERBB2",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"11q42.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5307T>A",
        "Protein Change":"p.Leu150Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006889%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:74019788",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2891",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"1q77.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7452T>G",
        "Protein Change":"p.Gly112Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007116%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:20522778",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2892",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q8.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7564G>C",
        "Protein Change":"p.Arg237Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004262%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:32608073",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2893",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q69.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1116G>C",
        "Protein Change":"p.Ser482Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004371%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:90866616",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2894",
        "Gene Name":"BRCA1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"20q78.9",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7444G>A",
        "Protein Change":"p.Leu100Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007543%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:45777469",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2895",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"7q96.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7697G>A",
        "Protein Change":"p.Arg236Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009969%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70908835",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2896",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"2q61.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9895G>G",
        "Protein Change":"p.Pro27Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002681%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:39182416",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2897",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q45.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1350A>T",
        "Protein Change":"p.Pro243Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009398%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:88981201",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2898",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"3q6.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6968A>G",
        "Protein Change":"p.Ser159Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000821%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:46501598",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2899",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"18q7.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5339G>A",
        "Protein Change":"p.Ser280Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001879%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:33101436",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2900",
        "Gene Name":"TP53",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q88.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2876C>A",
        "Protein Change":"p.Arg334Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00184%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:99378434",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2901",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q61.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.5468A>A",
        "Protein Change":"p.Arg281Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00478%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66743221",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2902",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q18.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9876A>G",
        "Protein Change":"p.Arg234Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001812%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:75282731",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2903",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"20q77.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4538A>T",
        "Protein Change":"p.Gln241Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.0089%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47923271",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2904",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"13q70.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.4857G>C",
        "Protein Change":"p.Arg318Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005471%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:68113343",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2905",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"12q8.8",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9973C>C",
        "Protein Change":"p.Leu133Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006903%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:39910539",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2906",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"9q10.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1828T>C",
        "Protein Change":"p.Gln298Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004442%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:52854537",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2907",
        "Gene Name":"TP53",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q98.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6203A>G",
        "Protein Change":"p.Leu57Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002196%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:57480009",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2908",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q76.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1970A>T",
        "Protein Change":"p.Gly303Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005541%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:16827095",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2909",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q43.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9662T>C",
        "Protein Change":"p.Ser119Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.000196%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:28829995",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2910",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q96.9",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2860C>T",
        "Protein Change":"p.Leu473Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004419%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10624199",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2911",
        "Gene Name":"BRCA1",
        "Mutation Type":"Missense",
        "Chromosome Location":"22q93.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.2847T>G",
        "Protein Change":"p.Arg493Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007884%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:74267076",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2912",
        "Gene Name":"AKT1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q21.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6074C>C",
        "Protein Change":"p.Arg46Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009283%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:37850244",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2913",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q54.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9194T>A",
        "Protein Change":"p.Gly416Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005534%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:94691480",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2914",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"6q35.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3189G>G",
        "Protein Change":"p.Gly469Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009307%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:43613316",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2915",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"13q88.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.561T>A",
        "Protein Change":"p.Ser265Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007205%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:35365095",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2916",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q76.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.518A>T",
        "Protein Change":"p.Pro27Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006694%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:67728436",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2917",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"14q32.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7633C>T",
        "Protein Change":"p.Ser275Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003423%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:66134053",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2918",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"5q8.1",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.7435G>T",
        "Protein Change":"p.Leu295Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000307%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:81187269",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2919",
        "Gene Name":"AKT1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"10q92.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3692C>G",
        "Protein Change":"p.Leu99Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002239%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:66473752",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2920",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"16q4.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3772G>G",
        "Protein Change":"p.Gln134Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006834%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16185662",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2921",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q93.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7978A>C",
        "Protein Change":"p.Arg209Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004779%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13654487",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2922",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q40.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4040C>C",
        "Protein Change":"p.Gln34Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004073%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34084614",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2923",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"1q85.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.714C>C",
        "Protein Change":"p.Gly309Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002023%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46643452",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2924",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Missense",
        "Chromosome Location":"2q89.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2248A>T",
        "Protein Change":"p.Gln299Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008618%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:16163200",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2925",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"13q59.1",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.307T>G",
        "Protein Change":"p.Leu470Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001133%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:83943961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2926",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q23.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.776A>C",
        "Protein Change":"p.Gly90Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002874%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:59465815",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2927",
        "Gene Name":"ERBB2",
        "Mutation Type":"Missense",
        "Chromosome Location":"14q42.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9149T>G",
        "Protein Change":"p.Gln35Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00136%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:95897205",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2928",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"7q72.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8397A>C",
        "Protein Change":"p.Ser138Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008805%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45360735",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2929",
        "Gene Name":"PTEN",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q74.4",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6180A>C",
        "Protein Change":"p.Pro477Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005935%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85238839",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2930",
        "Gene Name":"PTEN",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q40.6",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7785T>T",
        "Protein Change":"p.Arg497Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008109%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:74988916",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2931",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q30.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2444A>T",
        "Protein Change":"p.Ser175Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002143%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:89740800",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2932",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q43.8",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.1389T>C",
        "Protein Change":"p.Leu383Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008479%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:44443996",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2933",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q65.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.1678A>C",
        "Protein Change":"p.Arg500Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002266%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:30896979",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2934",
        "Gene Name":"GATA3",
        "Mutation Type":"Insertion",
        "Chromosome Location":"18q64.6",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6508T>T",
        "Protein Change":"p.Pro86Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006648%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:12969907",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2935",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q4.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4451G>C",
        "Protein Change":"p.Ser297Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007271%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:56366272",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2936",
        "Gene Name":"GATA3",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"20q5.1",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.900T>G",
        "Protein Change":"p.Gly474Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006323%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:29409499",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2937",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"15q89.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4574A>C",
        "Protein Change":"p.Pro40Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.004855%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:13408695",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2938",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"12q4.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.6676T>T",
        "Protein Change":"p.Gly292Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002173%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:39040210",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2939",
        "Gene Name":"CDH1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"5q23.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9134C>A",
        "Protein Change":"p.Gly147Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007006%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66031461",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2940",
        "Gene Name":"BRCA2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q21.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7822C>T",
        "Protein Change":"p.Leu291Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002913%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:91755131",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2941",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"21q33.7",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8295A>G",
        "Protein Change":"p.Arg343Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006002%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:70871078",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2942",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q99.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9922T>G",
        "Protein Change":"p.Gln397Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009391%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:52997575",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2943",
        "Gene Name":"BRCA2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"5q1.8",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4436C>A",
        "Protein Change":"p.Arg269Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.001421%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:95309322",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2944",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"19q42.1",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.3137G>T",
        "Protein Change":"p.Leu170Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004369%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:25617888",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2945",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"16q13.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.944T>T",
        "Protein Change":"p.Ser379Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001894%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58508843",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2946",
        "Gene Name":"AKT1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"5q85.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7373C>A",
        "Protein Change":"p.Arg293Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004565%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:69970405",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2947",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q25.3",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7708G>T",
        "Protein Change":"p.Leu125Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.002172%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:14296285",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2948",
        "Gene Name":"GATA3",
        "Mutation Type":"Amplification",
        "Chromosome Location":"17q56.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9323T>C",
        "Protein Change":"p.Gln40Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002002%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:89666297",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2949",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"21q3.5",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7749T>C",
        "Protein Change":"p.Gln169Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004725%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12737214",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2950",
        "Gene Name":"AKT1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q57.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7960T>A",
        "Protein Change":"p.Arg5Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009062%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:48452935",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2951",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"16q33.3",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6333C>A",
        "Protein Change":"p.Leu98Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00748%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64701294",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2952",
        "Gene Name":"BRCA1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q85.1",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.4772T>G",
        "Protein Change":"p.Gly471Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003962%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:71134656",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2953",
        "Gene Name":"ERBB2",
        "Mutation Type":"Deletion",
        "Chromosome Location":"11q71.2",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3173T>C",
        "Protein Change":"p.Pro499Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009419%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:60377059",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2954",
        "Gene Name":"CDH1",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q43.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.3986T>T",
        "Protein Change":"p.Arg125Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002337%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:86271160",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2955",
        "Gene Name":"GATA3",
        "Mutation Type":"Deletion",
        "Chromosome Location":"5q77.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8393T>A",
        "Protein Change":"p.Arg126Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.00884%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46498205",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2956",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"20q51.8",
        "Clinical Significance":"Uncertain",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2455T>C",
        "Protein Change":"p.Leu422Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000771%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66696539",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2957",
        "Gene Name":"BRCA1",
        "Mutation Type":"Deletion",
        "Chromosome Location":"19q10.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.8553T>C",
        "Protein Change":"p.Arg17Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009202%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:41159555",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2958",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q49.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6151A>C",
        "Protein Change":"p.Leu438Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002579%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:85426020",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2959",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"22q44.2",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2230C>A",
        "Protein Change":"p.Gly114Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009162%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:58702792",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2960",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q16.7",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.2325A>G",
        "Protein Change":"p.Leu25Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009041%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:11638282",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2961",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"14q79.9",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.5495C>C",
        "Protein Change":"p.Ser339Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001902%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:81241480",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2962",
        "Gene Name":"BRCA1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"1q44.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9820T>G",
        "Protein Change":"p.Leu357Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.003082%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:47095375",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2963",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"10q53.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.6288A>C",
        "Protein Change":"p.Ser421Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008194%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:62063880",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2964",
        "Gene Name":"CDH1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q28.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7190A>G",
        "Protein Change":"p.Gly242Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008186%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:27887910",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2965",
        "Gene Name":"GATA3",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"11q35.3",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3659A>G",
        "Protein Change":"p.Pro34Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.007665%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:18160210",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2966",
        "Gene Name":"TP53",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"18q55.1",
        "Clinical Significance":"Uncertain",
        "Data Source":"TCGA",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.2155T>G",
        "Protein Change":"p.Pro489Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004081%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:19799043",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2967",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Insertion",
        "Chromosome Location":"7q65.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9370C>T",
        "Protein Change":"p.Leu15Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003082%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:66079847",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2968",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"12q44.5",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5439G>G",
        "Protein Change":"p.Ser383Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.001948%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:63557084",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2969",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"15q13.3",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6707T>G",
        "Protein Change":"p.Arg222Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008531%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:34193857",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2970",
        "Gene Name":"BRCA1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"2q94.9",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.6367A>C",
        "Protein Change":"p.Arg431Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.005884%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:76800381",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2971",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q6.4",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8989G>A",
        "Protein Change":"p.Leu254Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008404%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:61127743",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2972",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"18q26.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.1820A>C",
        "Protein Change":"p.Ser178Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004814%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:36404797",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2973",
        "Gene Name":"CDH1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"7q91.5",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.9756A>C",
        "Protein Change":"p.Gln431Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002624%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:10724223",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2974",
        "Gene Name":"PTEN",
        "Mutation Type":"Missense",
        "Chromosome Location":"12q99.7",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.952C>T",
        "Protein Change":"p.Gly280Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007585%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:17533599",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2975",
        "Gene Name":"AKT1",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"22q5.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9302C>T",
        "Protein Change":"p.Gly349Gly",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006546%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:72035140",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2976",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"6q91.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.5826G>A",
        "Protein Change":"p.Arg146Pro",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006112%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:11914562",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2977",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"21q71.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.7287C>A",
        "Protein Change":"p.Ser259Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.009721%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:47180692",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2978",
        "Gene Name":"GATA3",
        "Mutation Type":"Missense",
        "Chromosome Location":"1q27.6",
        "Clinical Significance":"Uncertain",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.415T>A",
        "Protein Change":"p.Gly331Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.006081%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:45798342",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3VD6",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2979",
        "Gene Name":"TP53",
        "Mutation Type":"Nonsense",
        "Chromosome Location":"1q32.6",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.3550G>G",
        "Protein Change":"p.Leu154Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006288%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31493421",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2980",
        "Gene Name":"BRCA2",
        "Mutation Type":"Missense",
        "Chromosome Location":"15q80.5",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.9092G>A",
        "Protein Change":"p.Arg273Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006749%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:59856081",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2981",
        "Gene Name":"CDH1",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"17q98.5",
        "Clinical Significance":"Benign",
        "Data Source":"COSMIC",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.396A>G",
        "Protein Change":"p.Gly149Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003288%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:92773257",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2982",
        "Gene Name":"PTEN",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"19q97.3",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.8146A>C",
        "Protein Change":"p.Pro11Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.00814%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:53535111",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2983",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"17q86.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9638A>G",
        "Protein Change":"p.Gln98Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002355%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:82318186",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2984",
        "Gene Name":"AKT1",
        "Mutation Type":"Missense",
        "Chromosome Location":"4q84.9",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8337T>A",
        "Protein Change":"p.Ser464Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003854%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44696030",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:3O96",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2985",
        "Gene Name":"ERBB2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"2q59.8",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.8047G>T",
        "Protein Change":"p.Ser319Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009229%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:27577541",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2986",
        "Gene Name":"ERBB2",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"7q12.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.4083G>C",
        "Protein Change":"p.Arg243Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.000183%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:82934781",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2987",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q38.6",
        "Clinical Significance":"Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.7334A>C",
        "Protein Change":"p.Gln30Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004034%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:76932845",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2988",
        "Gene Name":"BRCA2",
        "Mutation Type":"Insertion",
        "Chromosome Location":"14q67.5",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.7212T>G",
        "Protein Change":"p.Gln318Leu",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.007352%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:71193961",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1MIU",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2989",
        "Gene Name":"TP53",
        "Mutation Type":"Insertion",
        "Chromosome Location":"17q79.7",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.1483C>C",
        "Protein Change":"p.Gly219Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009287%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:13598337",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2990",
        "Gene Name":"BRCA1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"4q49.4",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.5800C>T",
        "Protein Change":"p.Gly495Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008822%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:44111047",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1T15",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2991",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"16q1.9",
        "Clinical Significance":"Benign",
        "Data Source":"ClinVar",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.8989G>G",
        "Protein Change":"p.Ser328Gln",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006927%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:51895805",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2992",
        "Gene Name":"TP53",
        "Mutation Type":"Deletion",
        "Chromosome Location":"2q57.7",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Luminal A",
        "Nucleotide Change":"c.6638C>C",
        "Protein Change":"p.Ser20Arg",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004423%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Pancreatic cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:12418565",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:2OCJ",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2993",
        "Gene Name":"PTEN",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"13q97.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Responds to Trastuzumab",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.823G>C",
        "Protein Change":"p.Gln302Gly",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.002249%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"None",
        "Mutation Pathway":"Cell Cycle Regulation",
        "References":"PMID:84773165",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2994",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Amplification",
        "Chromosome Location":"3q80.2",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Sensitive to PI3K inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.2534G>G",
        "Protein Change":"p.Gly73Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.006817%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Leukemia",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:31186248",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2995",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Amplification",
        "Chromosome Location":"16q72.1",
        "Clinical Significance":"Oncogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.9979G>T",
        "Protein Change":"p.Pro483Arg",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.008616%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"None",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:83524149",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2996",
        "Gene Name":"PTEN",
        "Mutation Type":"Insertion",
        "Chromosome Location":"9q48.4",
        "Clinical Significance":"Benign",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.9110C>A",
        "Protein Change":"p.Pro325Gln",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.004481%",
        "Mutation Consequence":"Protein truncation",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:46501817",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"Yes, PARP inhibitors",
        "3D Structure Link":"PDB:1D5R",
        "Expression Level":"Low Expression"
    },
    {
        "Mutation ID":"MUT2997",
        "Gene Name":"CDH1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"2q42.2",
        "Clinical Significance":"Oncogenic",
        "Data Source":"COSMIC",
        "Treatment Response":"Resistant to PARP inhibitors",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4922A>G",
        "Protein Change":"p.Arg223Ser",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.0008%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:64908802",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Neutral",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:4ZTE",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT2998",
        "Gene Name":"PIK3CA",
        "Mutation Type":"Frameshift",
        "Chromosome Location":"15q46.2",
        "Clinical Significance":"Pathogenic",
        "Data Source":"ClinVar",
        "Treatment Response":"Loss of adhesion, high invasion potential",
        "Related Cancer Subtype":"Luminal B",
        "Nucleotide Change":"c.250T>A",
        "Protein Change":"p.Arg79Pro",
        "Functional Impact":"Loss of Function",
        "Population Frequency":"0.003011%",
        "Mutation Consequence":"Increased oncogenic activity",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:44609088",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"Yes, PI3K inhibitors",
        "3D Structure Link":"PDB:4JPS",
        "Expression Level":"Moderate Expression"
    },
    {
        "Mutation ID":"MUT2999",
        "Gene Name":"MAP3K1",
        "Mutation Type":"Splice Site",
        "Chromosome Location":"9q60.3",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"HER2+",
        "Nucleotide Change":"c.4347C>G",
        "Protein Change":"p.Gly239Ser",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.009539%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"DNA Repair Pathway",
        "References":"PMID:70810593",
        "Mutation Hotspot":"Yes",
        "Mutation Stability":"Decreased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:5V8K",
        "Expression Level":"High Expression"
    },
    {
        "Mutation ID":"MUT3000",
        "Gene Name":"ERBB2",
        "Mutation Type":"Amplification",
        "Chromosome Location":"22q47.6",
        "Clinical Significance":"Likely Pathogenic",
        "Data Source":"TCGA",
        "Treatment Response":"Poor response to chemotherapy",
        "Related Cancer Subtype":"Basal-like",
        "Nucleotide Change":"c.3051A>T",
        "Protein Change":"p.Gly243Leu",
        "Functional Impact":"Gain of Function",
        "Population Frequency":"0.005958%",
        "Mutation Consequence":"Frameshift causing premature stop codon",
        "Associated Diseases":"Ovarian cancer",
        "Mutation Pathway":"PI3K-AKT Pathway",
        "References":"PMID:94269012",
        "Mutation Hotspot":"No",
        "Mutation Stability":"Increased Stability",
        "Drug Targetability":"No known drugs",
        "3D Structure Link":"PDB:3PP0",
        "Expression Level":"Low Expression"
    }
]